
<html lang="en"     class="pb-page"  data-request-id="33739793-6fd8-4442-a957-ddd744606268"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-24;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.7b01192;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii" /></meta><meta name="dc.Creator" content="Florentine U.  Rutaganira" /></meta><meta name="dc.Creator" content="Jennifer  Barks" /></meta><meta name="dc.Creator" content="Mary Savari  Dhason" /></meta><meta name="dc.Creator" content="Qiuling  Wang" /></meta><meta name="dc.Creator" content="Michael S.  Lopez" /></meta><meta name="dc.Creator" content="Shaojun  Long" /></meta><meta name="dc.Creator" content="Joshua B.  Radke" /></meta><meta name="dc.Creator" content="Nathaniel G.  Jones" /></meta><meta name="dc.Creator" content="Amarendar R.  Maddirala" /></meta><meta name="dc.Creator" content="James W.  Janetka" /></meta><meta name="dc.Creator" content="Majida  El Bakkouri" /></meta><meta name="dc.Creator" content="Raymond  Hui" /></meta><meta name="dc.Creator" content="Kevan M.  Shokat" /></meta><meta name="dc.Creator" content="L. David  Sibley" /></meta><meta name="dc.Description" content="Calcium dependent protein kinase 1 (CDPK1) is an essential enzyme in the opportunistic pathogen Toxoplasma gondii. CDPK1 controls multiple processes that are critical to the intracellular replicati..." /></meta><meta name="Description" content="Calcium dependent protein kinase 1 (CDPK1) is an essential enzyme in the opportunistic pathogen Toxoplasma gondii. CDPK1 controls multiple processes that are critical to the intracellular replicati..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 9, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01192" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01192" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01192" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01192" /></link>
        
    
    

<title>Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01192" /></meta><meta property="og:title" content="Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0009.jpeg" /></meta><meta property="og:description" content="Calcium dependent protein kinase 1 (CDPK1) is an essential enzyme in the opportunistic pathogen Toxoplasma gondii. CDPK1 controls multiple processes that are critical to the intracellular replicative cycle of T. gondii including secretion of adhesins, motility, invasion, and egress. Remarkably, CDPK1 contains a small glycine gatekeeper residue in the ATP binding pocket making it sensitive to ATP-competitive inhibitors with bulky substituents that complement this expanded binding pocket. Here we explored structure–activity relationships of a series of pyrazolopyrimidine inhibitors of CDPK1 with the goal of increasing selectivity over host enzymes, improving antiparasite potency, and improving metabolic stability. The resulting lead compound 24 exhibited excellent enzyme inhibition and selectivity for CDPK1 and potently inhibited parasite growth in vitro. Compound 24 was also effective at treating acute toxoplasmosis in the mouse, reducing dissemination to the central nervous system, and decreasing reactivation of chronic infection in severely immunocompromised mice. These findings provide proof of concept for the development of small molecule inhibitors of CDPK1 for treatment of CNS toxoplasmosis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01192"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01192">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01192&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01192&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01192&amp;href=/doi/10.1021/acs.jmedchem.7b01192" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 9976-9989</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01663" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Featured Article</span><a href="/doi/10.1021/acs.jmedchem.7b00275" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by <i>Toxoplasma gondii</i></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florentine+U.++Rutaganira">Florentine U. Rutaganira</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Barks">Jennifer Barks</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Savari++Dhason">Mary Savari Dhason</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qiuling++Wang">Qiuling Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+S.++Lopez">Michael S. Lopez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shaojun++Long">Shaojun Long</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joshua+B.++Radke">Joshua B. Radke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nathaniel+G.++Jones">Nathaniel G. Jones</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amarendar+R.++Maddirala">Amarendar R. Maddirala</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+W.++Janetka">James W. Janetka</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Majida++El+Bakkouri">Majida El Bakkouri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raymond++Hui">Raymond Hui</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevan+M.++Shokat">Kevan M. Shokat</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6900-8380" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=L.+David++Sibley">L. David Sibley</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-7110-0285" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Howard Hughes Medical Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94158, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63130, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63130, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Structural Genomics Consortium, University of Toronto, MaRS South Tower, 101 College St, Toronto, ON M5G 1L7, Canada</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Toronto General Hospital Research Institute, 200 Elizabeth St., Toronto, ON M5G 2C4, Canada</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#80f3e9e2ece5f9c0f7f5f3f4ecaee5e4f5"><span class="__cf_email__" data-cfemail="6c1f050e0009152c1b191f180042090819">[email protected]</span></a>. Phone: 314-362-8873.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01192&amp;href=/doi/10.1021%2Facs.jmedchem.7b01192" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 9976–9989</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 21, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 August 2017</li><li><span class="item_label"><b>Published</b> online</span>9 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 December 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01192" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01192</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9976%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFlorentine%2BU.%2BRutaganira%252C%2BJennifer%2BBarks%252C%2BMary%2BSavari%2BDhason%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D24%26contentID%3Dacs.jmedchem.7b01192%26title%3DInhibition%2Bof%2BCalcium%2BDependent%2BProtein%2BKinase%2B1%2B%2528CDPK1%2529%2Bby%2BPyrazolopyrimidine%2BAnalogs%2BDecreases%2BEstablishment%2Band%2BReoccurrence%2Bof%2BCentral%2BNervous%2BSystem%2BDisease%2Bby%2BToxoplasma%2Bgondii%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9989%26publicationDate%3DDecember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01192"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2669</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">38</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01192" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Florentine&quot;,&quot;last_name&quot;:&quot;U. Rutaganira&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Barks&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Savari Dhason&quot;},{&quot;first_name&quot;:&quot;Qiuling&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;S. Lopez&quot;},{&quot;first_name&quot;:&quot;Shaojun&quot;,&quot;last_name&quot;:&quot;Long&quot;},{&quot;first_name&quot;:&quot;Joshua&quot;,&quot;last_name&quot;:&quot;B. Radke&quot;},{&quot;first_name&quot;:&quot;Nathaniel&quot;,&quot;last_name&quot;:&quot;G. Jones&quot;},{&quot;first_name&quot;:&quot;Amarendar&quot;,&quot;last_name&quot;:&quot;R. Maddirala&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;W. Janetka&quot;},{&quot;first_name&quot;:&quot;Majida&quot;,&quot;last_name&quot;:&quot;El Bakkouri&quot;},{&quot;first_name&quot;:&quot;Raymond&quot;,&quot;last_name&quot;:&quot;Hui&quot;},{&quot;first_name&quot;:&quot;Kevan&quot;,&quot;last_name&quot;:&quot;M. Shokat&quot;},{&quot;first_name&quot;:&quot;L.&quot;,&quot;last_name&quot;:&quot;David Sibley&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;9976-9989&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01192&quot;},&quot;abstract&quot;:&quot;Calcium dependent protein kinase 1 (CDPK1) is an essential enzyme in the opportunistic pathogen Toxoplasma gondii. CDPK1 controls multiple processes that are critical to the intracellular replicative cycle of T. gondii including secretion of adhesins, motility, invasion, and egress. Remarkably, CDPK1 contains a small glycine gatekeeper residue in the ATP binding pocket making it sensitive to ATP-competitive inhibitors with bulky substituents that complement this expanded binding pocket. Here we explored structure–activity relationships of a series of pyrazolopyrimidine inhibitors of CDPK1 with the goal of increasing selectivity over host enzymes, improving antiparasite potency, and improving metabolic stability. The resulting lead compound 24 exhibited excellent enzyme inhibition and selectivity for CDPK1 and potently inhibited parasite growth in vitro. Compound 24 was also effective at treating acute toxoplasmosis in the mouse, reducing dissemination to the central nervous system, and decreasing reactivation&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01192&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01192" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01192&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01192" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01192&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01192" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01192&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01192&amp;href=/doi/10.1021/acs.jmedchem.7b01192" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01192" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01192" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01192%26sid%3Dliteratum%253Aachs%26pmid%3D28933846%26genre%3Darticle%26aulast%3DRutaganira%26date%3D2017%26atitle%3DInhibition%2Bof%2BCalcium%2BDependent%2BProtein%2BKinase%2B1%2B%2528CDPK1%2529%2Bby%2BPyrazolopyrimidine%2BAnalogs%2BDecreases%2BEstablishment%2Band%2BReoccurrence%2Bof%2BCentral%2BNervous%2BSystem%2BDisease%2Bby%2BToxoplasma%2Bgondii%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D24%26spage%3D9976%26epage%3D9989%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/jmcmar.2017.60.issue-24/20171228/jmcmar.2017.60.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Calcium dependent protein kinase 1 (CDPK1) is an essential enzyme in the opportunistic pathogen <i>Toxoplasma gondii</i>. CDPK1 controls multiple processes that are critical to the intracellular replicative cycle of <i>T. gondii</i> including secretion of adhesins, motility, invasion, and egress. Remarkably, CDPK1 contains a small glycine gatekeeper residue in the ATP binding pocket making it sensitive to ATP-competitive inhibitors with bulky substituents that complement this expanded binding pocket. Here we explored structure–activity relationships of a series of pyrazolopyrimidine inhibitors of CDPK1 with the goal of increasing selectivity over host enzymes, improving antiparasite potency, and improving metabolic stability. The resulting lead compound <b>24</b> exhibited excellent enzyme inhibition and selectivity for CDPK1 and potently inhibited parasite growth in vitro. Compound <b>24</b> was also effective at treating acute toxoplasmosis in the mouse, reducing dissemination to the central nervous system, and decreasing reactivation of chronic infection in severely immunocompromised mice. These findings provide proof of concept for the development of small molecule inhibitors of CDPK1 for treatment of CNS toxoplasmosis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15373" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15373" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><i>Toxoplasma gondii</i> is a widespread protozoan parasite of animals that causes zoonotic infections in humans. Although most human cases are well controlled, infection in immunocompromised patients leads to serious sequelae, including toxoplasmic encephalitis and pneumonia, which are life-threatening if not treated.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Although the advent of HAART therapy has reduced the frequency of toxoplasmosis as an opportunistic pathogen in developed countries, it is still a serious complication in many parts of the world where patients do not have adequate access to testing or treatment for HIV infection.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5">(2-5)</a> Additionally, toxoplasmosis can cause serious problems in organ transplant and cancer chemotherapy patients due to their immunocompromised status.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Furthermore, toxoplasmosis is a recognized cause of severe ocular disease in healthy adults in some locations such as Brazil.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Current therapy for toxoplasmosis is based on combination of pyrimethamine, which blocks dihydrofolate reductase (DHFR), and sulfadiazine, a folate antagonist. Collectively these drugs disrupt replication by inhibiting nucleic acid synthesis. This drug combination is efficacious in treating acute infection through blocking replication of tachyzoites. Unfortunately pyrimethamine is associated with several adverse side effects including anemia due to bone marrow suppression,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and many patients experience allergic reactions to sulfonamide drugs.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Chronic infections caused by <i>T. gondii</i> are typified by slow growing bradyzoites that reside within thick-walled tissue cysts.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The emergence of bradyzoites upon cyst rupture is thought to give rise to daughter cysts that sustain the chronic infection and contribute to recurrence of actively replicating tachyzoites when the parasite reverts to the lytic form. Hence, treatments that could block re-emergence from the tissue cyst or block invasion of host cells by bradyzoites could interrupt this cycle and eliminate chronic infection. Unfortunately, current therapies that inhibit DHFR and antagonize the folate pathway are not effective at clearing chronic infection, as evidenced by the high relapse in immunocompromised patients when therapy is discontinued,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> presumably due to the slow and sporadic replication of bradyzoites.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">One of the key steps in defining new leads for therapeutic intervention is to identify essential pathways that can be targeted by small molecules. One potential new target that fulfills these criteria is calcium dependent protein kinase 1 (CDPK1) in <i>T. gondii</i>.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Genetic depletion or chemical inhibition of CDPK1 blocks adhesion secretion and compromises motility, cell invasion, and egress,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> thus demonstrating the essentiality of this target. The X-ray crystal structure of CDPK1 also revealed an unusual feature in the ATP-binding pocket where a glycine residue occupies the gatekeeper position where there is normally a larger hydrophobic residue.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> The presence of G gatekeeper is entirely unprecedented in human kinases,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and CDPK1 is the only kinase in <i>T. gondii</i> with this unusual feature.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> As a consequence, CDPK1 is exquisitely sensitive to bulky ATP competitive inhibitors such as pyrazolopyrimidines (PP), which mimic the nucleotide binding interactions with the hinge region within the ATP-binding pocket and project bulky substituents into the expanded hydrophobic pocket created by the G gatekeeper.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> These features have been exploited to develop PP analogs that are potent inhibitors of CDPK1 in <i>T. gondii</i>,<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> and the most promising of these compounds show good efficacy in mouse models of toxoplasmosis.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a></div><div class="NLM_p last">Our prior studies involving derivatives with substituents (R<sub>1</sub>) to the C3 position of the pyrazolopyrimidine (PP) core revealed the importance of the methylene linkage at C3 to confer flexibility of R<sub>1</sub> substituent binding.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> However, compounds with the methylene linkage overall were not stable in the presence of rat liver microsomes, potentially due to the methylene bridge being subject to cytochrome P450 metabolism. To address these deficiencies, we have more fully explored the design and synthesis of different heteroatom linkages at the C3 position and expanded the diversity of substituents at the R<sub>2</sub> position. Collectively, these rationally driven modifications have identified new TgCDPK1 inhibitors with excellent potency in addition to improved selectivity, metabolic stability, and in vivo efficacy in controlling toxoplasmosis in the mouse.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design and Synthesis of New PP Analogs Targeting CDPK1</h3><div class="NLM_p">To identify compounds with improved metabolic stability that would also exploit structural differences between CDPK1 and human Src (hSrc) active sites, we designed and synthesized a compound library containing varied functional groups at R<sub>1</sub> attached to the C3 position of the PP core (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). These were either linked to the core pyrazolopyrimidine or pyrrolopyrimidine scaffold via methylene or heteroatom linkages (X) in combination with <i>t-</i>butyl or various R<sub>2</sub> groups at the N1 position (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The hSrc kinase was chosen for initial counter-screening because it contains a threonine (T) gatekeeper residue that represents one of the smallest amino acids found in native human kinases.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> All compounds were synthesized using previously described methods to form the pyrazolopyrimidine scaffold or with advanced pyrrolopyrimidine intermediates.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Methods to generate compounds with methylene linkage at C3 have been previously reported,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and heteroatom linkages were incorporated using established aryl coupling chemistry<a onclick="showRef(event, 'ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30">(27-30)</a> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Detailed procedures for chemical synthesis and compound characterization are presented in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_001.pdf" class="ext-link">Supporting Information</a>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) R<sub>1</sub>OH, copper iodide, <i>N</i>,<i>N</i>-dimethylglycine, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 120 °C, 18 h; (ii) R<sub>1</sub>NH<sub>2</sub>, BrettPhosPd G3, KOtBu, dioxane, 90 °C, 18 h; (iii) R<sub>1</sub>SH, copper iodide, ethylene glycol, 2-propanol, K<sub>2</sub>CO<sub>3</sub>, 130 °C, 1 h. Positions on the PP scaffold are labeled numerically in blue italics.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Analysis of New PP Analogs Modified at the R<sub>1</sub> Position</h3><div class="NLM_p">To develop a structure–activity relationship (SAR) profile, we investigated the effects of modifying the R<sub>1</sub> group and different linkers to the core scaffold at position C3 in a series of compounds that contained <i>tertiary</i> butyl at the N1 position (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). We tested compounds for their potency against CDPK1 in vitro, using an ELISA assay for phosphorylated substrate, described previously.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In parallel, we tested the inhibitors for their ability to inhibit parasite growth in vitro using a β-Gal expressing line of <i>T. gondii</i> to determine EC<sub>50</sub> values, as described previously.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Finally, we screened each analog for stability in vitro in the presence of rat liver microsomes, as a surrogate for estimating in vivo metabolic stability.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure–activity profile of initial CDPK1 inhibitor series. (A) Structures of initial CDPK1 inhibitors highlighting modifications at R<sub>1</sub> and heteroatom linkages of R<sub>1</sub> to the pyrazolopyrimidine core are shown in tabular form with associated biochemical inhibition (IC<sub>50</sub>) of CDPK1, inhibition of parasite growth (EC<sub>50</sub>), off-target biochemical inhibition (IC<sub>50</sub>) of Src, metabolic stability in rat microsomes (half-life in minutes), and calculated clogP values. IC<sub>50</sub> and EC<sub>50</sub> values are the average of 2 or more biological replicates. (B) Compound <b>1</b> binds within the CDPK1 active site forming hydrogen bonds (black dashes) to the CDPK1 hinge and extends its R<sub>1</sub> substituent into the CDPK1 hydrophobic pocket. Amino acids in close proximity to compound <b>1</b> are labeled as well as the glycine gatekeeper (green). The orange map shows the 2<i>F</i><sub>0</sub> – <i>F</i><sub>c</sub> simulated annealing map of compound <b>1</b> contoured at 1σ. (C) An overlay of compounds <b>1</b>, <b>2</b>, <b>3</b>, and <b>4</b> shows similar binding poses for inhibitors possessing heteroatom linkages. Interacting residues are labeled as well as methionine 112 (yellow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Starting with parent compound <b>1,</b> replacement of the C3 methylene linker with an ether, thioether, or amine linkage improved metabolic stability for ether and amine linkages (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). This result confirms XenoSite in silico predictions of metabolism at the methylene as in compound <b>1</b>, which is less likely with ether and amine linkages as in compounds <b>2</b> and <b>4</b> but is still possible with thioether linkages as in <b>3</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_001.pdf" class="ext-link">Supplementary Figure S1</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The thioether linkage was also associated with substantial loss of activity in the parasite inhibition assay (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). We also observed increased metabolic stability of the ether linkage over methylene for another compound set consisting of compounds <b>5</b> and <b>6</b>. Analogs bearing halogen substitutions were generally more stable, especially in the presence of the ether linkage. The addition of some <i>meta</i> substituents on the benzyl ring was associated with loss of metabolic stability, despite having an ether linkage, for example, addition of the methoxy group in compound <b>9</b> and the methyl group for compound <b>10</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). Since the ether linkage generally improved metabolic stability while maintaining efficacy against parasite replication, we selected ether linkages for further optimization.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Structural Interactions between PP Compounds and CDPK1</h3><div class="NLM_p last">To better understand the binding interactions of PP analogs and the CDPK1 enzyme, we solved a series of high-resolution cocrystal X-ray structures, using previously described methods.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The cocrystal structure of CDPK1 with the lead compound <b>1</b> revealed a characteristic hydrogen-bonding (H-bonding) pattern of interaction between the aminopyridine and the kinase hinge. More specifically, the primary amine at C4 of the PP core acts as a H-bond donor in an interaction with the backbone carbonyl of glutamate 129, and the N5 in the PP core acts as a H-bond acceptor in an interaction with the backbone amide of tyrosine 131 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B). Importantly, the cocrystal structures of compounds <b>1–4</b> bound to CDPK1 show that these modifications do not substantially change the binding conformations (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C). Key H-bonding interactions between the PP core and the hinge region are maintained with R<sub>1</sub> occupying the hydrophobic pocket formed by the presence of the small G gatekeeper residue (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Analysis of New PP Analogs Modified at the R<sub>2</sub> Position</h3><div class="NLM_p">Previous studies of PP analogs have shown that larger substituents are tolerated at the R<sub>2</sub> position and can lead to gain of potency and selectivity for CDPK1.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> To explore the size tolerance within the CDPK1 pocket at this region, we generated a series of analogs with cyclic amines at R<sub>2</sub> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). Structural studies have shown that methylpiperidine in the R<sub>2</sub> is positioned to form a H-bond with glutamate 135 in the ribose binding region of the ATP pocket of CDPK1.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> A cocrystal structure of compound <b>13</b> confirmed that this interaction is also present in the series studied here (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). The piperidine is predicted to be protonated under physiological conditions, and as shown in the cocrystal structure, the additional H likely forms a salt bridge with glutamine 135 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). We explored a series of cyclic amines based on piperidine where we elucidated the importance of proper placement and direction of the amine to form the favorable charge–charge salt bridge interaction with E135. We found that any deviation from the piperidine of <b>13</b> in this series abrogated CDPK1 activity and decreased inhibition of parasite replication in culture (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). Compounds <b>16</b> and <b>15</b>, which contain a tetrahydropyran and pyridine group, respectively, each significantly lost potency, emphasizing the key contribution of the H-bond donor of the piperidine (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). On the other hand, all cyclic amines showed greatly enhanced stability in the rat liver microsome assay thus providing much support for further R<sub>2</sub> modification as an approach to improving metabolic stability (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Exploration of R<sub>2</sub> with ether linked substituent. (A) Structures of CDPK1 inhibitors highlighting modifications at R<sub>2</sub> with <i>meta</i> chloro and ether linkage to the pyrazolopyrimidine core are shown in tabular form with associated biochemical inhibition (IC<sub>50</sub>) of CDPK1, inhibition of parasite growth (EC<sub>50</sub>), off-target biochemical inhibition (IC<sub>50</sub>) of Src, metabolic stability in rat microsomes (half-life in minutes), and calculated clogP values. IC<sub>50</sub> and EC<sub>50</sub> values are the average of 2 or more biological replicates. (B) Compound <b>13</b> binds within the CDPK1 active site maintaining hinge binding to the CDPK1 hinge and forms an additional hydrogen bond with E135 within the CDPK1 ribose binding region.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In another series, we explored the combination of methylpiperidine at R<sub>2</sub> together with the prior functional groups at R<sub>1</sub> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Consistent with findings above, the methylpiperidine containing analogs generally showed improved metabolic stability in comparison to their <i>t-</i>butyl counterparts (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). For example, the presence of the methylpiperidine in compound <b>17</b> could impart stability despite having a methylene linkage to C3 of the PP core (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Compounds with additional halogens in the benzyl ring at R<sub>1</sub> gained further increases in microsome stability (e.g., <b>21</b> and <b>22</b>) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Furthermore, there were no significant differences between pyrazolopyrimidine and pyrrolopyrimidine as the core scaffold as demonstrated by compounds <b>18</b> vs <b>23</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Exploration of methylpiperidine at R<sub>2</sub> for enhanced metabolic stability. (A) Structures of CDPK1 inhibitors highlighting modifications at R<sub>1</sub> with methylpiperidine at R<sub>2</sub> of a pyrazolopyrimidine core are shown in the top section, while modification of one compound to contain a pyrrolopyrimidine core is shown between the dotted lines. Structures of CDPK1 inhibitors highlighting modifications at R<sub>2</sub> on a pyrazolopyrimidine core that were generated in attempts to reduce cellular efflux are shown in the bottom section of the table. Biochemical inhibition (IC<sub>50</sub>) of CDPK1, inhibition of parasite growth (EC<sub>50</sub>), off-target biochemical inhibition (IC<sub>50</sub>) of Src, metabolic stability in rat microsomes (half-life in minutes), and calculated clogP values. IC<sub>50</sub> and EC<sub>50</sub> values are the average of 2 or more biological replicates assays. (B) Homology model of compound <b>24</b> based on the cocrystal structure of compound <b>13</b> and CDPK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite the reproducible ability of methylpiperidine to improve microsome stability throughout the entire series, this modification also resulted in reduced biochemical potency and ability to block parasite replication. Hence, incorporation of methylpiperidine at R<sub>2</sub> results in a trade-off between improved metabolic stability and loss in potency. This effect may be explained by the larger size of these inhibitors, which may not be as easily accommodated in the CDPK binding pocket. The combination of ether linked R<sub>1</sub> as <i>m</i>-Cl with R<sub>2</sub> piperidine as in compound <b>13</b> showed the largest improvement over parent compound <b>1</b>, while retaining reasonable activity in both inhibition of CDPK1 and parasite growth (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). In contrast, methylation of the piperidine nitrogen in compound <b>25</b> led to a loss in potency, further highlighting the importance of the H-bonding ability of the protonated amine (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Converting the piperidine to a 6-membered ring δ-lactam in compound <b>26</b> also lead to a loss in enzyme potency and a complete loss in antiparasitic activity (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). We also explored modifying the piperidine by addition of difluorine (di-F), as such modifications are known to favorably affect the properties of drug-like molecules.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The di-F modification in compound <b>24</b> vs <b>13</b>, which both have ether-linked R<sub>1</sub> substitutions to the PP core, slightly improved enzyme inhibition and antiparasitic activity (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). A homology model of <b>24</b>, based on the cocrystal structure of compound <b>13</b> with CDPK1, suggests that the piperidine amine is still in an appropriate position to interact with E135 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). We also made a similar modification of di-F in the piperidine of compound <b>18</b> to generate the compound <b>28</b>, both of which have a thioether linkage connecting R<sub>1</sub> to C3 in the PP core. Surprisingly in this case, the di-F modification reduced enzyme activity and greatly diminished antiparasitic activity. Modification of R<sub>2</sub> to contain a trifluormethylcyclopropyl moiety was also synthesized in an attempt to reduce metabolic instability, based on a previous study showing this modification can improve stability of biaryl compounds relative to those containing <i>t</i>-butyl.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> This compound <b>27</b> lost potency (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), suggesting it does not optimally fit in the CDPK1 ATP binding pocket; moreover it did not improve stability, perhaps due to the methylene linkage of the trifluormethylcyclopropyl moiety to N1 of the core.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Physical Parameters, Metabolic Stability, Efflux, And Toxicity of Select Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center" char=".">ClogP<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">tPSA</th><th class="colsep0 rowsep0" align="center" char=".">p<i>K</i><sub>a</sub></th><th class="colsep0 rowsep0" align="center" char=".">protein binding (%)</th><th class="colsep0 rowsep0" align="center" char="."><i>P</i><sub>app</sub> 10<sup>–6</sup> cs/s A to B<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>P</i><sub>app</sub> 10<sup>–6</sup> cs/s B to A<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">efflux ratio<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">microsomes<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a> CL<sub>int</sub><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a> mL/(min·mg)</th><th class="colsep0 rowsep0" align="center" char=".">cell toxicity<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a> (mM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">3.15</td><td class="colsep0 rowsep0" align="char" char=".">66.34</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">99.2</td><td class="colsep0 rowsep0" align="char" char=".">42.9</td><td class="colsep0 rowsep0" align="char" char=".">28.7</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">0.452</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">3.48</td><td class="colsep0 rowsep0" align="char" char=".">75.57</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">99.8</td><td class="colsep0 rowsep0" align="char" char=".">34.8</td><td class="colsep0 rowsep0" align="char" char=".">30.6</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">0.281</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">3.41</td><td class="colsep0 rowsep0" align="char" char=".">75.57</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">98.4</td><td class="colsep0 rowsep0" align="char" char=".">15.0</td><td class="colsep0 rowsep0" align="char" char=".">14.6</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1.240</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">2.57</td><td class="colsep0 rowsep0" align="char" char=".">87.6</td><td class="colsep0 rowsep0" align="char" char=".">10.4</td><td class="colsep0 rowsep0" align="char" char=".">73.5</td><td class="colsep0 rowsep0" align="char" char=".">1.07</td><td class="colsep0 rowsep0" align="char" char=".">9.58</td><td class="colsep0 rowsep0" align="char" char=".">8.9</td><td class="colsep0 rowsep0" align="char" char=".">0.019</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">87.6</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">88.3</td><td class="colsep0 rowsep0" align="char" char=".">22.8</td><td class="colsep0 rowsep0" align="char" char=".">21.2</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">0.694</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">3.25</td><td class="colsep0 rowsep0" align="char" char=".">78.37</td><td class="colsep0 rowsep0" align="char" char=".">10.4</td><td class="colsep0 rowsep0" align="char" char=".">87.5</td><td class="colsep0 rowsep0" align="char" char=".">2.76</td><td class="colsep0 rowsep0" align="char" char=".">25.6</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">0.072</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">3.57</td><td class="colsep0 rowsep0" align="char" char=".">78.37</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">91.8</td><td class="colsep0 rowsep0" align="char" char=".">27.1</td><td class="colsep0 rowsep0" align="char" char=".">25.3</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">0.887</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Determined in Chemdraw Ultra 12.0, PerkinElmer Informatics.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Apparent permeability (Papp), apical to basolateral (A-B).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Apparent permeability (Papp) basolateral to apical (B-A).</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Papp (B to A)/Papp (A to B).</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">CI<sub>Iint</sub> = k/P, where k is the elimination rate constant and P is the protein concentration in the assay</p></div><div class="footnote" id="t1fn6"><sup>f</sup><p class="last">Mouse liver microsomes</p></div><div class="footnote" id="t1fn7"><sup>g</sup><p class="last">Inhibition of replication of human HFF cells</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Inhibition of CDPK1 in Vitro Correlates with Parasite Growth Inhibition</h3><div class="NLM_p">To compare the potency of all of the new PP analogs synthesized here, we plotted the log<sub>10</sub> values for CDPK1 enzyme inhibition (IC<sub>50</sub>) vs log<sub>10</sub> values for parasite growth inhibition (EC<sub>50</sub>) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). Fitting these data with a linear regression analysis indicated a reasonable correlation (<i>r</i><sup>2</sup> = 0.58), supporting the conclusion that the activity of these compounds against parasite growth stems largely from inhibition of CDPK1. However, the fact that this correlation is not higher suggests that <i>in vivo</i> potency is also affected by other factors. Some inhibitors lie above the diagonal line, which represents a perfect correlation, indicating they are less potent in blocking parasite growth, perhaps due to differences in cell permeability or efflux (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). Among the most potent inhibitors was the initial lead <b>1</b>, and derivatives that contain an oxygen linkage at R<sub>1</sub> (e.g., <b>2</b> and <b>10</b>), as well as those that contain the methylpiperidine at R<sub>2</sub> (e.g., <b>13</b>, <b>24</b>)(<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). Based on a combination of potency, selectivity, and PK properties, we prioritized compounds and selected these five analogs for further study. Other compounds that were potent in both assays were deprioritized for lack of specificity (e.g., <b>4</b>) or lack of stability (e.g., <b>9</b>).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Activity of PP analogs against tachyzoites and bradyzoites and PK studies in mice. (A) Comparison of enzyme inhibition vs parasite growth inhibition by PP analogs. Values for IC<sub>50</sub> for inhibition of CDPK1 enzyme activity were plotted vs EC<sub>50</sub> values for inhibition of parasite growth. The plot was analyzed by linear regression (solid line), shown with 95% confidence interval (dotted lines), <i>r</i><sup>2</sup> = 0.58. Highlighted are potent inhibitors that were further profiled in the following studies. (B) Ex vivo treatment of bradyzoites with PP analogs. (top) Schematic for isolation of tissue cysts containing bradyzoites, shown for PRU-GFP strain. Following Percoll enrichment of mouse-brain derived cysts, bradyzoites were liberated by acid-pepsin treatment, followed by neutralization. Liberated bradyzoites were used to infect HFF monolayers. Compounds were used to treat parallel cultures either with continuous treatment or following 4 h treatment and washing to remove extracellular parasites and compounds. (bottom) Following isolation of bradyzoites from the ME49Δ<i>hx</i>::FLUC line, compounds were used to treat cultures as described in top panel. Plaque forming units were enumerated in triplicate from three independent experiments. Compounds <b>1</b>, <b>13</b>, and <b>24</b> were used at 2.5 μM, while pyrimethamine (Pyr) was used at 3 μM. Mean ± SEM, <i>n</i> = 3 independent biological replicates with three technical replicates each. Two-way ANOVA with Dunnett’s correction: *<i>P</i> ≤ 0.05; **<i>P</i> ≤ 0.01, ***<i>P</i> ≤ 0.001. (C) Pharmacokinetic analysis of compound FUR7-27 in mice. Dose dependent kinetics of serum levels of compound following oral administration. Compound <b>24</b> suspended in 25%-PEG-400–PBS with 5% DMSO was administered by oral gavage; <i>n</i> = 3 animals per time point. Reference lines shows the free serum level of compound <b>24</b> that would correspond to the EC<sub>50</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Metabolic Stability and Cellular Update of PP Analogs</h3><div class="NLM_p last">To help choose PP analogs most likely to be active in vivo, we broadly examined the physical properties, metabolic stability in mouse liver microsomes, and cellular uptake of a select group of PP analogs (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). All compounds have modest cLogP values, consistent with their intermediate hydrophobicity, and are predicted to have relatively small total polar surface area, properties that should facilitate penetration of the CNS (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Consistent with the findings in rat liver microsomes, the ether linkage in compound <b>2</b> reduced metabolic clearance in mouse liver microsomes when compared to compound <b>1</b>, although both values are still relatively high (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Compound <b>10</b>, which had similar clearance to compound <b>1</b> in rat liver microsomes despite having an ether linkage, was more rapidly cleared in mouse liver microsomes (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), suggesting the methyl group at C3 might be prone to metabolism. Stability was further improved when the R<sub>2</sub> group was switched from <i>t</i>-butyl to methylpiperidine as in compounds <b>13</b> and <b>18</b>. However, these latter two compounds, which contain a basic amine group that is charged at neutral pH, were also associated with substantial efflux in MDCK cells (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). In addition to the many other useful aspects of fluorine substitutions in medicinal chemistry, in some contexts it has been shown to reduce the basicity of proximal amines by lowering the p<i>K</i><sub>a</sub>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Accordingly, we modified the piperidine ring by addition of difluorine (di-F), a modification that reduced the p<i>K</i><sub>a</sub> and nicely eliminated the efflux problem (<b>24</b> and <b>28</b>; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). However, metabolic stability was diminished by the di-F modification in these compounds. Analogs such as <b>1</b> showed high levels of plasma protein binding (PPB) (i.e., 99%); however this property was greatly reduced for compounds containing methylpiperidine or the di-F methylpiperidine (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Importantly, none of the PP analogs tested affected the growth of human foreskin fibroblasts (HFF) cells in vitro at 10 μM, indicating that they are not toxic to host cells (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Analysis of Target Specificity of Select PP Analogs</h3><div class="NLM_p">To provide an assay for inhibitor selectivity, we cloned a variant of human Src, which has a threonine residue at the gatekeeper (c-Src allele), which provides for an intermediate level of sensitivity to pyrazolopyrimidine compounds.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Although the initial lead compound <b>1</b> potently inhibited hSrc, modification of the R<sub>1</sub> linkage to the PP core via an ether or thioether at C3 led to greater selectivity (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). Modification of R<sub>2</sub> to include cyclic amines, including piperidine, also led to large increases in selectivity for CDPK1 over hSrc (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). Although Src has been used as a surrogate for human kinases with intermediate sensitivity to PP analogs,<a onclick="showRef(event, 'ref19 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref21">(19, 21)</a> it is only one member of a diverse family of tyrosine kinases that differ substantially in their sensitivity to PP inhibitors.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> As such, we profiled select inhibitors <b>1</b>, <b>2</b>, <b>13</b>, and <b>24</b>, which marked key transitions in our SAR profile. We screened all four analogs at 1 μM against a broad panel of 489 wild type and disease-associated human kinases (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Inhibitor selectivity increased along our SAR profile, starting from thirty-nine kinases that are inhibited or displaced by compound <b>1</b> by over 50% to only one kinase (CK1ε) that was inhibited or displaced by <b>24</b> by over 50% (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_001.pdf" class="ext-link">Supplementary Table S2</a>). Although compounds <b>13</b> and <b>24</b> exhibited IC<sub>50</sub> values of ≤100 nM at 2 μM ATP, these values were increased almost 10-fold in the presence of 100 μM ATP (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_001.pdf" class="ext-link">Supplementary Table S2</a>). Additionally, we profiled an earlier inhibitor 3-methyl-benzyl-PP (compound <b>1</b> in ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>) to compare our initial lead <b>1</b> in this prior series. We determined that the selectivity profile for both of these compounds was similar (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_001.pdf" class="ext-link">Supplementary Figure S3</a>), while selectivity was greatly increased for compounds <b>13</b> and <b>14</b>. Full inhibitor profiling data is provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_001.pdf" class="ext-link">Supporting Information</a> (Supplementary Tables S3–S5).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Human kinome profiling of compounds to determine inhibitor selectivity. Selectivity of compounds toward a panel of kinases in the ThermoFisher ACCESS program that are inhibited (red) by more than 50% or show greater than 50% tracer displacement (blue). Circle size reflects percent inhibition or displacement in the presence of inhibitor, and percentages are the mean of 2 data points. The % inhibition value for Src is shown as a yellow triangle and is emphasized by a dashed line connecting an * to the yellow triangle. Kinome tree images were generated using KinMap<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and the kinase tree illustration is reproduced courtesy of Cell Signaling Technology, Inc. (<a href="http://www.cellsignal.com" class="extLink">www.cellsignal.com</a>). Inhibitors were screened at 1 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Potency of Select PP Analogs against ex Vivo Bradyzoites</h3><div class="NLM_p last">Previous studies have emphasized the ability of PP analogs to block host cell invasion and egress by the rapidly growing tachyzoite stage of <i>T. gondii</i>.<a onclick="showRef(event, 'ref19 ref21 ref23'); return false;" href="javascript:void(0);" class="ref ref19 ref21 ref23">(19, 21, 23)</a> To examine the ability of our PP inhibitors to block invasion of bradyzoites, we purified mature tissue cysts from the brains of chronically infected mice and treated them in vitro with selected PP inhibitors. We compared the effects of treatment for short intervals (i.e., 4 h followed by wash-out and further culture in the absence of compound) vs continuous treatment during a 10–14 day plaquing assay. Consistent with previous reports showing that treatment with pyrimethamine requires overnight treatment to be effective in blocking tachyzoite growth<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> we observed that short-term treatment with pyrimethamine had minimal effect on infection by bradyzoites, while continuous treatment blocked plaque formation (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). In contrast, the PP inhibitors showed good (e.g., <b>13</b>), or excellent (e.g., <b>1</b>, <b>24</b>), ability to block infection following even short-term incubation (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). Because the compounds were only present during the initial interaction of the parasite with the host cell monolayer, we interpret these results to indicate that PP inhibitors can block bradyzoite entry into host cells during the 4 h treatment period, resulting in greatly diminished plaque formation. Additionally, continual culture with PP compounds resulted in greater inhibition (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B), consistent with its ability to block the multiple rounds of invasion and egress that occur during plaque formation, although it is likely that tachyzoites predominate during these longer-term assays.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Mouse Pharmacokinetic Studies</h3><div class="NLM_p">We examined the pharmacokinetics (PK) of several PP inhibitors in mice following either iv injection or po administration in mice. Compounds <b>1</b> and <b>2</b> showed reasonable oral bioavailability (<i>F</i>) ranging from ∼25% to 30%, <i>C</i><sub>max</sub> levels, and moderate clearance (Cl) values that were below the level of single pass circulation through the liver in mouse (∼90 mL/(min·kg)) (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Compound <b>10</b> showed a higher clearance rate but had similar half-life (<i>T</i><sub>1/2)</sub> to <b>1</b> and <b>2</b> of ∼1.5–2 h (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). However, this compound suffered from poor oral bioavailability (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Although compound <b>13</b> had greater in vitro stability in microsomes (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), it also displayed rapid clearance in vivo, perhaps due to efflux as indicated above. Compound <b>13</b> also showed lower <i>C</i><sub>max</sub> values and high tissue exposure as evidenced by its volume of distribution (<i>V</i><sub>ss</sub>) (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Finally, compound <b>24</b> showed the best combination of properties with good <i>C</i><sub>max</sub> following oral dosing, moderate clearance rate, <i>T</i><sub>1/2</sub> ≈ 1.5 h, and very high oral availability (e.g., ∼94%) (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). These collective properties of compound <b>24</b> provided the best PK profile and highest values for AUC, reflecting prolonged serum exposure following oral dosing.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vivo Pharmacokinetic Properties Based on Plasma Levels of Select Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center" char=".">dose, mg/kg</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub>, h</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>o</sub>/<i>C</i><sub>max</sub>,<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> ng/mL</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>last</sub>, ng/(mL h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>inf</sub>, ng/(mL h)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub>, h</th><th class="colsep0 rowsep0" align="center" char=".">CL,<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> mL/(min·kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> L/kg</th><th class="colsep0 rowsep0" align="center" char=".">%<i>F</i><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6892.94</td><td class="colsep0 rowsep0" align="char" char=".">1075.29</td><td class="colsep0 rowsep0" align="char" char=".">1081.76</td><td class="colsep0 rowsep0" align="char" char=".">2.06</td><td class="colsep0 rowsep0" align="char" char=".">46.22</td><td class="colsep0 rowsep0" align="char" char=".">1.09</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">585.42</td><td class="colsep0 rowsep0" align="char" char=".">918.80</td><td class="colsep0 rowsep0" align="char" char=".">930.88</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">5471.09</td><td class="colsep0 rowsep0" align="char" char=".">1146.49</td><td class="colsep0 rowsep0" align="char" char=".">1149.99</td><td class="colsep0 rowsep0" align="char" char=".">1.56</td><td class="colsep0 rowsep0" align="char" char=".">43.48</td><td class="colsep0 rowsep0" align="char" char=".">1.10</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">1136.36</td><td class="colsep0 rowsep0" align="char" char=".">1172.75</td><td class="colsep0 rowsep0" align="char" char=".">1279.20</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">2741.80</td><td class="colsep0 rowsep0" align="char" char=".">619.33</td><td class="colsep0 rowsep0" align="char" char=".">625.04</td><td class="colsep0 rowsep0" align="char" char=".">1.74</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">2.32</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">76.69</td><td class="colsep0 rowsep0" align="char" char=".">85.47</td><td class="colsep0 rowsep0" align="char" char=".">91.42</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">535.79</td><td class="colsep0 rowsep0" align="char" char=".">449.57</td><td class="colsep0 rowsep0" align="char" char=".">523.99</td><td class="colsep0 rowsep0" align="char" char=".">3.68</td><td class="colsep0 rowsep0" align="char" char=".">95.42</td><td class="colsep0 rowsep0" align="char" char=".">19.59</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">2.00</td><td class="colsep0 rowsep0" align="char" char=".">182.56</td><td class="colsep0 rowsep0" align="char" char=".">757.85</td><td class="colsep0 rowsep0" align="char" char=".">891.24</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1205.19</td><td class="colsep0 rowsep0" align="char" char=".">975.90</td><td class="colsep0 rowsep0" align="char" char=".">988.58</td><td class="colsep0 rowsep0" align="char" char=".">1.56</td><td class="colsep0 rowsep0" align="char" char=".">50.58</td><td class="colsep0 rowsep0" align="char" char=".">3.68</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">1048.80</td><td class="colsep0 rowsep0" align="char" char=".">3058.44</td><td class="colsep0 rowsep0" align="char" char=".">3547.95</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">94</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last"><i>C</i><sub>max</sub> for po route, <i>C</i><sub>0</sub> (initial concn).</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">CL, clearance.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last"><i>V</i><sub>ss</sub> steady-state volume of distribution.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Oral availability determined from AUC<sub>last</sub>.</p></div></div></div><div class="NLM_p last">Based on these favorable properties, we examined the PK of <b>24</b> in mice using increasing oral doses from 10, 25, and 50 mg/kg (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C). At higher dose, <b>24</b> showed a two-phase decay curve in plasma, with rapid initial drop followed by a more gradual plateau that was seen at 25 and 50 mg/kg (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C). Based on its protein binding properties (12% free in serum), the concentration of compound <b>24</b> in serum would need to be 2.08 μM, for the free value to attain a level equivalent to the in vitro EC<sub>50</sub> of ∼0.250 μM. This corresponds to a value of 856 ng/mL in serum, as shown by the red line in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C. The protein bound fraction in brain was slightly higher at 97.2% or 2.8% free, and the ratio of total compound in the CNS vs serum was 5.6, for an effective brain vs plasma ratio ∼1.3. Consequently, we would expect that the free concentration of compound <b>24</b> in the brain was approximately the same or slightly higher than that shown for serum in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Treatment of Acute Toxoplasmosis</h3><div class="NLM_p">Based on its favorable PK parameters, we tested compound <b>24</b> for its ability to prevent toxoplasmosis in the mouse model. Following an initial loading dose of 50 mg/kg, <b>24</b> was administered orally at 25 mg/kg BID for 6 days, beginning 24 h after challenge with tachyzoites of the ME49 strain of <i>T. gondii</i>. Treatment with <b>24</b> decreased the frequency of lethal infection (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A), and this was associated with reduced weight loss (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B) and with decreased tissue burdens of the parasite, as revealed by bioluminescent imaging (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C). Consistent with a decrease in acute burden, there were fewer tissue cysts formed in the brains of chronically infected mice following treatment with <b>24</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D). The dramatic ability of <b>24</b> to decrease dissemination was further shown by bioluminescent imaging, where control animals showed extensive expansion of the parasite with in the peritoneum at day 8 and spread to the head at day 18 (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>E,F). In contrast, treated mice were able to restrict the growth of the parasite to the site of injection and did not show detectable signal in the head (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>E,F). Following treatment with <b>24</b>, many animals showed tissue cyst levels below the levels of detection (40 cysts per brain) (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D). These animals were subsequently bioassayed by oral feeding of 20% of their brain homogenate into a naive interferon gamma receptor knock out mouse (Ifngr1<sup>–/–</sup>). Although 5 of 6 recipient animals succumbed to infection, reflecting a low level of chronic infection in the donor, one remained alive, indicating that compound <b>24</b> treatment had resulted in a complete cure in this animal (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D, red triangle).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo treatment of acute toxoplasmosis with compound <b>24</b>. (A) Survival curve of mice infected with ME49-FLUC strain parasites and treated with compound <b>24</b> (treated) vs vehicle control (control) as monitored for 30 days. Animals were infected with 5000 tachyzoites by ip injection on day 0. At 24 h postinfection, animals were given compound <b>24</b> at 50 mg/kg or vehicle control, followed by a second dose of 25 mg/kg 12 h later, and then treated with 25 mg/kg BID for 5 additional days. Mantel–Cox test, <i>P</i> ≤ 0.05. (B) Weight loss of infected animals shown in panel B. Values are reported as % Control, which refers to the average weight at day 0 for each group treated separately. (C) Bioluminescence imaging of parasite numbers in animals shown in panel A. Whole body imaging was used to determine the mean intensity of luciferase signal, which is expressed as relative light units (RLU). Individual animals shown by symbols; median values graphed in the lines. Student’s <i>t</i> test with Holm–Sidak correction for multiple tests, ***<i>P</i> ≤ 0.001. (D) The number of cysts in surviving animals from panel A were determined by counting aliquots of brain homogenate. Means ± SD, <i>n</i> = 6–9. Threshold for detection = 40 cysts. Red triangle denotes animal where bioassay was negative indicating it was cured. Mann–Whitney nonparametric test, **<i>P</i> ≤ 0.01. (E) Bioluminescence imaging of representative control and treated mice from panel A imaged at day 8. (F) Bioluminescence imaging of control and treated mice from panel A imaged at day 18.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Treatment of Reactivated CNS Toxoplasmosis</h3><div class="NLM_p">To determine whether compound <b>24</b> could prevent reactivation of chronic toxoplasmosis, we utilized mice lacking the IFNγ receptor (i.e., Ifngr1<sup>–/–</sup>), which are highly susceptible and rapidly succumb to infection.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Treatment of such animals with sulfadiazine will suppress the growth of tachyzoites, while allowing the development of chronic tissue cysts.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Subsequent removal of sulfadiazine results in rapid reactivation, characterized by CNS encephalitis, pneumonia, and death.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> We injected Ifngr1<sup>–/–</sup> mice with a type II strain capable of causing chronic infection and treated them from day 2 to 22 with sulfadiazine in the drinking water, which prevented otherwise lethal infection. Following removal of sulfadiazine (48 h later), mice were treated with compound <b>24</b> at a dose of 25 or 40 mg/kg BID or with vehicle only control by oral gavage for 8 days (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A). Withdrawal of sulfadiazine from the control animals lead to rapid reactivation of chronic infection and led to death of the control mice within 10 days (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B). In contrast, treatment with compound <b>24</b> prolonged survival (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B). We also monitored the progression of infection using bioluminescence. At the beginning of the treatment period, all of the animals were negative for bioluminescence, consistent with the infection being chronic. Monitoring of the control animals revealed that reactivation was first centered in the CNS, with later spread to the lungs prior to death (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>C). In contrast to the rapid expansion of parasites seen in control mice, the bioluminescence signal was muted in compound <b>24</b> treated mice, and reactivation was significantly delayed (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>C). Consistent with this delay in reactivation, compound <b>24</b> treated mice survived significantly longer (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B). One animal treated with compound <b>24</b> at 25 mg/kg and two animals treated at 40 mg/kg remained negative for bioluminescence signals and survived for an additional 22 days after removal of compound (red triangles in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B). Subsequent bioassay of brain homogenates from these treated mice into naive Ifngr1<sup>–/–</sup> mice did not result in transfer of infection, confirming that these animals had been cured (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vivo treatment of reactivation of CNS toxoplasmosis. (A) Schematic for treatment during reactivation in an immunocompromised mouse. Ifngr1<sup>–/–</sup> mice were infected with 10 cysts of the ME49-FLUC strain and treated from day 2–22 with sulfadiazine in the drinking water. Two days (48 h) after removal of sulfadiazine, animals were treated po with compound <b>24</b> or vehicle control (control, <i>n</i> = 6) for 8 days. Animals in one group (<i>n</i> = 9) received a loading dose of 50 mg/kg followed by 25 mg/kg 12 h later and then 25 mg/kg BID for seven additional days. A second group of animals (<i>n</i> = 5) received 40 mg/kg BID for 8 days. (B) Animals were evaluated for survival and imaged for bioluminescence over a period of 30 days. Treated mice survived significantly longer than controls, log-rank, Mantel–Cox test, <i>P</i> < 0.001 (***). Animals that survived in the treated groups (red triangles) were negative by bioassay, indicating they were cured. (C) Bioluminescence imaging at day 6 indicates that a number of control animals that have perished (red X) and remaining animals show a positive signal in the head and upper thorax. In contrast, all treated mice were alive and mice treated with 25 mg/kg show reduced signals while those treated with 40 mg/kg showed no sign of activation. Animals marked * were determined to be cured based on bioassay at the end of the experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82120" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82120" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In previous work, we demonstrated that PP inhibitors containing <i>meta</i> chloro benzyl substituents at C3 of the PP core provide potent inhibition of CDPK1 in <i>T gondii</i>.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> However, when coupled with isopropyl or <i>t-</i>butyl at R<sub>2</sub>, these compounds suffer from metabolic instability.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Our profiling of host kinases here also reveals that compounds like <b>1</b> lack specificity, and this is also likely true of other related derivatives that share this basic architecture. To alleviate this problem, we altered the linkage connecting R<sub>1</sub> to C3 from a methylene to a heteroatom consisting of O, S, or N. An ether linkage proved most optimal in increasing stability and selectivity, while compounds with a thioether linkage were typically less active and compounds with an amine linkage were less selective. The reasons for these differences are not exactly clear as cocrystal structures of these analogs showed very close overlap of the analogs in the binding pocket. The lower activity of the thioether linkage may relate to the bulkier nature of this atom within the linker, which is very close to the hinge region in the crystal structure. We have previously shown that even subtle modification to this linker, such as substitution of fluorine for hydrogen, ablates activity.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">By combining the ether linkage at C3 with a methylpiperidine at R<sub>2</sub>, we achieved further gains in specificity, with only modest loss of potency. Other modifications to R<sub>2</sub>, such as including a pyridine or methylation of the piperidine nitrogen, ablated activity suggesting that the unsubstituted alkyl amine is critical for the potency. Indeed a cocrystal structure of compound <b>13</b> revealed that this amine is important for forming a hydrogen bond with glutamate 135 in the ribose-binding region, likely stabilizing the interaction of the compound with the ATP-binding pocket. Addition of the piperidine group in the scaffold described here also resulted in dramatic improvement in specificity over host kinases compared to the initial lead compounds <b>1</b> and <b>2</b>. Compounds <b>13</b> and <b>24</b> only potently inhibited a single human kinase, CK1ε, under conditions tested here. Surprisingly, CK1ε is also sensitive to other PP analogs including 1-NM-PP1 and 1-NA-PP1, despite its methionine gatekeeper, which is normally a hallmark for resistance to such analogs.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The sensitivity of CKε to PP analogs has been attributed to an unusual flexibility in the M side-chain that allows access of bulky PP analogs into the ATP-binding pocket.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Further modification of the PP scaffold may result in inhibitors that would retain potency for CDPK1 over CKε. However, this off target activity may be less of an issue in vivo since compound <b>24</b> retains good potency against parasite growth in a cell-based assay, while off target activity against CKε drops appreciably at higher ATP levels.</div><div class="NLM_p">Despite the improvements in specificity achieved with the piperidine analogs, these charged primary amines suffered from efflux problems in our study, likely due to the high p<i>K</i><sub>a</sub>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Addition of di-F in the piperidine ring decreased the predicted p<i>K</i><sub>a</sub> and eliminated the efflux problem, consistent with previous examples in other scaffolds.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Previous experimental measurements of piperidine amines with fluoro substituents,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> combined with computational predictions of the compound <b>24</b> piperidine amine p<i>K</i><sub>a</sub> suggest that the piperidine amine in compound <b>24</b> is partially protonated at physiological pH. Based on these properties and its potency, we would predict that compound <b>24</b> is still able to form a H-bond with E135 in CDPK1. Unfortunately, modification of di-F <i>meta</i> to the amine in the piperdine was also associated with some loss of metabolic stability, which likely limited its in vivo efficacy. We did not explore modification with fluorine-directed modifications at other positions in the piperidine ring, but conceivably some of these may have a more optimal combination of features.</div><div class="NLM_p">One of the goals of our study was to obtain molecules with better metabolic stability to improve in vivo PK properties for treating acute and chronic toxoplasmosis in the mouse. Compound <b>24</b> exhibited many of the desired properties in terms of PK in the mouse. Although <i>C</i><sub>max</sub> levels were high, it was relatively rapidly cleared from serum, likely as a consequence of metabolism in the liver as the half-life in microsomes was relatively short. This was partially offset by high oral availability and moderate protein binding, resulting in reasonable serum profiles and good AUC profiles. However, we were only able to obtain free serum levels that exceeded the EC<sub>50</sub> based on free drug for a period of ∼2 h after oral dosing in the mouse. Nonetheless, dosing schemes of 25–50 mg/kg were able to decrease acute infection, preventing weight loss and death in a majority of immunocompetent animals. Additionally, treatment during acute infection resulted in dramatically lower cyst counts during chronic infection, likely as a consequence of decreasing dissemination to the CNS. Indeed, treatment was sufficient to provide a complete cure in one animal with no evidence of chronic infection.</div><div class="NLM_p last">Although previous studies have largely focused on the acute infection model, the primary concern for immunocompromised patients is the reactivation of prior chronic infections.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Here we modeled this situation using severely immunocompromised Ifngr<sup>–/–</sup> mice, which are highly susceptible to <i>T. gondii</i> infection.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> As Ifngr<sup>–/–</sup> mice completely lack the ability to respond to IFNγ, a critical mediator of host defense, it is likely that a single tissue cyst or single viable organism is capable of causing lethal infection in this model. Hence they provide an extremely sensitive measure of the ability of compounds to cure infection. Treatment with atovaquone<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> or artemisinin<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> derivatives is able to prolong survival of such severely immunocompromised mice, but treated animals ultimately always succumb to infection following removal of these drugs. Similarly, treatment with sulfadiazine is only able to prevent lethal infection in this model, but not eliminate the tissue cysts, such that when it is removed, animals quickly succumb due to reactivation of rapidly growing tachyzoites. Treatment with compound <b>24</b> prolonged survival of Ifngr1<sup>–/–</sup> mice and resulted in a radical cure in some animals, a result not previously seen with other compounds. The efficacy of compound <b>24</b> in this model likely stems from its ability to block tachyzoite invasion and egress, but it was also able to block bradyzoite invasion in vitro, suggesting it may directly affect the formation and turnover of cysts in vivo. Other PP analogs have been reported to reduce the chronic cyst burden in infected mice, albeit at very high serum doses, which exceed the level where they are selective for CDPK1.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In contrast, compound <b>24</b> retains antitoxoplasma activity at very modest serum levels, which are well within the range where it is selective for CPDK1 in <i>T. gondii</i>.<a onclick="showRef(event, 'ref12 ref23'); return false;" href="javascript:void(0);" class="ref ref12 ref23">(12, 23)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54282" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54282" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">CDPK1 is an essential kinase in <i>T. gondii</i> and hence has been the focus of development of potent and selective inhibitors. Here we report new PP inhibitors that were designed to improve metabolic stability and specificity for CDPK1. The optimal molecule in this series, compound <b>24</b>, showed low nanomolar inhibition of CDPK1 in vitro, submicromolar inhibition of parasite growth in vitro, and improved metabolic stability. In vivo administration of this analog, which showed excellent oral availability and moderate PK parameters, decreased the severity of acute infection, reduced tissue cyst levels, and delayed reactivation of chronic toxoplasmosis in the mouse. Additionally, compound <b>24</b> is remarkable in being able to completely cure a portion of immunocompromised animals. As radical cure is currently not possible for humans infected with <i>T. gondii</i>, compounds that can achieve this goal with higher efficacy would greatly enhance the potential utility of PP analogs for treatment of toxoplasmosis. Collectively, these advances underscore the utility of the PP scaffold as a new therapeutic agent for treatment of acute and chronic toxoplasmosis.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70235" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70235" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemical Synthesis</h3><div class="NLM_p last">Starting materials, solvents, and reagents obtained commercially were reagent grade and were used without further purification. NMR spectra were obtained at the University of California, San Francisco, NMR facility: <sup>1</sup>H NMR were recorded on a Bruker AvanceIII HD 400 at 400 MHz, and <sup>13</sup>C spectra were recorded on a Bruker AvanceIII HD 400 at 400 MHz or a Bruker Advance DRX500. High-resolution mass spectra (HRMS) were acquired by electrospray ionization (ESI) in positive ion mode using Finnigan LTQ FT mass spectrometer (Thermo) at the QB3/Chemistry Mass Spectrometry Facility (University of California, Berkeley). Samples were directly injected into ESI source via syringe pump with flow rate 5 μL/min. Reactions were monitored by thin layer chromatography (TLC), using Merck silica gel 60 F254 glass plates (0.25 mm thick). Flash chromatography was conducted with Teledyne Isco RediSep Rf silica flash cartridges on a Teledyne Isco CombiFlash Rf+. All RP-HPLC were performed with a Waters 2545 binary gradient module equipped with an XBridge prep C18 column using H<sub>2</sub>O + 0.1% formic acid and CH<sub>3</sub>CN + 0.1% formic acid (5–95% gradient) while monitoring at 254 nm. All final compounds were >95% pure as measured by liquid chromatography–mass spectrometry (LCMS) using a Waters Acquity UPLC/ESI-TQD BEH C18 (1.7 μm) column using H<sub>2</sub>O + 0.1% formic acid and CH<sub>3</sub>CN + 0.1% formic acid (5–95% gradient) over 1.8 min at 600 μL/min. Full compound characterization details are presented in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_001.pdf" class="ext-link">Supporting Information</a>. All compounds reported here were screened for Pan Assay Interference (PAINS) and found to pass all the filters contained in the FAF-Drugs4 Web server (<a href="http://fafdrugs4.mti.univ-paris-diderot.fr/" class="extLink">http://fafdrugs4.mti.univ-paris-diderot.fr/</a>).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Parasite Strains and Cell Lines</h3><div class="NLM_p last">Tachyzoites of <i>T. gondii</i> strains were grown in monolayers of human foreskin fibroblasts (HFF) maintained in complete medium (DMEM containing 10% FBS, 10 mM glutamine, and 10 μg/mL gentamycin) at 37 °C in 5% CO<sub>2</sub>. Following natural egress, tachyzoites were purified in HBSS containing 10 mM HEPES, 0.1 mM EGTA, and separated from host debris using 3.0 micro polycarbonate membrane filters, followed by centrifugation at 400<i>g</i>. HFF monolayers obtained from an anonymous donor were provided by Dr. John Boothroyd’s laboratory (Stanford University). All strains and host cell lines were determined to be mycoplasma negative using the e-Myco plus kit (Intron Biotechnology).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Enzyme Expression and Purification</h3><div class="NLM_p last">Full-length <i>T. gondii</i> CDPK1 enzyme was expressed with a C-terminal His tag in pET22b(+), as described previously.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> CDPK1 was expressed in BL21 (DE3)V2RpAcYc-LIC+LamP <i>E. coli</i>, which contains the LamP phosphatase. A cDNA fragment encoding human Src (hSrc) kinase domain amino acids 254–536 was amplified using the primers Scr-F (GATATACATATGCAGACTCAGGGCCTGGC) and Scr-R (GTGGTGCTCGAGGAGGTTCTCCCC) and cloned into pET22b using restriction enzymes <i>Nde</i>I and <i>Xho</i>I. hSrc containing a Thr gatekeeper residue (equivalent of Thr338 in the full length sequence of the c-Src allele) was expressed in BL21 (DE3)V2RpAcYc-LIC+LamP <i>E. coli</i>, which contains the LamP phosphatase. Following overnight growth in Terrific Broth at 37 °C, the culture was diluted 1:100 and grown for 3 h at 37 °C (OD 0.6–0.8), then induced with 0.3 mM IPTG during overnight growth at 15 or 30 °C. Cells were lysed by sonication, and soluble proteins were purified using HIS-select Nickel Affinity Gel. Purified proteins were dialyzed (50 mM Tris-HCL, pH 7.5, 150 mM NaCl), and stored in 25% glycerol containing 0.5 mM DTT at −80 °C. Protein purity and concentrations were determined by SDS-PAGE and staining with SYPRO Ruby (Invitrogen).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Crystallography Method</h3><div class="NLM_p last">For the purpose of crystallization, recombinant <i>Tg</i>CDPK1 was expressed, purified, and set up in crystal trial with inhibitors as previously described.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Diffracting crystals were obtained by cocrystallization with compounds <b>3</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W9E">5W9E</a>), <b>1</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W8R">5W8R</a>), <b>2</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=41H8">41H8</a>), <b>13</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W80">5W80</a>), and <b>4</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W91">5W91</a>). Crystallographic data were collected at beamline 19ID of Argonne National Laboratory’s Advanced Photon Source (<a href="http://www.sbc.anl.gov/index.html" class="extLink">http://www.sbc.anl.gov/index.html</a>) and processed using <i>HKL-3000</i>.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> All structures were solved using Phaser for molecular replacement and the previously deposited <i>Tg</i>CDPK1 coordinates (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=41H8">41H8</a>) as a search model. The models were refined using <i>Buster</i><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and <i>REFMAC</i><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> combined with iterative manual model building using the molecular graphics program <i>Coot</i>.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The geometry of all final models was checked using <i>MolProbity</i>.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Crystallographic details and refinement statistics are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_001.pdf" class="ext-link">Table S1</a>. Atomic coordinates and experimental data will be released on publication.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Homology Modeling</h3><div class="NLM_p last">Compound <b>24</b> was modeled using the cocrystal structure of compound <b>13</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W9E">5W9E</a>) in Molecular Operating Environment (MOE) version 2015.1 by Chemical Computing Group.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Difluorine was added to the piperidine of compound <b>13</b> using the ligand builder to create compound <b>24</b>, and the structure was prepared and minimized using LigX with the Amber10:EHT force field (used Protonate3D for protonation, allowed ASN/GLN/HIS “Flips” in Protonate3D, deleted water molecules farther than 4.5 Å from compound <b>24</b> or CDPK1; tethering parameters: receptor strength at 5000 to minimize large changes to the CDPK1 backbone, fixed atoms father than 8 Å away from compound <b>24</b>, hydrogens close to compound <b>24</b> not fixed, and refined compound <b>24</b>–CDPK complex to an RMS gradient of 0.1 kcal/(mol·Å)).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Enzyme Assays and IC<sub>50</sub> Values</h3><div class="NLM_p">CDPK1 activity was monitored based on phosphorylation of syntide-2 peptide (Callbiochem), which was detected using mAb MS-6E6 (MBL Intl, Corp) using an ELISA protocol described previously.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Kinase reactions were conducted at 30 °C for 20 min in 20 mM HEPES, pH 7.5, 10 mM MgCl<sub>2</sub>, 1 mM DTT, 2.5 mM CaCl<sub>2</sub>, 0.1 mM EGTA, 0.005% Tween 20. Reactions were conducted using 25 μM ATP (the <i>K</i><sub>m</sub> for the enzyme) using 140 ng of kinase per reaction. To determine the potency of inhibitors, duplicate wells were treated with a range of compound concentrations from 10 μM to 0.5 nM. Inhibitors were preincubated with the enzyme in the reaction buffer for 10 min before addition of ATP. Individual IC<sub>50</sub> values were determined from two or more independent biological replicates and are reported as mean values. Src activity was monitored by phosphorylation of the Abltide peptide (EAIYAAPFAKKK, Enzo Life Sciences), which was detected using a monoclonal antibody to phosphotyrosine (Sigma) using an ELISA protocol similar to that used for CDPK1 above. Kinase reactions were conducted in 50 mM Tris-HCl, pH 7.5, 10 mM MgCl<sub>2</sub>, 2.5 nM MnCl<sub>2</sub>, 0.2 mM DTT, 0.5 mM EGTA. Reactions were conducted using 5 μM ATP (the <i>K</i><sub>m</sub> for the enzyme) using 75 ng of kinase per reaction. Compounds were tested at 10 μM in duplicate, in two biological replicates, and values are reported as mean ± SD. For compounds that showed >50% inhibition at 10 μM, serial dilutions from 10 μM to 0.5 nM were tested in duplicate to derive IC<sub>50</sub> values.</div><div class="NLM_p last">CK1ε (ThermoFisher) activity was monitored based on phosphorylation of dephosphorylated casein (Sigma-Aldrich) under the following conditions: 50 mM TRIS (pH 7.4), 10 mM MgCl<sub>2</sub>, 0.4 mg/mL casein, 2.5 mM DTT, 2% DMSO, 0.1 mg/mL BSA, 2 μM ATP (<i>K</i><sub>m,app</sub>), 1 μCi <sup>32</sup>P-ATP (PerkinElmer), 5 nM CK1ε. Additional activity assays were done at 100 μM ATP with 10 nM kinase. To determine the potency of inhibitors, duplicate wells were treated with a 10-fold dilution of compound from 200 μM to 200 pM. Inhibitors were preincubated with the enzyme in the reaction buffer for 15 min before addition of ATP and <sup>32</sup>P-ATP. Upon completion of the reaction (10 min for <i>K</i><sub>m,app</sub>, 55 min for 100 μM ATP), 3 μL was spotted onto P81 paper. The paper was dried for 5 min under a heat lamp followed by 1 × 30 s wash and 6 × 5 min washes in 1% phosphoric acid. The paper was dried for 15 min under a heat lamp followed by overnight exposure to a phosphor screen imaged on a Typhoon 9500. Intensities were quantified using densitometry, and IC<sub>50</sub> values were determined from quantification of two independent biological replicates of triplicate dose response determined by fitting the data to a sigmoid function in Prism 7.0 (GraphPad Software) and are reported as mean values.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Kinome Screen</h3><div class="NLM_p last">Human kinome profiling was conducted using the ThermoFisher Scientific SelectScreen ACCESS program to profile 489 kinases utilizing three assay formats: Z′-LYTE (284 kinases), Adapta (39 kinases), and LanthaScreen (166 kinases). Z′-LYTE and Adapta yield % inhibition values based on the mean of 2 points that measure the ability of the compound to inhibit an active kinase. LanthaScreen yields % displacement values based on the mean of 2 points that measure the ability of the inhibitor to displace a tracer bound to an inactive or weakly active kinase. Inhibitors were screened at 1 μM.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Parasite Growth Assays and EC<sub>50</sub> Values</h3><div class="NLM_p last">Parasite growth inhibition assays were conducted using the type I RH strain, 2F clone, which expresses bacterial β-galactosidase (β-gal), as described previously.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Compounds dissolved in DMSO at 10 mM stocks were diluted in medium to two times final concentrations and added to an equal volume of medium containing 5 × 10<sup>2</sup> parasites and incubated for 20 min. Mixtures of compounds (ranging from 10 μM to 0.01 nM) containing 0.1% (v/v) DMSO or DMSO alone was added to monolayers of HFF cells grown in 96 well plates, centrifuged at 300<i>g</i> for 5 min, and returned to culture at 37 °C, 5% CO<sub>2</sub>. After 4 h, the plates were washed to remove extracellular parasites and compounds and then returned to culture for 72 h. At the end of the incubation period, the monolayer was lysed in 1% Triton X-100 and β-gal activity monitored using 1 mM chlorophenol red−β-<span class="smallcaps smallerCapital">d</span>-galactopyranoside by absorption at 570 nm, as described previously.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Individual EC<sub>50</sub> values were determined from three or more independent biological replicates and are reported as mean values.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Host Toxicity Assays</h3><div class="NLM_p last">HFF cells were plated in complete medium and allowed to adhere for 4 h at 37 °C, 5% CO<sub>2</sub>. Compounds diluted to 10 μM in 0.1% (v/v) DMSO or DMSO alone was then added, and cells were incubated for an additional 72 h. Following the incubation period, samples were evaluated using a cell proliferation assay (CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay, Promega Corporation). As a positive control, mitomycin C (10 μM) was included in each plate. Compounds were tested in duplicate, in two biological replicates, and values are reported as means ± SD.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> In Vitro Analysis of Uptake, Efflux, Metabolism, and Protein Binding</h3><div class="NLM_p">Assays to monitor uptake and efflux of compounds by polarized epithelial cells were conduced by Absorption Systems Inc. (Exton, PA, USA). In brief, Caco-2 cells (Clone C2BBel from ATCC) were grown to confluence on collagen-coated polycarbonate membranes on transwell plates. Permeability assays were conducted in Hank’s balanced salt solution, containing 10 mM HEPES, 10 mM glucose, pH 7.4. Compounds were added at 5 μM to the apical (A) vs basolateral (B) side, and duplicate samples were taken at 120 min. Samples were analyzed by LC-MS/MS and expressed as apparent permeability (<i>P</i><sub>app</sub>) for uptake (A to B) vs efflux (B to A) and efflux ratio (<i>P</i><sub>app</sub>(B to A)/<i>P</i><sub>app</sub>(A to B)).</div><div class="NLM_p last">The stability of compounds in the presence of rat or mouse liver microsomes was conducted by Absorption Systems, Inc. In brief, rat liver microsomes or mouse rat liver microsome were incubated with compounds at 1 μM in a shaking water bath for 60 min. Aliquots were withdrawn at intervals, extracted, and analyzed by LC-MS/MS to evaluate the remaining parent compound. Half-lives were calculated using a single-phase exponential decay equation (Graph Pad). Intrinsic clearance was calculated as CL<sub>int</sub> = <i>k</i>/<i>P</i>, where <i>k</i> is the elimination rate constant and <i>P</i> is the protein concentration in the assay. For plasma protein binding, compounds were incubated at 5 μM in CD-1 mouse plasma, and protein bound fractions were monitored by equilibrium dialysis.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> In Vivo Pharmacokinetic Studies</h3><div class="NLM_p last">Pharmacokinetic (PK) studies were conducted by Sai Life Sciences Limited (India). Compounds were administered orally in 50% PEG-400 in PBS, while for iv administration, compounds were dissolved in 20% PEG-400–PBS. Mean plasma concentrations were determined following a single iv dose of 3 mg/kg in male Swiss Albino mice by sampling at 0.05, 0.25, 1, 2, 4, and 8 h. Separately, male mice were used for monitoring mean plasma concentrations following single oral dose of 10 mg/kg with similar time points. Separate animals were used to determine the brain distribution relative to plasma levels at 1 h following a single oral dose of 10 mg/kg. Selected compounds were tested for dose response of plasma concentrations following single or multiple oral administration of a single dose of 10, 25, and 50 mg/kg at time intervals of 0.25, 1, 2, 4, 8, and 24 h. Plasma samples were separated, processed by precipitation in acetonitrile, and analyzed by LC-MS/MS. Pharmacokinetic parameters, including those for plasma versus brain, and oral bioavailability were calculated with the noncompartmental analysis tools of the Phoenix WinNonLin (v6.3).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Animal Studies</h3><div class="NLM_p last">Animals were obtained from Jackson Laboratories and housed at Washington University in accordance with the U.S.A. Public Health Service Policy on Humane Care and Use of Laboratory Animals. Animals were maintained in an Association for Assessment and Accreditation of Laboratory Animal Care approved facilities, and protocols were approved by the Institutional Animal Studies Committee at the School of Medicine, Washington University in St. Louis.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Ex Vivo Bradyzoite Treatment Assays</h3><div class="NLM_p last">Adult (8–12 weeks old) female CD1 mice were infected with tachyzoites of the Pru Δ<i>hxg</i>Δ<i>ku8</i>0, LDH2-GFP (PRU-GFP),<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> or ME49Δ<i>hx</i>::FLUC<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> strains expressing firefly luciferase (FLUC)<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and allowed to develop chronic infections. Adult (8–12 weeks old) CBA/J mice were orally infected with 10–20 tissue cysts of the ME49Δ<i>hx</i>::FLUC strain. At 3–6 weeks postinoculum, brains were isolated from 2 to 3 animals, and tissue cysts were purified from brain homogenate by Percoll gradient, as previously described.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> A serological pipet was used to isolate the ∼9.0 mL of gradient between the erythrocyte layer and the brain homogenate layer after the initial centrifugation step (1200<i>g</i> for 15 min at 4 °C). Following purification, cysts were resuspended in acid-pepsin solution (170 mM NaCl, 60 mM HCl, 0.1 mg/mL pepsin (1:10000 activity)), incubated for 10 min at 37 °C, and then neutralized by addition of sodium carbonate solution (94 mM). Liberated bradyzoites were inoculated into parallel 6-well plates containing HFF monolayers with compounds (constant treatment vs washout). At 4 h postinfection, the washout 6-well plate was rinsed 3 times in fresh media to remove cell debris and noninvaded parasite and returned to incubator with fresh culture medium lacking compound. The constant treatment plate was allowed to incubate without washing. Plates were incubated for 10–14 days prior to ethanol fixation and staining with 0.1% crystal violet stain, and plaques were counted using an Axio Observer.D1 microscope under 2.5× magnification.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Treatment during Acute Challenge Studies</h3><div class="NLM_p last">Adult (8–12 weeks old) female Balb/C mice were infected with 5000 tachyzoites of the type II ME49Δ<i>hx</i>::FLUC line by ip injection. At 24 h postinfection, animals were dosed with compounds formulated in 25% PEG–PBS containing 5% DMSO or 25% PEG-400–PBS–5% DMSO alone, by oral gavage, and treatment was continued for 6 days. Treated mice received on day 1 an initial loading dose of compound <b>24</b> at 50 mg/kg in the morning, followed 12 h later by a second dose of 25 mg/kg, and then 25 mg/kg BID for 5 additional days. Bioluminescence imaging (see below) was used to monitor infection from day 6 to 20, and weight loss and survival were tracked over the first 30 days. At the end of 30 days, tissue cysts in the brain were quantified by staining with <i>Dolichos biflorus</i> lectin that was labeled with FITC, and microscopic examination, as described previously.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> For samples where no cysts were observed (lower threshold = 40 per brain), residual infection was tested by bioassay into a naive recipient. For bioassay experiments, 200 μL of brain homogenate was injected ip into a recipient Ifngr1<sup>–/–</sup> mouse, which lacks the ability to control parasite proliferation and readily succumbs to infection.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Treatment during Reactivation of Chronic Toxoplasmosis</h3><div class="NLM_p last">To provide a model for treatment during reactivation of chronic infection, we used a modification of a previously published protocol.<a onclick="showRef(event, 'ref38 ref41'); return false;" href="javascript:void(0);" class="ref ref38 ref41">(38, 41)</a> Male and female Ifngr1<sup>–/–</sup> mice were orally infected with 5 cysts of the type II ME49Δ<i>hx</i>::FLUC line, obtained from the brains of chronically infected wild type CD-1 mice. Animals were treated with sulfadiazine (0.25 g/L in the drinking water) from day 2 to 22. Two days (48 h) after removal of the sulfadiazine, compound <b>24</b> formulated in 25% PEG-400–PBS containing 5% DMSO or 25% PEG-400-PBS–5% DMSO alone (control) was administered by oral gavage for a total of 8 days. One group of treated mice received on day 1 an initial loading dose of compound <b>24</b> at 50 mg/kg in the morning, followed 12 h later by a second dose of 25 mg/kg, and then 25 mg/kg BID for 7 additional days. A second group of animals received compound <b>24</b> at 40 mg/kg BID for 8 days. Animals were monitored for weight loss, bioluminescence imaging, and survival for 30 days. At the end of 30 days, animals were examined for presence of cysts in the brain and by bioassay by inoculation of brain homogenate (200 μL of 1 mL) into a naive recipient Ifngr1<sup>–/–</sup> mouse, as described above. There were no differences in outcome associated with the sex of animals.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Bioluminescence Imaging</h3><div class="NLM_p last">Animals were monitored for bioluminescence using a Xenogen IVIS200 instrument, and images were analyzed using the Xenogen Living Image software (Caliper Life Sciences). Mice were anesthetized using 2% isoflurane and injected ip with <span class="smallcaps smallerCapital">d</span>-luciferin (Biosynth AG) at 150 mg/mg just prior to imaging.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Statistical Analyses</h3><div class="NLM_p last">Mathematical and statistical analyses were conducted in Prism (GraphPad). IC<sub>50</sub> and EC<sub>50</sub> values were determined using normalized, log-transformed (concn) data fit with nonlinear regression analysis based on sigmoidal dose–response curves with variable slope. For correlating IC<sub>50</sub> to EC<sub>50</sub> values, <i>r</i><sup>2</sup> values were generated using linear regression analysis. Mean values for inhibition of bradyzoite plaque formation were analyzed using two-way ANOVA with Dunnett’s correction for multiple comparisons. Survival curves were plotted as Kaplan–Meier survival curves, and significance determined by the Mantel–Cox test. Mean values for bioluminescence and weight loss were compared using Student’s <i>t</i> test with Holm–Sidak correction for multiple tests. The average numbers of cysts per brain were compared using a Mann–Whitney nonparametric test for non-normally distributed data with unequal variance. For all tests, a minimum value of <i>P</i> ≤ 0.05 was considered significant, and individual values are given in the figure legends.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01192">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71410" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71410" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01192" class="ext-link">10.1021/acs.jmedchem.7b01192</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Compound synthesis, characterization, metabolism analysis, X-ray crystallography information, kinome profiling (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Compound <b>24</b> homology model (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_001.pdf">jm7b01192_si_001.pdf (9.83 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_002.pdb">jm7b01192_si_002.pdb (657.58 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_003.csv">jm7b01192_si_003.csv (2.29 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The structure factors and pdb coordinates have been deposited at the protein databank (PDB) with the coordinates <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IHP">4IHP</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W8R">5W8R</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W80">5W80</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W9E">5W9E</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W91">5W91</a>. Compound 24 was modeled using the co-crystal structure of compound 13 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W9E">5W9E</a>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01192" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">L. David Sibley</span> - <span class="hlFld-Affiliation affiliation">Department of Molecular Microbiology, Washington
University School of Medicine, St. Louis, Missouri 63130, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7110-0285" title="Orcid link">http://orcid.org/0000-0001-7110-0285</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#42312b202e273b02353731362e6c272637"><span class="__cf_email__" data-cfemail="07746e656b627e47707274736b29626372">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florentine U. Rutaganira</span> - <span class="hlFld-Affiliation affiliation">Howard Hughes Medical
Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94158, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Barks</span> - <span class="hlFld-Affiliation affiliation">Department of Molecular Microbiology, Washington
University School of Medicine, St. Louis, Missouri 63130, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Savari Dhason</span> - <span class="hlFld-Affiliation affiliation">Department of Molecular Microbiology, Washington
University School of Medicine, St. Louis, Missouri 63130, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiuling Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Molecular Microbiology, Washington
University School of Medicine, St. Louis, Missouri 63130, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael S. Lopez</span> - <span class="hlFld-Affiliation affiliation">Howard Hughes Medical
Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94158, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shaojun Long</span> - <span class="hlFld-Affiliation affiliation">Department of Molecular Microbiology, Washington
University School of Medicine, St. Louis, Missouri 63130, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joshua B. Radke</span> - <span class="hlFld-Affiliation affiliation">Department of Molecular Microbiology, Washington
University School of Medicine, St. Louis, Missouri 63130, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathaniel G. Jones</span> - <span class="hlFld-Affiliation affiliation">Department of Molecular Microbiology, Washington
University School of Medicine, St. Louis, Missouri 63130, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amarendar R. Maddirala</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry and Molecular
Biophysics, Washington University School
of Medicine, St. Louis, Missouri 63130, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James W. Janetka</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry and Molecular
Biophysics, Washington University School
of Medicine, St. Louis, Missouri 63130, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Majida El Bakkouri</span> - <span class="hlFld-Affiliation affiliation">Structural Genomics Consortium, University of Toronto, MaRS South Tower, 101 College St, Toronto, ON M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raymond Hui</span> - <span class="hlFld-Affiliation affiliation">Structural Genomics Consortium, University of Toronto, MaRS South Tower, 101 College St, Toronto, ON M5G 1L7, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Toronto General Hospital Research Institute, 200 Elizabeth St., Toronto, ON M5G
2C4, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevan M. Shokat</span> - <span class="hlFld-Affiliation affiliation">Howard Hughes Medical
Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94158, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6900-8380" title="Orcid link">http://orcid.org/0000-0002-6900-8380</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.B., M.S.D., and Q.W., listed alphabetically, contributed equally. F.U.R. and M.S.L. performed the chemical syntheses and physical characterization of the compounds described here. J.B. performed the in vitro cell-based assays for parasite and host cell growth inhibition. M.S.D. and S.L. performed the enzyme purification and enzyme assays. Q.W. conducted the animal studies with assistance from L.D.S. N.J. and J.B.R. performed the ex vivo tissue cyst experiments. A.R.M. purified select chemicals for in vivo studies. J.W.J. provided advice on chemical synthesis. M.E.B. and R.H. performed the structural studies. L.D.S. and K.M.S. supervised the research. F.U.R. and L.D.S. performed data analyses, generated the figures, and wrote the manuscript with input from all authors.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d115e2935-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48313" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48313" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Keliang Tang who performed the initial studies on enzyme kinetics and established the enzyme assays and to Martin John Rodgers for his early support of this project. We also thank John R. Walker of the Structural Genomics Consortium for verifying the crystallographic structures and for their deposition into the Protein Data Bank and the UCSF NMR Lab and QB3/Chemistry Mass Spectrometry Facility (University of California, Berkeley) for access to instrumentation for compound characterization. Supported by a grant from the NIH (AI094098 to K.M.S. and L.D.S.). The compounds reported here are the subject of patent applications filed by UCSF and Washington University.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> Abbreviations Used:</h2><tr><td class="NLM_term">ANOVA</td><td class="NLM_def"><p class="first last">analysis of variance</p></td></tr><tr><td class="NLM_term">β-gal</td><td class="NLM_def"><p class="first last">β-galactosidase</p></td></tr><tr><td class="NLM_term">BID</td><td class="NLM_def"><p class="first last">bis in die (twice a day)</p></td></tr><tr><td class="NLM_term">CDPK1</td><td class="NLM_def"><p class="first last">calcium dependent protein kinase 1</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% effective concentration</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">HAART</td><td class="NLM_def"><p class="first last">highly active antiretroviral therapy</p></td></tr><tr><td class="NLM_term">HFF</td><td class="NLM_def"><p class="first last">human foreskin fibroblast</p></td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% inhibitor concentration</p></td></tr><tr><td class="NLM_term">FLUC</td><td class="NLM_def"><p class="first last">firefly luciferase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36573" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36573" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 51 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Montoya, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesenfeld, O.</span><span> </span><span class="NLM_article-title">Toxoplasmosis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1965</span><span class="NLM_x">–</span> <span class="NLM_lpage">1976</span><span class="refDoi"> DOI: 10.1016/S0140-6736(04)16412-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2FS0140-6736%2804%2916412-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=15194258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVemuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2004&pages=1965-1976&author=J.+G.+Montoyaauthor=O.+Liesenfeld&title=Toxoplasmosis&doi=10.1016%2FS0140-6736%2804%2916412-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasmosis</span></div><div class="casAuthors">Montoya, J. G.; Liesenfeld, O.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">9425</span>),
    <span class="NLM_cas:pages">1965-1976</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Toxoplasma gondii is a protozoan parasite that infects up to a third of the world's population.  Infection is mainly acquired by ingestion of food or water that is contaminated with oocysts shed by cats or by eating undercooked or raw meat contg. tissue cysts.  Primary infection is usually subclin. but in some patients cervical lymphadenopathy or ocular disease can be present.  Infection acquired during pregnancy may cause severe damage to the fetus.  In immunocompromised patients, reactivation of latent disease can cause life-threatening encephalitis.  Diagnosis of toxoplasmosis can be established by direct detection of the parasite or by serol. techniques.  The most commonly used therapeutic regimen, and probably the most effective, is the combination of pyrimethamine with sulfadiazine and folinic acid.  This Seminar provides an overview and update on management of patients with acute infection, pregnant women who acquire infection during gestation, fetuses or infants who are congenitally infected, those with ocular disease, and immunocompromised individuals.  Controversy about the effectiveness of primary and secondary prevention in pregnant women is discussed.  Important topics of current and future research are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjtqSI8fuY4rVg90H21EOLACvtfcHk0lij8zKqwAHbZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVemuro%253D&md5=7fe37d0af87e4bbff2e087b416dcf5c0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2804%2916412-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252804%252916412-X%26sid%3Dliteratum%253Aachs%26aulast%3DMontoya%26aufirst%3DJ.%2BG.%26aulast%3DLiesenfeld%26aufirst%3DO.%26atitle%3DToxoplasmosis%26jtitle%3DLancet%26date%3D2004%26volume%3D363%26spage%3D1965%26epage%3D1976%26doi%3D10.1016%2FS0140-6736%2804%2916412-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Dennis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napravnik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sena, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eron, J. J.</span><span> </span><span class="NLM_article-title">Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span><span class="refDoi"> DOI: 10.1093/cid/cir434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1093%2Fcid%2Fcir434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=21844031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADC%252BC3MjmsF2kuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2011&pages=480-487&author=A.+M.+Dennisauthor=S.+Napravnikauthor=A.+C.+Senaauthor=J.+J.+Eron&title=Late+entry+to+HIV+care+among+Latinos+compared+with+non-Latinos+in+a+southeastern+US+cohort&doi=10.1093%2Fcid%2Fcir434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort</span></div><div class="casAuthors">Dennis Ann M; Napravnik Sonia; Sena Arlene C; Eron Joseph J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">480-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Late diagnosis of human immunodeficiency virus (HIV) infection remains common despite advances in therapy and prognosis.  The southeastern United States is a rapidly growing Latino settlement area where ethnic disparities may contribute to late presentation to care.  METHODS:  We assessed demographic and clinical factors between racial/ethnic groups at the time of HIV care initiation in the University of North Carolina Center for AIDS Research Clinical Cohort.  We identified independent predictors of late presentation, defined as a CD4(+) T lymphocyte (CD4) count <350 cells/mm(3) or an AIDS-defining event (ADE), using log-linear binomial regression.  RESULTS:  During the period 1999-2009, 853 patients initiated HIV care, of whom 11% were Latino, 28% were white, and 61% were black.  Median initial CD4 counts were lower for Latino patients (186 cells/mm(3)) than white patients (292 cells/mm(3); P = .006) and black patients (302 cells/mm(3); P = .02).  Latino persons were more likely to be late presenters than white or black persons (76% vs 58%; P < .001) and accounted for 86%, 75%, and 50% of all presenting cases of active tuberculosis, histoplasmosis, and toxoplasmosis, respectively.  Latino ethnicity, older age, male sex, and earlier entry year were independently associated with late presentation (P < .05 for all).  In multivariable analyses, Latino persons were 1.29 times more likely to present to care late than white or black persons (95% confidence interval, 1.15-1.45).  CONCLUSIONS:  Latinos are more likely to initiate HIV care later in the course of illness than are black and white persons and account for a majority of several ADEs.  Strategies to improve earlier HIV testing among Latinos in new settlement areas are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnoJeuH0wzSWxpATR2EQURfW6udTcc2eZwcyCxeiFk4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjmsF2kuw%253D%253D&md5=8953553d1fc7a52123825a6d7eab4a0c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcir434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcir434%26sid%3Dliteratum%253Aachs%26aulast%3DDennis%26aufirst%3DA.%2BM.%26aulast%3DNapravnik%26aufirst%3DS.%26aulast%3DSena%26aufirst%3DA.%2BC.%26aulast%3DEron%26aufirst%3DJ.%2BJ.%26atitle%3DLate%2520entry%2520to%2520HIV%2520care%2520among%2520Latinos%2520compared%2520with%2520non-Latinos%2520in%2520a%2520southeastern%2520US%2520cohort%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2011%26volume%3D53%26spage%3D480%26epage%3D487%26doi%3D10.1093%2Fcid%2Fcir434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kiderlen, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesenfeld, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schurmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T.</span><span> </span><span class="NLM_article-title">Toxoplasmic encephalitis in AIDS-patients before and after the introduction of highly active antiretroviral therapy (HAART)</span> <span class="citation_source-journal">Eur. J. Clin. Microbiol. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1521</span><span class="NLM_x">–</span> <span class="NLM_lpage">1525</span><span class="refDoi"> DOI: 10.1007/s10096-011-1254-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1007%2Fs10096-011-1254-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=1521-1525&author=T.+R.+Kiderlenauthor=O.+Liesenfeldauthor=D.+Schurmannauthor=T.+Schneider&title=Toxoplasmic+encephalitis+in+AIDS-patients+before+and+after+the+introduction+of+highly+active+antiretroviral+therapy+%28HAART%29&doi=10.1007%2Fs10096-011-1254-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs10096-011-1254-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10096-011-1254-6%26sid%3Dliteratum%253Aachs%26aulast%3DKiderlen%26aufirst%3DT.%2BR.%26aulast%3DLiesenfeld%26aufirst%3DO.%26aulast%3DSchurmann%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DT.%26atitle%3DToxoplasmic%2520encephalitis%2520in%2520AIDS-patients%2520before%2520and%2520after%2520the%2520introduction%2520of%2520highly%2520active%2520antiretroviral%2520therapy%2520%2528HAART%2529%26jtitle%3DEur.%2520J.%2520Clin.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2011%26volume%3D30%26spage%3D1521%26epage%3D1525%26doi%3D10.1007%2Fs10096-011-1254-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Oliveira, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greco, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christo, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimaraes, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, R. C.</span><span> </span><span class="NLM_article-title">Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience</span> <span class="citation_source-journal">Rev. Soc. Bras. Med. Trop.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1590/S0037-86822006000200002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1590%2FS0037-86822006000200002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=16699639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADC%252BD283ntVyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=146-151&author=J.+F.+Oliveiraauthor=D.+B.+Grecoauthor=G.+C.+Oliveiraauthor=P.+P.+Christoauthor=M.+D.+Guimaraesauthor=R.+C.+Oliveira&title=Neurological+disease+in+HIV-infected+patients+in+the+era+of+highly+active+antiretroviral+treatment%3A+a+Brazilian+experience&doi=10.1590%2FS0037-86822006000200002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience</span></div><div class="casAuthors">Oliveira Jacqueline Ferreira de; Greco Dirceu Bartolomeu; Oliveira Guilherme Correa; Christo Paulo Pereira; Guimaraes Mark Drew Crosland; Oliveira Rodrigo Correa</div><div class="citationInfo"><span class="NLM_cas:title">Revista da Sociedade Brasileira de Medicina Tropical</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-51</span>
        ISSN:<span class="NLM_cas:issn">0037-8682</span>.
    </div><div class="casAbstract">To study characteristics of neurological disorders in HIV/AIDS patients and their relationship to highly active antiretroviral treatment, a cross-sectional study was conducted in an infectious disease public hospital in Belo Horizonte, Brazil, between February 1999 and March 2000.  Of the 417 patients enrolled, neurological disease was observed in 194 (46.5%) and a new AIDS-defining neurological event developed in 23.7% of individuals.  Toxoplasmosis (42.3%), cryptococcosis meningitis (12.9%) and tuberculosis (10.8%) were the most common causes of neurological complications.  The majority (79.3%) of patients were on highly active antiretroviral treatment and these individuals using HAART showed higher CD4 cell counts (p = 0.014) and presented stable neurological disease (p = 0.0001), although no difference was found with respect to the profile of neurological complications.  The neurological diseases continue to be a frequent complication of HIV/AIDS and infections are still its main causes in Brazil, even in the highly active antiretroviral treatment era.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQqARn0gZHl4kFb3mqPUYDfW6udTcc2eaMVOzvpqbF3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283ntVyrsQ%253D%253D&md5=d2f7eb299c21df3f7f11949193c05717</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1590%2FS0037-86822006000200002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0037-86822006000200002%26sid%3Dliteratum%253Aachs%26aulast%3DOliveira%26aufirst%3DJ.%2BF.%26aulast%3DGreco%26aufirst%3DD.%2BB.%26aulast%3DOliveira%26aufirst%3DG.%2BC.%26aulast%3DChristo%26aufirst%3DP.%2BP.%26aulast%3DGuimaraes%26aufirst%3DM.%2BD.%26aulast%3DOliveira%26aufirst%3DR.%2BC.%26atitle%3DNeurological%2520disease%2520in%2520HIV-infected%2520patients%2520in%2520the%2520era%2520of%2520highly%2520active%2520antiretroviral%2520treatment%253A%2520a%2520Brazilian%2520experience%26jtitle%3DRev.%2520Soc.%2520Bras.%2520Med.%2520Trop.%26date%3D2006%26volume%3D39%26spage%3D146%26epage%3D151%26doi%3D10.1590%2FS0037-86822006000200002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Palella, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loveless, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satten, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmberg, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">The HIV Outpatient Study Investigators</span><span> </span><span class="NLM_article-title">Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span><span class="refDoi"> DOI: 10.1056/NEJM199803263381301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1056%2FNEJM199803263381301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=9516219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADyaK1c7mslyjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1998&pages=853-860&author=F.+J.+Palellaauthor=K.+M.+Delaneyauthor=A.+C.+Moormanauthor=M.+O.+Lovelessauthor=J.+Fuhrerauthor=G.+A.+Sattenauthor=D.+J.+Aschmanauthor=S.+D.+Holmbergauthor=The+HIV+Outpatient+Study+Investigators&title=Declining+morbidity+and+mortality+among+patients+with+advanced+human+immunodeficiency+virus+infection&doi=10.1056%2FNEJM199803263381301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators</span></div><div class="casAuthors">Palella F J Jr; Delaney K M; Moorman A C; Loveless M O; Fuhrer J; Satten G A; Aschman D J; Holmberg S D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">853-60</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND AND METHODS:  National surveillance data show recent, marked reductions in morbidity and mortality associated with the acquired immunodeficiency syndrome (AIDS).  To evaluate these declines, we analyzed data on 1255 patients, each of whom had at least one CD4+ count below 100 cells per cubic millimeter, who were seen at nine clinics specializing in the treatment of human immunodeficiency virus (HIV) infection in eight U.S. cities from January 1994 through June 1997.  RESULTS:  Mortality among the patients declined from 29.4 per 100 person-years in the first quarter of 1995 to 8.8 per 100 in the second quarter of 1997.  There were reductions in mortality regardless of sex, race, age, and risk factors for transmission of HIV.  The incidence of any of three major opportunistic infections (Pneumocystis carinii pneumonia, Mycobacterium avium complex disease, and cytomegalovirus retinitis) declined from 21.9 per 100 person-years in 1994 to 3.7 per 100 person-years by mid-1997.  In a failure-rate model, increases in the intensity of antiretroviral therapy (classified as none, monotherapy, combination therapy without a protease inhibitor, and combination therapy with a protease inhibitor) were associated with stepwise reductions in morbidity and mortality.  Combination antiretroviral therapy was associated with the most benefit; the inclusion of protease inhibitors in such regimens conferred additional benefit.  Patients with private insurance were more often prescribed protease inhibitors and had lower mortality rates than those insured by Medicare or Medicaid.  CONCLUSIONS:  The recent declines in morbidity and mortality due to AIDS are attributable to the use of more intensive antiretroviral therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6uVwzPlrzo4IRAdBLKY41fW6udTcc2eaMVOzvpqbF3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7mslyjuw%253D%253D&md5=63bd6978cc957517f4bcfae251adc3ef</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJM199803263381301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199803263381301%26sid%3Dliteratum%253Aachs%26aulast%3DPalella%26aufirst%3DF.%2BJ.%26aulast%3DDelaney%26aufirst%3DK.%2BM.%26aulast%3DMoorman%26aufirst%3DA.%2BC.%26aulast%3DLoveless%26aufirst%3DM.%2BO.%26aulast%3DFuhrer%26aufirst%3DJ.%26aulast%3DSatten%26aufirst%3DG.%2BA.%26aulast%3DAschman%26aufirst%3DD.%2BJ.%26aulast%3DHolmberg%26aufirst%3DS.%2BD.%26aulast%3D%26atitle%3DDeclining%2520morbidity%2520and%2520mortality%2520among%2520patients%2520with%2520advanced%2520human%2520immunodeficiency%2520virus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D338%26spage%3D853%26epage%3D860%26doi%3D10.1056%2FNEJM199803263381301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Israelski, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remington, J. S.</span><span> </span><span class="NLM_article-title">Toxoplasmosis in the non-AIDS immunocompromised host</span> <span class="citation_source-journal">Curr. Clin. Top. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=8397917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADyaK2c%252FgtVGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=322-356&author=D.+M.+Israelskiauthor=J.+S.+Remington&title=Toxoplasmosis+in+the+non-AIDS+immunocompromised+host"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasmosis in the non-AIDS immunocompromised host</span></div><div class="casAuthors">Israelski D M; Remington J S</div><div class="citationInfo"><span class="NLM_cas:title">Current clinical topics in infectious diseases</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">322-56</span>
        ISSN:<span class="NLM_cas:issn">0195-3842</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTywXsaUPD8jYMcDoIzZtNkfW6udTcc2ebUB36zAGt6F7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FgtVGjsQ%253D%253D&md5=3406defb6b29dc6140e9eb0a1ada956c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsraelski%26aufirst%3DD.%2BM.%26aulast%3DRemington%26aufirst%3DJ.%2BS.%26atitle%3DToxoplasmosis%2520in%2520the%2520non-AIDS%2520immunocompromised%2520host%26jtitle%3DCurr.%2520Clin.%2520Top.%2520Infect.%2520Dis.%26date%3D1993%26volume%3D13%26spage%3D322%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Arantes, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silveira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldhardt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belfort, R.,  Jr.</span><span> </span><span class="NLM_article-title">Ocular involvement following postnatally acquired <i>Toxoplasma gondii</i> infection in southern Brazil: A 28-year experience</span> <span class="citation_source-journal">Am. J. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">1002</span><span class="refDoi"> DOI: 10.1016/j.ajo.2015.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2Fj.ajo.2015.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=25743338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADC%252BC2Mnht1ensw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2015&pages=1002&author=T.+E.+Arantesauthor=C.+Silveiraauthor=G.+N.+Hollandauthor=C.+Muccioliauthor=F.+Yuauthor=J.+L.+Jonesauthor=R.+Goldhardtauthor=K.+G.+Lewisauthor=R.+Belfort&title=Ocular+involvement+following+postnatally+acquired+Toxoplasma+gondii+infection+in+southern+Brazil%3A+A+28-year+experience&doi=10.1016%2Fj.ajo.2015.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Ocular Involvement Following Postnatally Acquired Toxoplasma gondii Infection in Southern Brazil: A 28-Year Experience</span></div><div class="casAuthors">Arantes Tiago E F; Silveira Claudio; Holland Gary N; Muccioli Cristina; Belfort Rubens Jr; Yu Fei; Goldhardt Raquel; Lewis Kevan G; Jones Jeffrey L</div><div class="citationInfo"><span class="NLM_cas:title">American journal of ophthalmology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1002-1012.e2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To determine the incidence of, and risk factors for, ocular involvement among people known to have postnatally acquired Toxoplasma gondii infection in a region of southern Brazil where there is a high prevalence of endemic disease.  DESIGN:  Retrospective longitudinal cohort study.  METHODS:  Records of 302 patients with serologic evidence of recent T gondii infection (a positive anti-T gondii IgM antibody test) from Erechim, Rio Grande do Sul state, Brazil (1974-2002) were analyzed.  The incidence of ocular involvement was calculated in terms of person-years (PY) of follow-up.  Risk factors for ocular involvement were analyzed using log-rank and Fisher exact tests.  RESULTS:  At initial ocular examination (baseline), 30 patients (9.9%) had intraocular inflammation only (anterior chamber cells and flare, vitreous inflammatory reactions, retinal whitening), without clinically apparent necrotizing retinochoroiditis.  At baseline, men were more likely to have ocular involvement (P = .043) and antiparasitic treatment was associated with less ocular involvement (P = .015).  Follow-up examinations were performed on 255 patients (median follow-up, 13.7 months [range 0.4-261.9 months]).  Among those without ocular involvement at baseline, the incidence of necrotizing retinochoroiditis was 6.4/100 PY.  Patients >40 years of age at first IgM test had a greater risk of incident necrotizing retinochoroiditis (hazard ratio = 4.47, 95% CI = 1.67-11.93, P = .003) than younger patients.  The incidence of recurrent necrotizing retinochoroiditis was 10.5/100 PY.  CONCLUSION:  Isolated intraocular inflammatory reactions can be an initial manifestation of T gondii infection, with necrotizing retinochoroiditis occurring months or years later.  Male sex and older age are risk factors for toxoplasmic retinochoroiditis.  Antitoxoplasmic treatment may protect against early ocular involvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgOsPLFPhvd8KL0FlyGHDofW6udTcc2ebUB36zAGt6F7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mnht1ensw%253D%253D&md5=7012af4f07b5e4017c49a434a135e634</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ajo.2015.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajo.2015.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DArantes%26aufirst%3DT.%2BE.%26aulast%3DSilveira%26aufirst%3DC.%26aulast%3DHolland%26aufirst%3DG.%2BN.%26aulast%3DMuccioli%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DJones%26aufirst%3DJ.%2BL.%26aulast%3DGoldhardt%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DK.%2BG.%26aulast%3DBelfort%26aufirst%3DR.%26atitle%3DOcular%2520involvement%2520following%2520postnatally%2520acquired%2520Toxoplasma%2520gondii%2520infection%2520in%2520southern%2520Brazil%253A%2520A%252028-year%2520experience%26jtitle%3DAm.%2520J.%2520Ophthalmol.%26date%3D2015%26volume%3D159%26spage%3D1002%26doi%3D10.1016%2Fj.ajo.2015.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Jacobson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainey, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raasch, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, B. J.</span><span> </span><span class="NLM_article-title">Pyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for <i>Toxoplasma gondii</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1360</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=1360-1365&author=J.+M.+Jacobsonauthor=M.+Davidianauthor=P.+M.+Raineyauthor=R.+Hafnerauthor=R.+H.+Raaschauthor=B.+J.+Luft&title=Pyrimethamine+pharmacokinetics+in+human+immunodeficiency+virus-positive+patients+seropositive+for+Toxoplasma+gondii"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DJ.%2BM.%26aulast%3DDavidian%26aufirst%3DM.%26aulast%3DRainey%26aufirst%3DP.%2BM.%26aulast%3DHafner%26aufirst%3DR.%26aulast%3DRaasch%26aufirst%3DR.%2BH.%26aulast%3DLuft%26aufirst%3DB.%2BJ.%26atitle%3DPyrimethamine%2520pharmacokinetics%2520in%2520human%2520immunodeficiency%2520virus-positive%2520patients%2520seropositive%2520for%2520Toxoplasma%2520gondii%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1996%26volume%3D40%26spage%3D1360%26epage%3D1365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">McCabe, R. E.</span><span> </span><span class="NLM_article-title">Antitoxoplasma chemotherapy</span>. In  <span class="citation_source-book">Toxoplasmosis: a Comprehensive Clinical Guide</span>; <span class="NLM_contrib-group">Joynson, D. H. M.; Wreghitt, T. G.</span>, Eds.; <span class="NLM_publisher-name">Cambridge Univ. Press</span>: <span class="NLM_publisher-loc">Cambridge</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1017%2FCBO9780511527005.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=319-359&author=R.+E.+McCabeauthor=D.+H.+M.+Joynson&author=T.+G.+Wreghitt&title=Toxoplasmosis%3A+a+Comprehensive+Clinical+Guide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1017%2FCBO9780511527005.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1017%252FCBO9780511527005.015%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DR.%2BE.%26atitle%3DAntitoxoplasma%2520chemotherapy%26btitle%3DToxoplasmosis%253A%2520a%2520Comprehensive%2520Clinical%2520Guide%26aulast%3DJoynson%26aufirst%3DD.%2BH.%2BM.%26pub%3DCambridge%2520Univ.%2520Press%26date%3D2001%26spage%3D319%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Weiss, L. M.; Kim, K.</span><span> </span><span class="NLM_article-title">Bradyzoite development</span>. In  <span class="citation_source-book">Toxoplasma gondii the Model Apicomplexan: Perspectives and Methods</span>; <span class="NLM_contrib-group">Weiss, L. M.; Kim, K.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2FB978-012369542-0%2F50015-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=341-366&author=L.+M.+Weiss&author=K.+Kimauthor=L.+M.+Weiss&author=K.+Kim&title=Toxoplasma+gondii+the+Model+Apicomplexan%3A+Perspectives+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FB978-012369542-0%2F50015-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-012369542-0%252F50015-5%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DL.%2BM.%26atitle%3DBradyzoite%2520development%26btitle%3DToxoplasma%2520gondii%2520the%2520Model%2520Apicomplexan%253A%2520Perspectives%2520and%2520Methods%26aulast%3DWeiss%26aufirst%3DL.%2BM.%26pub%3DAcademic%2520Press%26date%3D2007%26spage%3D341%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Watts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patwardhan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinai, A. P.</span><span> </span><span class="NLM_article-title">Novel approaches reveal that <i>Toxoplasma gondii</i> bradyzoites within tissue cysts are dynamic and replicating entities in vivo</span> <span class="citation_source-journal">mBio</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e01155-15</span><span class="refDoi"> DOI: 10.1128/mBio.01155-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FmBio.01155-15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=e01155-15&author=E.+Wattsauthor=Y.+Zhaoauthor=A.+Dharaauthor=B.+Ellerauthor=A.+Patwardhanauthor=A.+P.+Sinai&title=Novel+approaches+reveal+that+Toxoplasma+gondii+bradyzoites+within+tissue+cysts+are+dynamic+and+replicating+entities+in+vivo&doi=10.1128%2FmBio.01155-15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FmBio.01155-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01155-15%26sid%3Dliteratum%253Aachs%26aulast%3DWatts%26aufirst%3DE.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DDhara%26aufirst%3DA.%26aulast%3DEller%26aufirst%3DB.%26aulast%3DPatwardhan%26aufirst%3DA.%26aulast%3DSinai%26aufirst%3DA.%2BP.%26atitle%3DNovel%2520approaches%2520reveal%2520that%2520Toxoplasma%2520gondii%2520bradyzoites%2520within%2520tissue%2520cysts%2520are%2520dynamic%2520and%2520replicating%2520entities%2520in%2520vivo%26jtitle%3DmBio%26date%3D2015%26volume%3D6%26spage%3De01155-15%26doi%3D10.1128%2FmBio.01155-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lourido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span> </span><span class="NLM_article-title">Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.1038/nature09022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1038%2Fnature09022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=20485436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1Oisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=359-362&author=S.+Louridoauthor=J.+Shumanauthor=C.+Zhangauthor=K.+M.+Shokatauthor=R.+Huiauthor=L.+D.+Sibley&title=Calcium-dependent+protein+kinase+1+is+an+essential+regulator+of+exocytosis+in+Toxoplasma&doi=10.1038%2Fnature09022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma</span></div><div class="casAuthors">Lourido, Sebastian; Shuman, Joel; Zhang, Chao; Shokat, Kevan M.; Hui, Raymond; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7296</span>),
    <span class="NLM_cas:pages">359-362</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calcium-regulated exocytosis is a ubiquitous process in eukaryotes, whereby secretory vesicles fuse with the plasma membrane and release their contents in response to an intracellular calcium surge.  This process regulates various cellular functions such as plasma membrane repair in plants and animals, the discharge of defensive spikes in Paramecium, and the secretion of insulin from pancreatic cells, immune modulators from lymphocytes, and chem. transmitters from neurons.  In animal cells, serine/threonine kinases including cAMP-dependent protein kinase, protein kinase C and calmodulin kinases have been implicated in calcium-signal transduction leading to regulated secretion.  Although plants and protozoa also regulate secretion by means of intracellular calcium, the method by which these signals are relayed has not been explained.  Here we show that the Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) is an essential regulator of calcium-dependent exocytosis in this opportunistic human pathogen.  Conditional suppression of TgCDPK1 revealed that it controls calcium-dependent secretion of specialized organelles called micronemes, resulting in a block of essential phenotypes including parasite motility, host-cell invasion, and egress.  These phenotypes were recapitulated by using a chem. biol. approach in which pyrazolopyrimidine-derived compds. specifically inhibited TgCDPK1 and disrupted the parasite's life cycle at stages dependent on microneme secretion.  Inhibition was specific to TgCDPK1, because expression of a resistant mutant kinase reversed sensitivity to the inhibitor.  TgCDPK1 is conserved among apicomplexans and belongs to a family of kinases shared with plants and ciliates, suggesting that related CDPKs may have a function in calcium-regulated secretion in other organisms.  Because this kinase family is absent from mammalian hosts, it represents a validated target that may be exploitable for chemotherapy against T. gondii and related apicomplexans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5sWOGpkZQn7Vg90H21EOLACvtfcHk0ljblGHP6c-Yyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1Oisr0%253D&md5=750f6bf5c933759605574d4a2ab5accc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature09022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09022%26sid%3Dliteratum%253Aachs%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DShuman%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DHui%26aufirst%3DR.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DCalcium-dependent%2520protein%2520kinase%25201%2520is%2520an%2520essential%2520regulator%2520of%2520exocytosis%2520in%2520Toxoplasma%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D359%26epage%3D362%26doi%3D10.1038%2Fnature09022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyloun, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaneda, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRocher, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inampudi, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakaki, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napuli, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hol, W. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, C.</span><span> </span><span class="NLM_article-title"><i>Toxoplasma gondii</i> calcium-dependent protein kinase 1 is a target for selective kinase inhibitors</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">602</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span><span class="refDoi"> DOI: 10.1038/nsmb.1818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1038%2Fnsmb.1818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=20436472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVyiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=602-607&author=K.+K.+Ojoauthor=E.+T.+Larsonauthor=K.+R.+Keylounauthor=L.+J.+Castanedaauthor=A.+E.+DeRocherauthor=K.+K.+Inampudiauthor=J.+E.+Kimauthor=T.+L.+Arakakiauthor=R.+C.+Murphyauthor=L.+Zhangauthor=A.+J.+Napuliauthor=D.+J.+Malyauthor=C.+L.+M.+J.+Verlindeauthor=F.+S.+Bucknerauthor=M.+Parsonsauthor=W.+G.+J.+Holauthor=E.+A.+Merrittauthor=C.+Van+Voorhis&title=Toxoplasma+gondii+calcium-dependent+protein+kinase+1+is+a+target+for+selective+kinase+inhibitors&doi=10.1038%2Fnsmb.1818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors</span></div><div class="casAuthors">Ojo, Kayode K.; Larson, Eric T.; Keyloun, Katelyn R.; Castaneda, Lisa J.; De Rocher, Amy E.; Inampudi, Krishna K.; Kim, Jessica E.; Arakaki, Tracy L.; Murphy, Ryan C.; Zhang, Li; Napuli, Alberto J.; Maly, Dustin J.; Verlinde, Christophe L. M. J.; Buckner, Frederick S.; Parsons, Marilyn; Hol, Wim G. J.; Merritt, Ethan A.; Van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">602-607</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">New drugs are needed to treat toxoplasmosis.  Toxoplasma gondii calcium-dependent protein kinases (TgCDPKs) are attractive targets because they are absent in mammals.  We show that TgCDPK1 is inhibited by low nanomolar levels of bumped kinase inhibitors (BKIs), compds. inactive against mammalian kinases.  Cocrystal structures of TgCDPK1 with BKIs confirm that the structural basis for selectivity is due to the unique glycine gatekeeper residue in the ATP-binding site.  We show that BKIs interfere with an early step in T. gondii infection of human cells in culture.  Furthermore, we show that TgCDPK1 is the in vivo target of BKIs because T. gondii expressing a glycine to methionine gatekeeper mutant enzyme show significantly decreased sensitivity to BKIs.  Thus, design of selective TgCDPK1 inhibitors with low host toxicity may be achievable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiGhHqXpYi-7Vg90H21EOLACvtfcHk0ljp51QPMm0Qew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVyiurk%253D&md5=f1630eba0dd5dec19e8a095c041996b1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1818%26sid%3Dliteratum%253Aachs%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DKeyloun%26aufirst%3DK.%2BR.%26aulast%3DCastaneda%26aufirst%3DL.%2BJ.%26aulast%3DDeRocher%26aufirst%3DA.%2BE.%26aulast%3DInampudi%26aufirst%3DK.%2BK.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DArakaki%26aufirst%3DT.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNapuli%26aufirst%3DA.%2BJ.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%2BM.%2BJ.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DVan%2BVoorhis%26aufirst%3DC.%26atitle%3DToxoplasma%2520gondii%2520calcium-dependent%2520protein%2520kinase%25201%2520is%2520a%2520target%2520for%2520selective%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D602%26epage%3D607%26doi%3D10.1038%2Fnsmb.1818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wernimont, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finerty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allali-Hassani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">senisterra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lourido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, R.</span><span> </span><span class="NLM_article-title">Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span><span class="refDoi"> DOI: 10.1038/nsmb.1795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1038%2Fnsmb.1795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=20436473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVyhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=596-601&author=A.+K.+Wernimontauthor=J.+D.+Artzauthor=P.+Finertyauthor=Y.+Linauthor=M.+Amaniauthor=A.+Allali-Hassaniauthor=G.+senisterraauthor=M.+Vedadiauthor=W.+Tempelauthor=F.+Mackenzieauthor=I.+Chauauthor=S.+Louridoauthor=L.+D.+Sibleyauthor=R.+Hui&title=Structures+of+apicomplexan+calcium-dependent+protein+kinases+reveal+mechanism+of+activation+by+calcium&doi=10.1038%2Fnsmb.1795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium</span></div><div class="casAuthors">Wernimont, Amy K.; Artz, Jennifer D.; Finerty, Patrick, Jr.; Lin, Yu-Hui; Amani, Mehrnaz; Allali-Hassani, Abdellah; Senisterra, Guillermo; Vedadi, Masoud; Tempel, Wolfram; MacKenzie, Farrell; Chau, Irene; Lourido, Sebastian; Sibley, L. David; Hui, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calcium-dependent protein kinases (CDPKs) have pivotal roles in the calcium-signaling pathway in plants, ciliates and apicomplexan parasites and comprise a calmodulin-dependent kinase (CaMK)-like kinase domain regulated by a calcium-binding domain in the C terminus.  To understand this intramol. mechanism of activation, we solved the structures of the autoinhibited (apo) and activated (calcium-bound) conformations of CDPKs from the apicomplexan parasites Toxoplasma gondii and Cryptosporidium parvum.  In the apo form, the C-terminal CDPK activation domain (CAD) resembles a calmodulin protein with an unexpected long helix in the N terminus that inhibits the kinase domain in the same manner as CaMKII.  Calcium binding triggers the reorganization of the CAD into a highly intricate fold, leading to its relocation around the base of the kinase domain to a site remote from the substrate binding site.  This large conformational change constitutes a distinct mechanism in calcium signal-transduction pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPNbf5csvAT7Vg90H21EOLACvtfcHk0ljp51QPMm0Qew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVyhsr0%253D&md5=7e34915b35107e30227a6a786f397da7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1795%26sid%3Dliteratum%253Aachs%26aulast%3DWernimont%26aufirst%3DA.%2BK.%26aulast%3DArtz%26aufirst%3DJ.%2BD.%26aulast%3DFinerty%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DAmani%26aufirst%3DM.%26aulast%3DAllali-Hassani%26aufirst%3DA.%26aulast%3Dsenisterra%26aufirst%3DG.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DTempel%26aufirst%3DW.%26aulast%3DMackenzie%26aufirst%3DF.%26aulast%3DChau%26aufirst%3DI.%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26aulast%3DHui%26aufirst%3DR.%26atitle%3DStructures%2520of%2520apicomplexan%2520calcium-dependent%2520protein%2520kinases%2520reveal%2520mechanism%2520of%2520activation%2520by%2520calcium%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D596%26epage%3D601%26doi%3D10.1038%2Fnsmb.1795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span><span class="refDoi"> DOI: 10.1126/science.1075762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome&doi=10.1126%2Fscience.1075762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0ljPxJGOYZunig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934%26doi%3D10.1126%2Fscience.1075762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Bakkouri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span> </span><span class="NLM_article-title">Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span><span class="refDoi"> DOI: 10.1016/j.tips.2015.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2Fj.tips.2015.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=26002073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVWitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=452-460&author=R.+Huiauthor=M.+El+Bakkouriauthor=L.+D.+Sibley&title=Designing+selective+inhibitors+for+calcium-dependent+protein+kinases+in+apicomplexans&doi=10.1016%2Fj.tips.2015.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans</span></div><div class="casAuthors">Hui, Raymond; El Bakkouri, Majida; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">452-460</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Apicomplexan parasites cause some of the most severe human diseases, including malaria (caused by Plasmodium), toxoplasmosis, and cryptosporidiosis.  Treatments are limited by the lack of effective drugs and development of resistance to available agents.  By exploiting novel features of protein kinases in these parasites, it may be possible to develop new treatments.  We summarize here recent advances in identifying small mol. inhibitors against a novel family of plant-like, calcium-dependent kinases that are uniquely expanded in apicomplexan parasites.  Anal. of the 3D structure, activation mechanism, and sensitivity to small mols. had identified several attractive chem. scaffolds that are potent and selective inhibitors of these parasite kinases.  Further optimization of these leads may yield promising new drugs for treatment of these parasitic infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-4M4FEBeFQrVg90H21EOLACvtfcHk0ljPxJGOYZunig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVWitLk%253D&md5=0081edfce5d381c6a34c396b011c24b8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DR.%26aulast%3DEl%2BBakkouri%26aufirst%3DM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DDesigning%2520selective%2520inhibitors%2520for%2520calcium-dependent%2520protein%2520kinases%2520in%2520apicomplexans%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D452%26epage%3D460%26doi%3D10.1016%2Fj.tips.2015.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bishop, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witucki, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Design of allele-specific inhibitors to probe protein kinase signaling</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span><span class="refDoi"> DOI: 10.1016/S0960-9822(98)70198-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2FS0960-9822%2898%2970198-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=9501066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADyaK1cXhvVWqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=257-266&author=A.+C.+Bishopauthor=K.+Shahauthor=Y.+Liuauthor=L.+Wituckiauthor=C.+Kungauthor=K.+M.+Shokat&title=Design+of+allele-specific+inhibitors+to+probe+protein+kinase+signaling&doi=10.1016%2FS0960-9822%2898%2970198-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Design of allele-specific inhibitors to probe protein kinase signaling</span></div><div class="casAuthors">Bishop, Anthony C.; Shah, Kavita; Liu, Yi; Witucki, Laurie; Kung, Chi-yun; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">257-266</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">Deconvoluting protein kinase signaling pathways using conventional genetic and biochem. approaches has been difficult because of the overwhelming no. of closely related kinases.  If cell-permeable inhibitors of individual kinases could be designed, the role of each kinase could be systematically assessed.  The authors have devised an approach combining chem. and genetics to develop the first highly specific cell-permeable inhibitor of the oncogenic tyrosine kinase v-Src.  A functionally silent active-site mutation was made in v-Src to distinguish it from all other cellular kinases.  A tight-binding cell-permeable inhibitor of this mutant kinase that does not inhibit wild-type kinases was designed and synthesized.  In vitro and whole-cell assays established the unique specificity of the mutant v-Src-inhibitor pair.  The inhibitor reversed cell transformation by the engineered but not the 'wild type' v-Src, establishing that changes in cellular signaling can be attributed to specific inhibition of the engineered kinase.  The generality of the method was tested by engineering another tyrosine kinase, Fyn, to contain the corresponding active-site mutation to the one in v-Src.  The same compd. that inhibited mutant v-Src could also potently inhibit the engineered Fyn kinase.  Thus allele-specific cell-permeable inhibitors of individual Src family kinases can be rapidly developed in an approach that should be applicable to all kinases.  This approach will be useful for the deconvolution of kinase-mediated cellular pathways and for validating novel kinases as good targets for drug discovery both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLSMWJloQ0rbVg90H21EOLACvtfcHk0liq0RioIp0d7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvVWqtb0%253D&md5=5bceaa956d196318db19f20250b85f7d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2898%2970198-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252898%252970198-8%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DA.%2BC.%26aulast%3DShah%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWitucki%26aufirst%3DL.%26aulast%3DKung%26aufirst%3DC.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DDesign%2520of%2520allele-specific%2520inhibitors%2520to%2520probe%2520protein%2520kinase%2520signaling%26jtitle%3DCurr.%2520Biol.%26date%3D1998%26volume%3D8%26spage%3D257%26epage%3D266%26doi%3D10.1016%2FS0960-9822%2898%2970198-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witucki, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraybill, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubersax, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blethrow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Structural basis for selective inhibition of Src family kinases by PP1</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span><span class="refDoi"> DOI: 10.1016/S1074-5521(99)80118-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2FS1074-5521%2899%2980118-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10467133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFaqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=671-678&author=Y.+Liuauthor=A.+Bishopauthor=L.+Wituckiauthor=B.+Kraybillauthor=E.+Shimizuauthor=J.+Tsienauthor=J.+Ubersaxauthor=J.+Blethrowauthor=D.+O.+Morganauthor=K.+M.+Shokat&title=Structural+basis+for+selective+inhibition+of+Src+family+kinases+by+PP1&doi=10.1016%2FS1074-5521%2899%2980118-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for selective inhibition of Src family kinases by PP1</span></div><div class="casAuthors">Liu, Yi; Bishop, Anthony; Witucki, Laurie; Kraybill, Brian; Shimizu, Eiji; Tsien, Joe; Ubersax, Jeff; Blethrow, Justin; Morgan, David O.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">671-678</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that can target individual kinases are powerful tools for use in signal transduction research.  It is difficult to find such compds. because of the enormous no. of protein kinases and the highly conserved nature of their catalytic domains.  Recently, a novel, potent, Src family selective tyrosine kinase inhibitor was reported (PP1).  Here, we study the structural basis for this inhibitor's specificity for Src family kinases.  A single residue corresponding to Ile338 (v-Src numbering; Thr338 in c-Src) in Src family tyrosine kinases largely controls PP1's ability to inhibit protein kinases.  Mutation of Ile338 to a larger residue such as methionine or phenylalanine in v-Src makes this inhibitor less potent.  Conversely, mutation of Ile338 to alanine or glycine increases PP1's potency.  PP1 can inhibit Ser/Thr kinases if the residue corresponding to Ile338 in v-Src is mutated to glycine.  We have accurately predicted several non-Src family kinases that are moderately (IC50 ∼1 μM) inhibited by PP1, including c-Abl and the MAP kinase p38.  Our mutagenesis studies of the ATP-binding site in both tyrosine kinases and Ser/Thr kinases explain why PP1 is a specific inhibitor of Src family tyrosine kinases.  Detn. of the structural basis of inhibitor specificity will aid in the design of more potent and more selective protein kinase inhibitors.  The ability to desensitize a particular kinase to PP1 inhibition of residue 338 or conversely to sensitize a kinase to PP1 inhibition by mutation should provide a useful basis for chem. genetic studies of kinase signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC8HNYPVy4RLVg90H21EOLACvtfcHk0liq0RioIp0d7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFaqur4%253D&md5=4d09cc5fb95c2ed5d538c02f356c0842</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980118-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980118-5%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DBishop%26aufirst%3DA.%26aulast%3DWitucki%26aufirst%3DL.%26aulast%3DKraybill%26aufirst%3DB.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DTsien%26aufirst%3DJ.%26aulast%3DUbersax%26aufirst%3DJ.%26aulast%3DBlethrow%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DStructural%2520basis%2520for%2520selective%2520inhibition%2520of%2520Src%2520family%2520kinases%2520by%2520PP1%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D671%26epage%3D678%26doi%3D10.1016%2FS1074-5521%2899%2980118-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Johnson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geiger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRocher, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maly, D. J.</span><span> </span><span class="NLM_article-title">Development of <i>Toxoplasma gondii</i> calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2416</span><span class="NLM_x">–</span> <span class="NLM_lpage">2426</span><span class="refDoi"> DOI: 10.1021/jm201713h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201713h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVeksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2416-2426&author=S.+M.+Johnsonauthor=R.+C.+Murphyauthor=J.+A.+Geigerauthor=A.+E.+DeRocherauthor=Z.+Zhangauthor=K.+K.+Ojoauthor=E.+T.+Larsonauthor=B.+G.+Pereraauthor=E.+J.+Daleauthor=P.+Heauthor=M.+C.+Reidauthor=A.+M.+Foxauthor=N.+R.+Muellerauthor=E.+A.+Merrittauthor=E.+Fanauthor=M.+Parsonsauthor=W.+C.+Van+Voorhisauthor=D.+J.+Maly&title=Development+of+Toxoplasma+gondii+calcium-dependent+protein+kinase+1+%28TgCDPK1%29+inhibitors+with+potent+anti-toxoplasma+activity&doi=10.1021%2Fjm201713h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitors with Potent Anti-Toxoplasma Activity</span></div><div class="casAuthors">Johnson, Steven M.; Murphy, Ryan C.; Geiger, Jennifer A.; DeRocher, Amy E.; Zhang, Zhongsheng; Ojo, Kayode K.; Larson, Eric T.; Perera, B. Gayani K.; Dale, Edward J.; He, Panqing; Reid, Molly C.; Fox, Anna M. W.; Mueller, Natascha R.; Merritt, Ethan A.; Fan, Erkang; Parsons, Marilyn; Van Voorhis, Wesley C.; Maly, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2416-2426</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toxoplasmosis is a disease of prominent health concern that is caused by the protozoan parasite Toxoplasma gondii.  Proliferation of T. gondii is dependent on its ability to invade host cells, which is mediated in part by calcium-dependent protein kinase 1 (CDPK1).  We have developed ATP competitive inhibitors of TgCDPK1 that block invasion of parasites into host cells, preventing their proliferation.  The presence of a unique glycine gatekeeper residue in TgCDPK1 permits selective inhibition of the parasite enzyme over human kinases.  These potent TgCDPK1 inhibitors do not inhibit the growth of human cell lines and represent promising candidates as toxoplasmosis therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxuYszPit90rVg90H21EOLACvtfcHk0lhEeA-vLUQ-fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVeksb8%253D&md5=862ac0e5066f60d7eeaccc723c2c4e75</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm201713h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201713h%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BM.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DGeiger%26aufirst%3DJ.%2BA.%26aulast%3DDeRocher%26aufirst%3DA.%2BE.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DPerera%26aufirst%3DB.%2BG.%26aulast%3DDale%26aufirst%3DE.%2BJ.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DReid%26aufirst%3DM.%2BC.%26aulast%3DFox%26aufirst%3DA.%2BM.%26aulast%3DMueller%26aufirst%3DN.%2BR.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3DDevelopment%2520of%2520Toxoplasma%2520gondii%2520calcium-dependent%2520protein%2520kinase%25201%2520%2528TgCDPK1%2529%2520inhibitors%2520with%2520potent%2520anti-toxoplasma%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2416%26epage%3D2426%26doi%3D10.1021%2Fjm201713h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Larson, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leibly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hol, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, E. A.</span><span> </span><span class="NLM_article-title">Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2803</span><span class="NLM_x">–</span> <span class="NLM_lpage">2810</span><span class="refDoi"> DOI: 10.1021/jm201725v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201725v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2803-2810&author=E.+T.+Larsonauthor=K.+K.+Ojoauthor=R.+C.+Murphyauthor=S.+M.+Johnsonauthor=Z.+Zhangauthor=J.+E.+Kimauthor=D.+J.+Leiblyauthor=A.+M.+Foxauthor=M.+C.+Reidauthor=E.+J.+Daleauthor=B.+G.+Pereraauthor=J.+Kimauthor=S.+N.+Hewittauthor=W.+G.+Holauthor=C.+L.+Verlindeauthor=E.+Fanauthor=W.+C.+Van+Voorhisauthor=D.+J.+Malyauthor=E.+A.+Merritt&title=Multiple+determinants+for+selective+inhibition+of+apicomplexan+calcium-dependent+protein+kinase+CDPK1&doi=10.1021%2Fjm201725v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Determinants for Selective Inhibition of Apicomplexan Calcium-Dependent Protein Kinase CDPK1</span></div><div class="casAuthors">Larson, Eric T.; Ojo, Kayode K.; Murphy, Ryan C.; Johnson, Steven M.; Zhang, Zhongsheng; Kim, Jessica E.; Leibly, David J.; Fox, Anna M. W.; Reid, Molly C.; Dale, Edward J.; Perera, B. Gayani K.; Kim, Jae; Hewitt, Stephen N.; Hol, Wim G. J.; Verlinde, Christophe L. M. J.; Fan, Erkang; Van Voorhis, Wesley C.; Maly, Dustin J.; Merritt, Ethan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2803-2810</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Diseases caused by the apicomplexan protozoans Toxoplasma gondii and Cryptosporidium parvum are a major health concern.  The life cycle of these parasites is regulated by a family of calcium-dependent protein kinases (CDPKs) that have no direct homologs in the human host.  Fortuitously, CDPK1 from both parasites contains a rare glycine gatekeeper residue adjacent to the ATP-binding pocket.  This has allowed creation of a series of C3-substituted pyrazolopyrimidine compds. that are potent inhibitors selective for CDPK1 over a panel of human kinases.  Here we demonstrate that selectivity is further enhanced by modification of the scaffold at the C1 position.  The explanation for this unexpected result is provided by crystal structures of the inhibitors bound to CDPK1 and the human kinase c-SRC.  Furthermore, the insight gained from these studies was applied to transform an alternative ATP-competitive scaffold lacking potency and selectivity for CDPK1 into a low nanomolar inhibitor of this enzyme with no activity against SRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxAUMMe3qUybVg90H21EOLACvtfcHk0lhEeA-vLUQ-fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOgsLo%253D&md5=c8aae3a6d1811aaa2d1316eb98fa8251</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm201725v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201725v%26sid%3Dliteratum%253Aachs%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DJohnson%26aufirst%3DS.%2BM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DLeibly%26aufirst%3DD.%2BJ.%26aulast%3DFox%26aufirst%3DA.%2BM.%26aulast%3DReid%26aufirst%3DM.%2BC.%26aulast%3DDale%26aufirst%3DE.%2BJ.%26aulast%3DPerera%26aufirst%3DB.%2BG.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHewitt%26aufirst%3DS.%2BN.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26atitle%3DMultiple%2520determinants%2520for%2520selective%2520inhibition%2520of%2520apicomplexan%2520calcium-dependent%2520protein%2520kinase%2520CDPK1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2803%26epage%3D2810%26doi%3D10.1021%2Fjm201725v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Murphy, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellanos-Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyloun, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhandari, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maly, D. J.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of calcium-dependent protein kinase 1 (CDPK1) from <i>C.ryptosporidium parvum</i> and <i>Toxoplasma gondii</i></span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span><span class="refDoi"> DOI: 10.1021/ml100096t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100096t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=331-335&author=R.+C.+Murphyauthor=K.+K.+Ojoauthor=E.+T.+Larsonauthor=A.+Castellanos-Gonzalezauthor=B.+G.+Pereraauthor=K.+R.+Keylounauthor=J.+E.+Kimauthor=J.+G.+Bhandariauthor=N.+R.+Mullerauthor=C.+L.+Verlindeauthor=A.+C.+Whiteauthor=E.+A.+Merrittauthor=W.+C.+Van+Voorhisauthor=D.+J.+Maly&title=Discovery+of+potent+and+selective+inhibitors+of+calcium-dependent+protein+kinase+1+%28CDPK1%29+from+C.ryptosporidium+parvum+and+Toxoplasma+gondii&doi=10.1021%2Fml100096t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fml100096t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100096t%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DCastellanos-Gonzalez%26aufirst%3DA.%26aulast%3DPerera%26aufirst%3DB.%2BG.%26aulast%3DKeyloun%26aufirst%3DK.%2BR.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DBhandari%26aufirst%3DJ.%2BG.%26aulast%3DMuller%26aufirst%3DN.%2BR.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DWhite%26aufirst%3DA.%2BC.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520calcium-dependent%2520protein%2520kinase%25201%2520%2528CDPK1%2529%2520from%2520C.ryptosporidium%2520parvum%2520and%2520Toxoplasma%2520gondii%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D331%26epage%3D335%26doi%3D10.1021%2Fml100096t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Doggett, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span> </span><span class="NLM_article-title">Bumped kinase inhibitor 1294 treats established <i>Toxoplasma gondii</i> infection</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3547</span><span class="NLM_x">–</span> <span class="NLM_lpage">3549</span><span class="refDoi"> DOI: 10.1128/AAC.01823-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FAAC.01823-13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=3547-3549&author=J.+S.+Doggettauthor=K.+K.+Ojoauthor=E.+Fanauthor=D.+J.+Malyauthor=W.+C.+Van+Voorhis&title=Bumped+kinase+inhibitor+1294+treats+established+Toxoplasma+gondii+infection&doi=10.1128%2FAAC.01823-13"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FAAC.01823-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01823-13%26sid%3Dliteratum%253Aachs%26aulast%3DDoggett%26aufirst%3DJ.%2BS.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DBumped%2520kinase%2520inhibitor%25201294%2520treats%2520established%2520Toxoplasma%2520gondii%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D3547%26epage%3D3549%26doi%3D10.1128%2FAAC.01823-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lourido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barks, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wildman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span> </span><span class="NLM_article-title">Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by <i>Toxoplasma gondii</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3068</span><span class="NLM_x">–</span> <span class="NLM_lpage">3077</span><span class="refDoi"> DOI: 10.1021/jm4001314</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001314" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslSgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3068-3077&author=S.+Louridoauthor=C.+Zhangauthor=M.+S.+Lopezauthor=K.+Tangauthor=J.+Barksauthor=Q.+Wangauthor=S.+A.+Wildmanauthor=K.+M.+Shokatauthor=L.+D.+Sibley&title=Optimizing+small+molecule+inhibitors+of+calcium-dependent+protein+kinase+1+to+prevent+infection+by+Toxoplasma+gondii&doi=10.1021%2Fjm4001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Small Molecule Inhibitors of Calcium-Dependent Protein Kinase 1 to Prevent Infection by Toxoplasma gondii</span></div><div class="casAuthors">Lourido, Sebastian; Zhang, Chao; Lopez, Michael S.; Tang, Keliang; Barks, Jennifer; Wang, Qiuling; Wildman, Scott A.; Shokat, Kevan M.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3068-3077</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toxoplasma gondii is sensitive to bulky pyrazolo [3,4-d] pyrimidine (PP) inhibitors due to the presence of a Gly gatekeeper in the essential calcium dependent protein kinase 1 (CDPK1).  Here we synthesized a no. of new derivs. of 3-methyl-benzyl-PP (3-MB-PP, or 1).  The potency of PP analogs in inhibiting CDPK1 enzyme activity in vitro (low nM IC50 values) and blocking parasite growth in host cell monolayers in vivo (low μM EC50 values) were highly correlated and occurred in a CDPK1-specific manner.  Chem. modification of the PP scaffold to increase half-life in the presence of microsomes in vitro led to identification of compds. with enhanced stability while retaining activity.  Several of these more potent compds. were able to prevent lethal infection with T. gondii in the mouse model.  Collectively, the strategies outlined here provide a route for development of more effective compds. for treatment of toxoplasmosis and perhaps related parasitic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBcv37M-6fobVg90H21EOLACvtfcHk0ljnMW420Ktu2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslSgt78%253D&md5=352bb9e5b5304656aab52da763202b68</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm4001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001314%26sid%3Dliteratum%253Aachs%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DTang%26aufirst%3DK.%26aulast%3DBarks%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DOptimizing%2520small%2520molecule%2520inhibitors%2520of%2520calcium-dependent%2520protein%2520kinase%25201%2520to%2520prevent%2520infection%2520by%2520Toxoplasma%2520gondii%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3068%26epage%3D3077%26doi%3D10.1021%2Fjm4001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Vidadala, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulverson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zambriski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzual, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRocher, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddaramaiah, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hol, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freiberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempf, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isoherranen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doggett, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maly, D. J.</span><span> </span><span class="NLM_article-title">Development of an orally available and central nervous system (CNS) renetrant <i>Toxoplasma gondii</i> calcium-dependent protein kinase 1 (TgCDPK1) inhibitor with minimal human ether-a-go-go-related gene (hERG) activity for the treatment of toxoplasmosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">6531</span><span class="NLM_x">–</span> <span class="NLM_lpage">6546</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00760</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6531-6546&author=R.+S.+Vidadalaauthor=K.+L.+Rivasauthor=K.+K.+Ojoauthor=M.+A.+Hulversonauthor=J.+A.+Zambriskiauthor=I.+Bruzualauthor=T.+L.+Schultzauthor=W.+Huangauthor=Z.+Zhangauthor=S.+Scheeleauthor=A.+E.+DeRocherauthor=R.+Choiauthor=L.+K.+Barrettauthor=L.+K.+Siddaramaiahauthor=W.+G.+Holauthor=E.+Fanauthor=E.+A.+Merrittauthor=M.+Parsonsauthor=G.+Freibergauthor=K.+Marshauthor=D.+J.+Kempfauthor=V.+B.+Carruthersauthor=N.+Isoherranenauthor=J.+S.+Doggettauthor=W.+C.+Van+Voorhisauthor=D.+J.+Maly&title=Development+of+an+orally+available+and+central+nervous+system+%28CNS%29+renetrant+Toxoplasma+gondii+calcium-dependent+protein+kinase+1+%28TgCDPK1%29+inhibitor+with+minimal+human+ether-a-go-go-related+gene+%28hERG%29+activity+for+the+treatment+of+toxoplasmosis&doi=10.1021%2Facs.jmedchem.6b00760"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00760%26sid%3Dliteratum%253Aachs%26aulast%3DVidadala%26aufirst%3DR.%2BS.%26aulast%3DRivas%26aufirst%3DK.%2BL.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DZambriski%26aufirst%3DJ.%2BA.%26aulast%3DBruzual%26aufirst%3DI.%26aulast%3DSchultz%26aufirst%3DT.%2BL.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DScheele%26aufirst%3DS.%26aulast%3DDeRocher%26aufirst%3DA.%2BE.%26aulast%3DChoi%26aufirst%3DR.%26aulast%3DBarrett%26aufirst%3DL.%2BK.%26aulast%3DSiddaramaiah%26aufirst%3DL.%2BK.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DFreiberg%26aufirst%3DG.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DCarruthers%26aufirst%3DV.%2BB.%26aulast%3DIsoherranen%26aufirst%3DN.%26aulast%3DDoggett%26aufirst%3DJ.%2BS.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3DDevelopment%2520of%2520an%2520orally%2520available%2520and%2520central%2520nervous%2520system%2520%2528CNS%2529%2520renetrant%2520Toxoplasma%2520gondii%2520calcium-dependent%2520protein%2520kinase%25201%2520%2528TgCDPK1%2529%2520inhibitor%2520with%2520minimal%2520human%2520ether-a-go-go-related%2520gene%2520%2528hERG%2529%2520activity%2520for%2520the%2520treatment%2520of%2520toxoplasmosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6531%26epage%3D6546%26doi%3D10.1021%2Facs.jmedchem.6b00760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hanefeld, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. J.</span><span> </span><span class="NLM_article-title">One-pot synthesis of tetrasubstituted pyrazoles - proof of regiochemistry</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">0</span><span class="NLM_x">, </span> <span class="NLM_fpage">1545</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span><span class="refDoi"> DOI: 10.1039/P19960001545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1039%2FP19960001545" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=0&publication_year=1996&pages=1545-1552&author=U.+Hanefeldauthor=C.+W.+Reesauthor=A.+J.+P.+Whiteauthor=D.+J.+Williams&title=One-pot+synthesis+of+tetrasubstituted+pyrazoles+-+proof+of+regiochemistry&doi=10.1039%2FP19960001545"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FP19960001545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FP19960001545%26sid%3Dliteratum%253Aachs%26aulast%3DHanefeld%26aufirst%3DU.%26aulast%3DRees%26aufirst%3DC.%2BW.%26aulast%3DWhite%26aufirst%3DA.%2BJ.%2BP.%26aulast%3DWilliams%26aufirst%3DD.%2BJ.%26atitle%3DOne-pot%2520synthesis%2520of%2520tetrasubstituted%2520pyrazoles%2520-%2520proof%2520of%2520regiochemistry%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1996%26volume%3D0%26spage%3D1545%26epage%3D1552%26doi%3D10.1039%2FP19960001545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Schenone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musumeci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brullo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: an old scaffold as a new tool for medicinal chemistry and chemical biology studies</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">7189</span><span class="NLM_x">–</span> <span class="NLM_lpage">7238</span><span class="refDoi"> DOI: 10.1021/cr400270z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400270z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=7189-7238&author=S.+Schenoneauthor=M.+Radiauthor=F.+Musumeciauthor=C.+Brulloauthor=M.+Botta&title=Biologically+driven+synthesis+of+pyrazolo%5B3%2C4-d%5Dpyrimidines+as+protein+kinase+inhibitors%3A+an+old+scaffold+as+a+new+tool+for+medicinal+chemistry+and+chemical+biology+studies&doi=10.1021%2Fcr400270z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: An old scaffold as a new tool for medicinal chemistry and chemical biology studies</span></div><div class="casAuthors">Schenone, Silvia; Radi, Marco; Musumeci, Francesca; Brullo, Chiara; Botta, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7189-7238</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review was given on the design, synthesis, and biol. activity of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVe-x33MLF37Vg90H21EOLACvtfcHk0li4qFmv88rjSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWhsLo%253D&md5=ee2dcea73afb5841bffe333fead3485a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fcr400270z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400270z%26sid%3Dliteratum%253Aachs%26aulast%3DSchenone%26aufirst%3DS.%26aulast%3DRadi%26aufirst%3DM.%26aulast%3DMusumeci%26aufirst%3DF.%26aulast%3DBrullo%26aufirst%3DC.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DBiologically%2520driven%2520synthesis%2520of%2520pyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520protein%2520kinase%2520inhibitors%253A%2520an%2520old%2520scaffold%2520as%2520a%2520new%2520tool%2520for%2520medicinal%2520chemistry%2520and%2520chemical%2520biology%2520studies%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D7189%26epage%3D7238%26doi%3D10.1021%2Fcr400270z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kwong, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">A general, efficient, and inexpensive catalyst system for the coupling of aryl iodides and thiols</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3517</span><span class="NLM_x">–</span> <span class="NLM_lpage">3520</span><span class="refDoi"> DOI: 10.1021/ol0266673</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0266673" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvVGntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=3517-3520&author=F.+Y.+Kwongauthor=S.+L.+Buchwald&title=A+general%2C+efficient%2C+and+inexpensive+catalyst+system+for+the+coupling+of+aryl+iodides+and+thiols&doi=10.1021%2Fol0266673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A General, Efficient, and Inexpensive Catalyst System for the Coupling of Aryl Iodides and Thiols</span></div><div class="casAuthors">Kwong, Fuk Yee; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3517-3520</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient copper-catalyzed carbon-sulfur bond formation reaction was developed.  This method is particularly noteworthy given its exptl. simplicity, high generality, and exceptional level of functional group toleration and the low cost of the catalyst system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph2Qp54FuzDbVg90H21EOLACvtfcHk0li4qFmv88rjSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvVGntLk%253D&md5=2c54c4b4c4d34f7ae67ae44d2d8cd6c2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fol0266673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0266673%26sid%3Dliteratum%253Aachs%26aulast%3DKwong%26aufirst%3DF.%2BY.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DA%2520general%252C%2520efficient%252C%2520and%2520inexpensive%2520catalyst%2520system%2520for%2520the%2520coupling%2520of%2520aryl%2520iodides%2520and%2520thiols%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D3517%26epage%3D3520%26doi%3D10.1021%2Fol0266673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ley, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. W.</span><span> </span><span class="NLM_article-title">Modern synthetic methods for copper-mediated C(aryl)-O, C(aryl)-N, and C(aryl)-S bond formation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5400</span><span class="NLM_x">–</span> <span class="NLM_lpage">5449</span><span class="refDoi"> DOI: 10.1002/anie.200300594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1002%2Fanie.200300594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=14618572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFOqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=5400-5449&author=S.+V.+Leyauthor=A.+W.+Thomas&title=Modern+synthetic+methods+for+copper-mediated+C%28aryl%29-O%2C+C%28aryl%29-N%2C+and+C%28aryl%29-S+bond+formation&doi=10.1002%2Fanie.200300594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Modern synthetic methods for copper-mediated C(aryl)-O, C(aryl)-N, and C(aryl)-S bond formation</span></div><div class="casAuthors">Ley, Steven V.; Thomas, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">5400-5449</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The copper-mediated C(aryl)-N, C(aryl)-O, and C(aryl)-S bond formation is an important transformation and was developed to include a wide range of substrates.  This review highlights the recent developments in the copper-mediated (both stoichiometric and catalytic) reactions of aryl boronic acids, aryl halides, iodonium salts, siloxanes, stannanes, plumbanes, bismuthates, and trifluoroborate salts as aryl donors.  In particular, the recent introduction of boronic acids as reaction partners in both O- and N-arylation was a significant discovery and will occupy center-stage in this review.  Clear improvements can be obtained by the correct choice of copper source, base, ligands, and other additives.  Mechanistic investigations should provide insight into the catalytically active species, which would aid in the development of milder, more-efficient methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFt6Vxw-Bls7Vg90H21EOLACvtfcHk0ljnKfS9b1TYKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFOqtbk%253D&md5=b90d9ab6ac33d286ca570aeb9ef6a10b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fanie.200300594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200300594%26sid%3Dliteratum%253Aachs%26aulast%3DLey%26aufirst%3DS.%2BV.%26aulast%3DThomas%26aufirst%3DA.%2BW.%26atitle%3DModern%2520synthetic%2520methods%2520for%2520copper-mediated%2520C%2528aryl%2529-O%252C%2520C%2528aryl%2529-N%252C%2520and%2520C%2528aryl%2529-S%2520bond%2520formation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D5400%26epage%3D5449%26doi%3D10.1002%2Fanie.200300594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Q.</span><span> </span><span class="NLM_article-title">N,N-dimethyl glycine-promoted ullmann coupling reaction of phenols and aryl halides</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3799</span><span class="NLM_x">–</span> <span class="NLM_lpage">3802</span><span class="refDoi"> DOI: 10.1021/ol0350947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0350947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsFyrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=3799-3802&author=D.+Maauthor=Q.+Cai&title=N%2CN-dimethyl+glycine-promoted+ullmann+coupling+reaction+of+phenols+and+aryl+halides&doi=10.1021%2Fol0350947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">N,N-Dimethyl Glycine-Promoted Ullmann Coupling Reaction of Phenols and Aryl Halides</span></div><div class="casAuthors">Ma, Dawei; Cai, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3799-3802</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ullmann-type diaryl ether synthesis can be performed at 90 °C using either aryl iodides or aryl bromides as the substrates under the assistance of N,N-dimethylglycine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-5F2Dl8PWTbVg90H21EOLACvtfcHk0ljnKfS9b1TYKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsFyrurs%253D&md5=9d63bfcef4d0f32e18514874d5bd752f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fol0350947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0350947%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DQ.%26atitle%3DN%252CN-dimethyl%2520glycine-promoted%2520ullmann%2520coupling%2520reaction%2520of%2520phenols%2520and%2520aryl%2520halides%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D3799%26epage%3D3802%26doi%3D10.1021%2Fol0350947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Prim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagne, J.-m.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrioletti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, D.</span><span> </span><span class="NLM_article-title">Palladium-catalysed reactions of aryl halides with soft, non-organometallic nucleophiles</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2041</span><span class="NLM_x">–</span> <span class="NLM_lpage">2075</span><span class="refDoi"> DOI: 10.1016/S0040-4020(02)00076-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2FS0040-4020%2802%2900076-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsFSjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=2041-2075&author=D.+Primauthor=J.-m.+Campagneauthor=B.+Andriolettiauthor=D.+Joseph&title=Palladium-catalysed+reactions+of+aryl+halides+with+soft%2C+non-organometallic+nucleophiles&doi=10.1016%2FS0040-4020%2802%2900076-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed reactions of aryl halides with soft, non-organometallic nucleophiles</span></div><div class="casAuthors">Prim, Damien; Campagne, Jean-Marc; Joseph, Delphine; Andrioletti, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2041-2075</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review including N-, O-, B-, Si-, P-, S-, and C-based nucleophiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrafl_sFfa04LVg90H21EOLACvtfcHk0ljmmFCnhVQPsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsFSjt7w%253D&md5=47fee3fe9b0df2ac65a38d3a1bb94b71</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2802%2900076-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252802%252900076-5%26sid%3Dliteratum%253Aachs%26aulast%3DPrim%26aufirst%3DD.%26aulast%3DCampagne%26aufirst%3DJ.-m.%26aulast%3DAndrioletti%26aufirst%3DB.%26aulast%3DJoseph%26aufirst%3DD.%26atitle%3DPalladium-catalysed%2520reactions%2520of%2520aryl%2520halides%2520with%2520soft%252C%2520non-organometallic%2520nucleophiles%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D2041%26epage%3D2075%26doi%3D10.1016%2FS0040-4020%2802%2900076-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Zaretzki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matlock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swamidass, S. J.</span><span> </span><span class="NLM_article-title">XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3373</span><span class="NLM_x">–</span> <span class="NLM_lpage">3383</span><span class="refDoi"> DOI: 10.1021/ci400518g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci400518g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslKks77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=3373-3383&author=J.+Zaretzkiauthor=M.+Matlockauthor=S.+J.+Swamidass&title=XenoSite%3A+accurately+predicting+CYP-mediated+sites+of+metabolism+with+neural+networks&doi=10.1021%2Fci400518g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">XenoSite: Accurately Predicting CYP-Mediated Sites of Metabolism with Neural Networks</span></div><div class="casAuthors">Zaretzki, Jed; Matlock, Matthew; Swamidass, S. Joshua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3373-3383</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding how xenobiotic mols. are metabolized is important because it influences the safety, efficacy, and dose of medicines and how they can be modified to improve these properties.  The cytochrome P450s (CYPs) are proteins responsible for metabolizing 90% of drugs on the market, and many computational methods can predict which at. sites of a mol.-sites of metab. (SOMs)-are modified during CYP-mediated metab.  This study improves on prior methods of predicting CYP-mediated SOMs by using new descriptors and machine learning based on neural networks.  The new method, XenoSite, is faster to train and more accurate by as much as 4% or 5% for some isoenzymes.  Furthermore, some "incorrect" predictions made by XenoSite were subsequently validated as correct predictions by revaluation of the source literature.  Moreover, XenoSite output is interpretable as a probability, which reflects both the confidence of the model that a particular atom is metabolized and the statistical likelihood that its prediction for that atom is correct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlZ_8YN3XASbVg90H21EOLACvtfcHk0ljmmFCnhVQPsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslKks77E&md5=1de6321b1500c9571db548006767e708</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fci400518g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400518g%26sid%3Dliteratum%253Aachs%26aulast%3DZaretzki%26aufirst%3DJ.%26aulast%3DMatlock%26aufirst%3DM.%26aulast%3DSwamidass%26aufirst%3DS.%2BJ.%26atitle%3DXenoSite%253A%2520accurately%2520predicting%2520CYP-mediated%2520sites%2520of%2520metabolism%2520with%2520neural%2520networks%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D3373%26epage%3D3383%26doi%3D10.1021%2Fci400518g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Bohm, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendels, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obst-Sander, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span><span class="refDoi"> DOI: 10.1002/cbic.200301023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1002%2Fcbic.200301023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=15122635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=637-643&author=H.+J.+Bohmauthor=D.+Bannerauthor=S.+Bendelsauthor=M.+Kansyauthor=B.+Kuhnauthor=K.+Mullerauthor=U.+Obst-Sanderauthor=M.+Stahl&title=Fluorine+in+medicinal+chemistry&doi=10.1002%2Fcbic.200301023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry</span></div><div class="casAuthors">Bohm Hans-Joachim; Banner David; Bendels Stefanie; Kansy Manfred; Kuhn Bernd; Muller Klaus; Obst-Sander Ulrike; Stahl Martin</div><div class="citationInfo"><span class="NLM_cas:title">Chembiochem : a European journal of chemical biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">637-43</span>
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    </div><div class="casAbstract">Fluorinated compounds are synthesized in pharmaceutical research on a routine basis and many marketed compounds contain fluorine.  The present review summarizes some of the most frequently employed strategies for using fluorine substituents in medicinal chemistry.  Quite often, fluorine is introduced to improve the metabolic stability by blocking metabolically labile sites.  However, fluorine can also be used to modulate the physicochemical properties, such as lipophilicity or basicity.  It may exert a substantial effect on the conformation of a molecule.  Increasingly, fluorine is used to enhance the binding affinity to the target protein.  Recent 3D-structure determinations of protein complexes with bound fluorinated ligands have led to an improved understanding of the nonbonding protein-ligand interactions that involve fluorine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4zDG_wo1YGtts4TFFB11gfW6udTcc2eac-7HEMD0l6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D&md5=fa5ca2cfc278b83c80d5c96b18dfe312</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200301023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200301023%26sid%3Dliteratum%253Aachs%26aulast%3DBohm%26aufirst%3DH.%2BJ.%26aulast%3DBanner%26aufirst%3DD.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DObst-Sander%26aufirst%3DU.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D637%26epage%3D643%26doi%3D10.1002%2Fcbic.200301023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Barnes-Seeman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatsis, P.</span><span> </span><span class="NLM_article-title">Metabolically stable tert-butyl replacement</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">514</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span><span class="refDoi"> DOI: 10.1021/ml400045j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400045j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1ymt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=514-516&author=D.+Barnes-Seemanauthor=M.+Jainauthor=L.+Bellauthor=S.+Ferreiraauthor=S.+Cohenauthor=X.+H.+Chenauthor=J.+Aminauthor=B.+Snodgrassauthor=P.+Hatsis&title=Metabolically+stable+tert-butyl+replacement&doi=10.1021%2Fml400045j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolically Stable tert-Butyl Replacement</span></div><div class="casAuthors">Barnes-Seeman, David; Jain, Monish; Bell, Leslie; Ferreira, Suzie; Cohen, Scott; Chen, Xiao-Hui; Amin, Jakal; Snodgrass, Brad; Hatsis, Panos</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">514-516</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Susceptibility to metab. is a common issue with the tert-Bu group on compds. of medicinal interest.  The authors demonstrate an approach of removing all the fully Sp3 C-Hs from a tert-Bu group: replacing some C-Hs with C-Fs and increasing the s-character of the remaining C-Hs.  This approach gave a trifluoromethylcyclopropyl group, which increased metabolic stability.  Trifluoromethylcyclopropyl-contg. analogs had consistently higher metabolic stability in vitro and in vivo compared to their tert-butyl-contg. counterparts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrao2I5ukFsTrVg90H21EOLACvtfcHk0lgBwcujT8n_gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1ymt78%253D&md5=156572485ea3a48f5e1b6ea7409f1f61</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fml400045j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400045j%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes-Seeman%26aufirst%3DD.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DBell%26aufirst%3DL.%26aulast%3DFerreira%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DX.%2BH.%26aulast%3DAmin%26aufirst%3DJ.%26aulast%3DSnodgrass%26aufirst%3DB.%26aulast%3DHatsis%26aufirst%3DP.%26atitle%3DMetabolically%2520stable%2520tert-butyl%2520replacement%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D514%26epage%3D516%26doi%3D10.1021%2Fml400045j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Hicken, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmsater, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlachter, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topalov, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarlton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callejo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klopfenstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woessner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">Discovery of a novel class of imidazo[1,2-a]pyridines with potent PDGFR activity and oral bioavailability</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span><span class="refDoi"> DOI: 10.1021/ml4003953</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4003953" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=78-83&author=E.+J.+Hickenauthor=F.+P.+Marmsaterauthor=M.+C.+Munsonauthor=S.+T.+Schlachterauthor=J.+E.+Robinsonauthor=S.+Allenauthor=L.+E.+Burgessauthor=R.+K.+Delisleauthor=J.+P.+Rizziauthor=G.+T.+Topalovauthor=Q.+Zhaoauthor=J.+M.+Hicksauthor=N.+C.+Kallanauthor=E.+Tarltonauthor=A.+Allenauthor=M.+Callejoauthor=A.+Coxauthor=S.+Ranaauthor=N.+Klopfensteinauthor=R.+Woessnerauthor=J.+P.+Lyssikatos&title=Discovery+of+a+novel+class+of+imidazo%5B1%2C2-a%5Dpyridines+with+potent+PDGFR+activity+and+oral+bioavailability&doi=10.1021%2Fml4003953"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fml4003953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4003953%26sid%3Dliteratum%253Aachs%26aulast%3DHicken%26aufirst%3DE.%2BJ.%26aulast%3DMarmsater%26aufirst%3DF.%2BP.%26aulast%3DMunson%26aufirst%3DM.%2BC.%26aulast%3DSchlachter%26aufirst%3DS.%2BT.%26aulast%3DRobinson%26aufirst%3DJ.%2BE.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DBurgess%26aufirst%3DL.%2BE.%26aulast%3DDelisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DTopalov%26aufirst%3DG.%2BT.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DHicks%26aufirst%3DJ.%2BM.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DTarlton%26aufirst%3DE.%26aulast%3DAllen%26aufirst%3DA.%26aulast%3DCallejo%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKlopfenstein%26aufirst%3DN.%26aulast%3DWoessner%26aufirst%3DR.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520imidazo%255B1%252C2-a%255Dpyridines%2520with%2520potent%2520PDGFR%2520activity%2520and%2520oral%2520bioavailability%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D78%26epage%3D83%26doi%3D10.1021%2Fml4003953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Shim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. T.</span><span> </span><span class="NLM_article-title">The associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation</span> <span class="citation_source-journal">Oncol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1469</span><span class="refDoi"> DOI: 10.3892/ol.2017.5564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.3892%2Fol.2017.5564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=28454278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADC%252BC1crit12hsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=1463-1469&author=H.+J.+Shimauthor=H.+I.+Kimauthor=S.+T.+Lee&title=The+associated+pyrazolopyrimidines+PP1+and+PP2+inhibit+protein+tyrosine+kinase+6+activity+and+suppress+breast+cancer+cell+proliferation&doi=10.3892%2Fol.2017.5564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation</span></div><div class="casAuthors">Shim Hyun Jae; Kim Han Ie; Lee Seung-Taek</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1463-1469</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">Protein tyrosine kinase (PTK)6, also known as breast tumor kinase, is a non-receptor tyrosine kinase.  It is closely associated with, but evolutionarily distinct from, the Src family members.  PTK6 has a role in proliferation, migration and invasion in various cancers, and therefore has been suggested as a potentially valuable therapeutic target.  In an attempt to develop PTK6 inhibitors, chemicals known to inhibit various kinases were screened for their ability to inhibit PTK6.  Pyrazolopyrimidine (PP)1, PP2 and a lymphocyte-specific protein tyrosine kinase inhibitor strongly inhibited the catalytic activity of PTK6 in vitro.  These chemicals suppressed the phosphorylation of PTK6 substrate proteins, including signal transducer and activator of transcription 3, in human embryonic kidney (HEK) 293 cells expressing hyperactive PTK6.  They also expressed selectivity towards PTK6 over other PTK members in HEK 293 cells.  PP1 and PP2 specifically inhibited the PTK6-dependent proliferation of human breast carcinoma T-47D cells.  PP1 and PP2 were more selective for PTK6 than for Src family kinases, and may be useful for the treatment of PTK6-positive malignant diseases such as breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrSOuOV6FyA5QHPYJuLg8TfW6udTcc2eaWDEOi1hkzarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crit12hsA%253D%253D&md5=1d0e97970d72830939270cfe7c0538a2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3892%2Fol.2017.5564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2017.5564%26sid%3Dliteratum%253Aachs%26aulast%3DShim%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BI.%26aulast%3DLee%26aufirst%3DS.%2BT.%26atitle%3DThe%2520associated%2520pyrazolopyrimidines%2520PP1%2520and%2520PP2%2520inhibit%2520protein%2520tyrosine%2520kinase%25206%2520activity%2520and%2520suppress%2520breast%2520cancer%2520cell%2520proliferation%26jtitle%3DOncol.%2520Lett.%26date%3D2017%26volume%3D13%26spage%3D1463%26epage%3D1469%26doi%3D10.3892%2Fol.2017.5564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Lourido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeschke, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span> </span><span class="NLM_article-title">Exploiting the unique ATP-binding pocket of toxoplasma calcium-dependent protein kinase 1 to identify its substrates</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1155</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span><span class="refDoi"> DOI: 10.1021/cb400115y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400115y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1155-1162&author=S.+Louridoauthor=G.+R.+Jeschkeauthor=B.+E.+Turkauthor=L.+D.+Sibley&title=Exploiting+the+unique+ATP-binding+pocket+of+toxoplasma+calcium-dependent+protein+kinase+1+to+identify+its+substrates&doi=10.1021%2Fcb400115y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcb400115y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400115y%26sid%3Dliteratum%253Aachs%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DJeschke%26aufirst%3DG.%2BR.%26aulast%3DTurk%26aufirst%3DB.%2BE.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DExploiting%2520the%2520unique%2520ATP-binding%2520pocket%2520of%2520toxoplasma%2520calcium-dependent%2520protein%2520kinase%25201%2520to%2520identify%2520its%2520substrates%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1155%26epage%3D1162%26doi%3D10.1021%2Fcb400115y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Yap, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sher, A.</span><span> </span><span class="NLM_article-title">Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha- dependent host resistance to the intracellular pathogen</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1091</span><span class="refDoi"> DOI: 10.1084/jem.189.7.1083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1084%2Fjem.189.7.1083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=1999&pages=1083-1091&author=G.+S.+Yapauthor=A.+Sher&title=Effector+cells+of+both+nonhemopoietic+and+hemopoietic+origin+are+required+for+interferon+%28IFN%29-gamma-+and+tumor+necrosis+factor+%28TNF%29-alpha-+dependent+host+resistance+to+the+intracellular+pathogen&doi=10.1084%2Fjem.189.7.1083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1084%2Fjem.189.7.1083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.189.7.1083%26sid%3Dliteratum%253Aachs%26aulast%3DYap%26aufirst%3DG.%2BS.%26aulast%3DSher%26aufirst%3DA.%26atitle%3DEffector%2520cells%2520of%2520both%2520nonhemopoietic%2520and%2520hemopoietic%2520origin%2520are%2520required%2520for%2520interferon%2520%2528IFN%2529-gamma-%2520and%2520tumor%2520necrosis%2520factor%2520%2528TNF%2529-alpha-%2520dependent%2520host%2520resistance%2520to%2520the%2520intracellular%2520pathogen%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1999%26volume%3D189%26spage%3D1083%26epage%3D1091%26doi%3D10.1084%2Fjem.189.7.1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Dunay, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimesaat, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushrab, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasteh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesenfeld, O.</span><span> </span><span class="NLM_article-title">Atovaquone maintenance therapy prevents reactivation of toxopasmic encepahalitis in the murine model of reactivated toxoplasmosis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4848</span><span class="NLM_x">–</span> <span class="NLM_lpage">4854</span><span class="refDoi"> DOI: 10.1128/AAC.48.12.4848-4854.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FAAC.48.12.4848-4854.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=15561866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKmt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=4848-4854&author=I.+R.+Dunayauthor=M.+M.+Heimesaatauthor=F.+N.+Bushrabauthor=R.+H.+Mullerauthor=H.+Stockerauthor=K.+Arastehauthor=M.+Kurowskiauthor=R.+Fitznerauthor=K.+Bornerauthor=O.+Liesenfeld&title=Atovaquone+maintenance+therapy+prevents+reactivation+of+toxopasmic+encepahalitis+in+the+murine+model+of+reactivated+toxoplasmosis&doi=10.1128%2FAAC.48.12.4848-4854.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis</span></div><div class="casAuthors">Dunay, Ildiko R.; Heimesaat, Markus M.; Bushrab, Faris Nadiem; Mueller, Rainer H.; Stocker, Hartmut; Arasteh, Keikawus; Kurowski, Michael; Fitzner, Rudolf; Borner, Klaus; Liesenfeld, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4848-4854</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Acute therapy with pyrimethamine plus sulfadiazine is the treatment of choice for reactivated toxoplasmic encephalitis (TE).  Acute therapy is followed by lifelong maintenance therapy (secondary prophylaxis) with the same drugs at lower dosages.  The use of pyrimethamine plus sulfadiazine is hampered by severe side effects including allergic reactions and hematotoxicity.  Alternative treatment regimens with pyrimethamine plus clindamycin or other antiparasitic drugs are less efficacious.  Atovaquone nanosuspensions show excellent therapeutic effects for "acute" i.v. treatment of reactivated TE in a murine model.  In the present study, the therapeutic efficacy of atovaquone for oral "maintenance" therapy was investigated.  Mice with a targeted mutation in the interferon regulatory factor 8 gene were latently infected with Toxoplasma gondii, developed reactivated TE, and received acute i.v. therapy with atovaquone nanosuspensions.  Mice were then treated orally with atovaquone suspension or other antiparasitic drugs to prevent relapse of TE.  Maintenance therapy with atovaquone at daily doses of 50 or 100 mg/kg (body wt.) protected mice against reactivated TE and death.  This maintenance treatment was superior to std. therapy with pyrimethamine plus sulfadiazine.  The latter combination was superior to the combination of pyrimethamine plus clindamycin.  Inflammatory changes in the brain parenchyma and meninges, as well as parasite nos., in the brains of mice confirmed the therapeutic efficacy of atovaquone for maintenance therapy.  Atovaquone was detectable in sera, brains, livers, and lungs of infected mice by high-performance liq. chromatog. and/or mass spectrometry.  In conclusion, atovaquone appears to be superior to the std. maintenance therapy regimens in a murine model of reactivated TE.  The therapeutic efficacy of atovaquone for maintenance therapy against TE should be further investigated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKPKQMmt7eL7Vg90H21EOLACvtfcHk0ljkiO5PZe7skg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKmt7vJ&md5=3a5c765f82509aa8b1121dbb28720c33</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.12.4848-4854.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.12.4848-4854.2004%26sid%3Dliteratum%253Aachs%26aulast%3DDunay%26aufirst%3DI.%2BR.%26aulast%3DHeimesaat%26aufirst%3DM.%2BM.%26aulast%3DBushrab%26aufirst%3DF.%2BN.%26aulast%3DMuller%26aufirst%3DR.%2BH.%26aulast%3DStocker%26aufirst%3DH.%26aulast%3DArasteh%26aufirst%3DK.%26aulast%3DKurowski%26aufirst%3DM.%26aulast%3DFitzner%26aufirst%3DR.%26aulast%3DBorner%26aufirst%3DK.%26aulast%3DLiesenfeld%26aufirst%3DO.%26atitle%3DAtovaquone%2520maintenance%2520therapy%2520prevents%2520reactivation%2520of%2520toxopasmic%2520encepahalitis%2520in%2520the%2520murine%2520model%2520of%2520reactivated%2520toxoplasmosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D4848%26epage%3D4854%26doi%3D10.1128%2FAAC.48.12.4848-4854.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkbeiner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Structure-guided inhibitor design expands the scope of analog-sensitive kinase technology</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1931</span><span class="NLM_x">–</span> <span class="NLM_lpage">1938</span><span class="refDoi"> DOI: 10.1021/cb400376p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400376p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVOksbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1931-1938&author=C.+Zhangauthor=M.+S.+Lopezauthor=A.+C.+Darauthor=E.+Ladowauthor=S.+Finkbeinerauthor=C.+H.+Yunauthor=M.+J.+Eckauthor=K.+M.+Shokat&title=Structure-guided+inhibitor+design+expands+the+scope+of+analog-sensitive+kinase+technology&doi=10.1021%2Fcb400376p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Inhibitor Design Expands the Scope of Analog-Sensitive Kinase Technology</span></div><div class="casAuthors">Zhang, Chao; Lopez, Michael S.; Dar, Arvin C.; LaDow, Eva; Finkbeiner, Steven; Yun, Cai-Hong; Eck, Michael J.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1931-1938</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Engineered analog-sensitive (AS) protein kinases have emerged as powerful tools for dissecting phospho-signaling pathways, for elucidating the cellular function of individual kinases, and for deciphering unanticipated effects of clin. therapeutics.  A crucial and necessary feature of this technol. is a bioorthogonal small mol. that is innocuous toward native cellular systems but potently inhibits the engineered kinase.  In order to generalize this method, we sought a mol. capable of targeting divergent AS-kinases.  Here we employ x-ray crystallog. and medicinal chem. to unravel the mechanism of current inhibitors and use these insights to design the most potent, selective, and general AS-kinase inhibitors reported to date.  We use large-scale kinase inhibitor profiling to characterize the selectivity of these mols. as well as examine the consequences of potential off-target effects in chem. genetic expts.  The mols. reported here will serve as powerful tools in efforts to extend AS-kinase technol. to the entire kinome and the principles discovered may help in the design of other engineered enzyme/ligand pairs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNjAOxjjP0vLVg90H21EOLACvtfcHk0ljkiO5PZe7skg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVOksbfK&md5=678113c290dfa3b3df691cf272595260</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcb400376p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400376p%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DDar%26aufirst%3DA.%2BC.%26aulast%3DLadow%26aufirst%3DE.%26aulast%3DFinkbeiner%26aufirst%3DS.%26aulast%3DYun%26aufirst%3DC.%2BH.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DStructure-guided%2520inhibitor%2520design%2520expands%2520the%2520scope%2520of%2520analog-sensitive%2520kinase%2520technology%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1931%26epage%3D1938%26doi%3D10.1021%2Fcb400376p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">Structural basis for the potent and selective inhibition of casein kinase 1 epsilon</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10307</span><span class="NLM_x">–</span> <span class="NLM_lpage">10311</span><span class="refDoi"> DOI: 10.1021/jm301336n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301336n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10307-10311&author=A.+M.+Longauthor=H.+Zhaoauthor=X.+Huang&title=Structural+basis+for+the+potent+and+selective+inhibition+of+casein+kinase+1+epsilon&doi=10.1021%2Fjm301336n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm301336n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301336n%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DStructural%2520basis%2520for%2520the%2520potent%2520and%2520selective%2520inhibition%2520of%2520casein%2520kinase%25201%2520epsilon%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10307%26epage%3D10311%26doi%3D10.1021%2Fjm301336n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Dunay, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span> </span><span class="NLM_article-title">Artemisone and artemiside control acute and reactivated toxoplasmosis in the murine model</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4450</span><span class="NLM_x">–</span> <span class="NLM_lpage">4456</span><span class="refDoi"> DOI: 10.1128/AAC.00502-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FAAC.00502-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=19635951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KkurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=4450-4456&author=I.+R.+Dunayauthor=W.+C.+Chanauthor=R.+K.+Haynesauthor=L.+D.+Sibley&title=Artemisone+and+artemiside+control+acute+and+reactivated+toxoplasmosis+in+the+murine+model&doi=10.1128%2FAAC.00502-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model</span></div><div class="casAuthors">Dunay, Ildiko R.; Chan, Wing Chi; Haynes, Richard K.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4450-4456</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Immunocompromised patients are at risk of developing toxoplasmosis, and although chemotherapy is available, std. treatments are often complicated by severe side effects.  Artemisinin is a new highly potent antimalarial drug that has activity against Toxoplasma gondii in vitro.  However, artemisinin derivs. have previously been ineffective in vivo using a rat model of toxoplasmosis.  In the present study, the efficacy of several new artemisinin derivates was investigated for treatment of mice infected with the parasite Toxoplasma gondii.  Artemiside and artemisone displayed better inhibition than either artemisinin or artesunate against the parasite in vitro.  Artemiside and artemisone treatment controlled parasite replication in vivo, and mice survived the acute infection.  In a murine model of reactivated toxoplasmosis, both drugs increased survival, although artemiside was more effective.  These results indicate that these newer derivs. of artemisinin may have potential for treatment of toxoplasmosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2MtmJjyOHtbVg90H21EOLACvtfcHk0liiKM-zQsPTdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KkurjJ&md5=e86b366adcbd75b40fc3101344613137</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FAAC.00502-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00502-09%26sid%3Dliteratum%253Aachs%26aulast%3DDunay%26aufirst%3DI.%2BR.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DHaynes%26aufirst%3DR.%2BK.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DArtemisone%2520and%2520artemiside%2520control%2520acute%2520and%2520reactivated%2520toxoplasmosis%2520in%2520the%2520murine%2520model%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D4450%26epage%3D4456%26doi%3D10.1128%2FAAC.00502-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Minor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cymborowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chruszcz, M.</span><span> </span><span class="NLM_article-title">HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">866</span><span class="refDoi"> DOI: 10.1107/S0907444906019949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1107%2FS0907444906019949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=16855301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVWksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=859-866&author=W.+Minorauthor=M.+Cymborowskiauthor=Z.+Otwinowskiauthor=M.+Chruszcz&title=HKL-3000%3A+the+integration+of+data+reduction+and+structure+solution%2D%2Dfrom+diffraction+images+to+an+initial+model+in+minutes&doi=10.1107%2FS0907444906019949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">HKL-3000: the integration of data reduction and structure solution - from diffraction images to an initial model in minutes</span></div><div class="casAuthors">Minor, Wladek; Cymborowski, Marcin; Otwinowski, Zbyszek; Chruszcz, Maksymilian</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">859-866</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A new approach that integrates data collection, data redn., phasing and model building significantly accelerates the process of structure detn. and on av. minimizes the no. of data sets and synchrotron time required for structure soln.  Initial testing of the HKL-3000 system (the beta version was named HKL-2000_ph) with more than 140 novel structure detns. has proven its high value for MAD/SAD expts.  The heuristics for choosing the best computational strategy at different data resoln. limits of phasing signal and crystal diffraction are being optimized.  The typical end result is an interpretable electron-d. map with a partially built structure and, in some cases, an almost complete refined model.  The current development is oriented towards very fast structure soln. in order to provide feedback during the diffraction expt.  Work is also proceeding towards improving the quality of phasing calcn. and model building.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0c0DYtjFP7rVg90H21EOLACvtfcHk0liiKM-zQsPTdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVWksL8%253D&md5=2cd2fe288f954837abb4acae4c008a2f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444906019949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444906019949%26sid%3Dliteratum%253Aachs%26aulast%3DMinor%26aufirst%3DW.%26aulast%3DCymborowski%26aufirst%3DM.%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DChruszcz%26aufirst%3DM.%26atitle%3DHKL-3000%253A%2520the%2520integration%2520of%2520data%2520reduction%2520and%2520structure%2520solution--from%2520diffraction%2520images%2520to%2520an%2520initial%2520model%2520in%2520minutes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D859%26epage%3D866%26doi%3D10.1107%2FS0907444906019949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; W, P.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span> BUSTER version 2.10.0. <span class="NLM_publisher-name">Global Phasing Ltd</span>, <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>.<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bricogne%2C+G.%3B+Blanc%2C+E.%3B+Brandl%2C+M.%3B+Flensburg%2C+C.%3B+Keller%2C+P.%3B+W%2C+P.%3B+Roversi%2C+P.%3B+Sharff%2C+A.%3B+Smart%2C+O.+S.%3B+Vonrhein%2C+C.%3B+Womack%2C+T.+O.+BUSTER+version+2.10.0.+Global+Phasing+Ltd%2C+Cambridge%2C+United+Kingdom.+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0liiKM-zQsPTdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0liiKM-zQsPTdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaver-Fay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendall, W. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snoeyink, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span> </span><span class="NLM_article-title">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">W375</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span><span class="refDoi"> DOI: 10.1093/nar/gkm216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1093%2Fnar%2Fgkm216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=17452350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W375-383&author=I.+W.+Davisauthor=A.+Leaver-Fayauthor=V.+B.+Chenauthor=J.+N.+Blockauthor=G.+J.+Kapralauthor=X.+Wangauthor=L.+W.+Murrayauthor=W.+B.+Arendallauthor=J.+Snoeyinkauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+contacts+and+structure+validation+for+proteins+and+nucleic+acids&doi=10.1093%2Fnar%2Fgkm216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span></div><div class="casAuthors">Davis Ian W; Leaver-Fay Andrew; Chen Vincent B; Block Jeremy N; Kapral Gary J; Wang Xueyi; Murray Laura W; Arendall W Bryan 3rd; Snoeyink Jack; Richardson Jane S; Richardson David C</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W375-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MolProbity is a general-purpose web server offering quality validation for 3D structures of proteins, nucleic acids and complexes.  It provides detailed all-atom contact analysis of any steric problems within the molecules as well as updated dihedral-angle diagnostics, and it can calculate and display the H-bond and van der Waals contacts in the interfaces between components.  An integral step in the process is the addition and full optimization of all hydrogen atoms, both polar and nonpolar.  New analysis functions have been added for RNA, for interfaces, and for NMR ensembles.  Additionally, both the web site and major component programs have been rewritten to improve speed, convenience, clarity and integration with other resources.  MolProbity results are reported in multiple forms: as overall numeric scores, as lists or charts of local problems, as downloadable PDB and graphics files, and most notably as informative, manipulable 3D kinemage graphics shown online in the KiNG viewer.  This service is available free to all users at http://molprobity.biochem.duke.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuyhuetoNS59bHMBt0mMIXfW6udTcc2ebEUluwfwS53bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D&md5=726ca1e7e162ab2a4a05048f493731fb</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm216%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DLeaver-Fay%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DBlock%26aufirst%3DJ.%2BN.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DSnoeyink%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520contacts%2520and%2520structure%2520validation%2520for%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW375%26epage%3D383%26doi%3D10.1093%2Fnar%2Fgkm216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Molecular Operating Environment (MOE)</span><span class="NLM_x">, 2013.08. </span><span class="NLM_publisher-name">Chemical Computing Group ULC</span>: <span class="NLM_publisher-loc">Montreal, QC, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE%29%2C+2013.08.+Chemical+Computing+Group+ULC%3A+Montreal%2C+QC%2C+Canada%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3D%26pub%3DChemical%2520Computing%2520Group%2520ULC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Fox, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommereim, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigley, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesbron-Delauw, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzik, D. J.</span><span> </span><span class="NLM_article-title">Type II <i>Toxoplasma gondii</i> KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection</span> <span class="citation_source-journal">Eukaryotic Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span><span class="refDoi"> DOI: 10.1128/EC.00297-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FEC.00297-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=21531875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2hs7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=1193-1206&author=B.+A.+Foxauthor=A.+Fallaauthor=L.+M.+Rommereimauthor=T.+Tomitaauthor=J.+P.+Gigleyauthor=C.+Mercierauthor=M.+F.+Cesbron-Delauwauthor=L.+M.+Weissauthor=D.+J.+Bzik&title=Type+II+Toxoplasma+gondii+KU80+knockout+strains+enable+functional+analysis+of+genes+required+for+cyst+development+and+latent+infection&doi=10.1128%2FEC.00297-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection</span></div><div class="casAuthors">Fox, Barbara A.; Falla, Alejandra; Rommereim, Leah M.; Tomita, Tadakimi; Gigley, Jason P.; Mercier, Corinne; Cesbron-Delauw, Marie-France; Weiss, Louis M.; Bzik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Eukaryotic Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1193-1206</span>CODEN:
                <span class="NLM_cas:coden">ECUEA2</span>;
        ISSN:<span class="NLM_cas:issn">1535-9786</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Type II Toxoplasma gondii KU80 knockouts (Δku80) deficient in nonhomologous en joining were developed to delete the dominant pathway mediating random integration of targeting episomes.  Gene targeting frequency in the type II Δku80 Δhxgprt strain measured at the orotate (OPRT) and the uracil (UPRT) phosphoribosyltransferase loci was highly efficient.  To assess the potential of the type II Δku80 Δhxgprt strain to examine gene function affecting cyst biol. and latent stages of infection, we targeted the deletion of four parasite antigen genes (GRA4, GRA6, ROP7, and tgd057) that encode characterized CD8+ T cell epitopes that elicit corresponding antigen-specific CD8+ T cell populations assocd. with control of infection.  Cyst development in these type II mutant strains was not found to be strictly dependent on antigen-specific CD8+ T cell host responses.  In contrast, a significant biol. role was revealed for the dense granule proteins GRA4 and GRA6 in cyst development since brain tissue cyst burdens were drastically reduced specifically in mutant strains with GRA4 and/or GRA6 deleted.  Complementation of the Δgra4 and Δgra6 mutant strains using a functional allele of the deleted GRA coding region placed under the control of the endogenous UPRT locus was found to significantly restore brain cyst burdens.  These results reveal that GRA proteins play a functional role in establishing cyst burdens and latent infection.  Collectively, our results suggest that a type II Δku80 Δhxgprt genetic background enables a higher-throughput functional anal. of the parasite genome to reveal fundamental aspects of parasite biol. controlling virulence, pathogenesis, and transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtmNlE9c1rtLVg90H21EOLACvtfcHk0lgCGPJWN-SFtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2hs7vL&md5=97d29ee067ffaccc82c5dbd04ede19b8</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1128%2FEC.00297-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FEC.00297-10%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DB.%2BA.%26aulast%3DFalla%26aufirst%3DA.%26aulast%3DRommereim%26aufirst%3DL.%2BM.%26aulast%3DTomita%26aufirst%3DT.%26aulast%3DGigley%26aufirst%3DJ.%2BP.%26aulast%3DMercier%26aufirst%3DC.%26aulast%3DCesbron-Delauw%26aufirst%3DM.%2BF.%26aulast%3DWeiss%26aufirst%3DL.%2BM.%26aulast%3DBzik%26aufirst%3DD.%2BJ.%26atitle%3DType%2520II%2520Toxoplasma%2520gondii%2520KU80%2520knockout%2520strains%2520enable%2520functional%2520analysis%2520of%2520genes%2520required%2520for%2520cyst%2520development%2520and%2520latent%2520infection%26jtitle%3DEukaryotic%2520Cell%26date%3D2011%26volume%3D10%26spage%3D1193%26epage%3D1206%26doi%3D10.1128%2FEC.00297-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Tobin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, L. J.</span><span> </span><span class="NLM_article-title">A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1128/IAI.05543-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FIAI.05543-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=22006568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=55-61&author=C.+M.+Tobinauthor=L.+J.+Knoll&title=A+patatin-like+protein+protects+Toxoplasma+gondii+from+degradation+in+a+nitric+oxide-dependent+manner&doi=10.1128%2FIAI.05543-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner</span></div><div class="casAuthors">Tobin, Crystal M.; Knoll, Laura J.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toxoplasma gondii is an obligate intracellular parasite that uses immune cells to disseminate throughout its host.  T. gondii can persist and even slowly replicate in activated host macrophages by reducing the antimicrobial effects of mols. such as nitric oxide (NO).  A T. gondii patatin-like protein called TgPL1 was previously shown to be important for survival in activated macrophages.  Here we show that a T. gondii mutant with a deletion of the TgPL1 gene (ΔTgPL1) is degraded in activated macrophages.  This degrdn. phenotype is abolished by the removal of NO by the use of an inducible NO synthase (iNOS) inhibitor or iNOS-deficient macrophages.  The exogenous addn. of NO to macrophages results in reduced parasite growth but not the degrdn. of ΔTgPL1 parasites.  These results suggest that NO is necessary but not sufficient for the degrdn. of ΔTgPL1 parasites in activated macrophages.  While some patatin-like proteins have phospholipase A2 (PLA2) activity, recombinant TgPL1 purified from Escherichia coli does not have phospholipase activity.  This result was not surprising, as TgPL1 contains a G-to-S change at the predicted catalytic serine residue.  An epitope-tagged version of TgPL1 partially colocalized with a dense granule protein in the parasitophorous vacuole space.  These results may suggest that TgPL1 moves to the parasitophorous vacuole to protect parasites from nitric oxide by an undetd. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU1uPDCKZvk7Vg90H21EOLACvtfcHk0lgCGPJWN-SFtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlGitw%253D%253D&md5=4adbe39d3ed61bdd9d57a539cbe58e5f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FIAI.05543-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.05543-11%26sid%3Dliteratum%253Aachs%26aulast%3DTobin%26aufirst%3DC.%2BM.%26aulast%3DKnoll%26aufirst%3DL.%2BJ.%26atitle%3DA%2520patatin-like%2520protein%2520protects%2520Toxoplasma%2520gondii%2520from%2520degradation%2520in%2520a%2520nitric%2520oxide-dependent%2520manner%26jtitle%3DInfect.%2520Immun.%26date%3D2012%26volume%3D80%26spage%3D55%26epage%3D61%26doi%3D10.1128%2FIAI.05543-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Wang, Z. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span> </span><span class="NLM_article-title">Reassessment of the role of aromatic amino acid hydroxylases and the effect of infection by <i>Toxoplasma gondii</i> on host dopamine</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span><span class="refDoi"> DOI: 10.1128/IAI.02465-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FIAI.02465-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=25547791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFKrtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2015&pages=1039-1047&author=Z.+T.+Wangauthor=S.+Harmonauthor=K.+L.+O%E2%80%99Malleyauthor=L.+D.+Sibley&title=Reassessment+of+the+role+of+aromatic+amino+acid+hydroxylases+and+the+effect+of+infection+by+Toxoplasma+gondii+on+host+dopamine&doi=10.1128%2FIAI.02465-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Reassessment of the role of aromatic amino acid hydroxylases and the effect of infection by Toxoplasma gondii on host dopamine</span></div><div class="casAuthors">Wang, Zi T.; Harmon, Steve; O'Malley, Karen L.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1039-1047, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">1098-5522</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toxoplasma gondii infection has been described previously to cause infected mice to lose their fear of cat urine.  This behavioral manipulation has been proposed to involve alterations of host dopamine pathways due to parasite-encoded arom. amino acid hydroxylases.  Here, we report successful knockout and complementation of the arom. amino acid hydroxylase AAH2 gene, with no observable phenotype in parasite growth or differentiation in vitro and in vivo.  Addnl., expression levels of the two arom. amino acid hydroxylases were negligible both in tachyzoites and in bradyzoites.  Finally, we were unable to confirm previously described effects of parasite infection on host dopamine either in vitro or in vivo, even when AAH2 was overexpressed using the BAG1 promoter.  Together, these data indicate that AAH enzymes in the parasite do not cause global or regional alterations of dopamine in the host brain; although, they may affect this pathway locally.  Addnl., our findings suggest alternative roles for the AHH enzymes in T. gondii, since AAH1 is essential for growth in nondopaminergic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQLlcjGlRoV7Vg90H21EOLACvtfcHk0ljKIKxEkp5-Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFKrtr8%253D&md5=e641c4048811b23c61689578c1da1d37</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1128%2FIAI.02465-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.02465-14%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%2BT.%26aulast%3DHarmon%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DK.%2BL.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DReassessment%2520of%2520the%2520role%2520of%2520aromatic%2520amino%2520acid%2520hydroxylases%2520and%2520the%2520effect%2520of%2520infection%2520by%2520Toxoplasma%2520gondii%2520on%2520host%2520dopamine%26jtitle%3DInfect.%2520Immun.%26date%3D2015%26volume%3D83%26spage%3D1039%26epage%3D1047%26doi%3D10.1128%2FIAI.02465-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Eid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rippmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulle, S.</span><span> </span><span class="NLM_article-title">KinMap: a web-based tool for interactive navigation through human kinome data</span> <span class="citation_source-journal">BMC Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="refDoi"> DOI: 10.1186/s12859-016-1433-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1186%2Fs12859-016-1433-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=28056780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=16&author=S.+Eidauthor=S.+Turkauthor=A.+Volkamerauthor=F.+Rippmannauthor=S.+Fulle&title=KinMap%3A+a+web-based+tool+for+interactive+navigation+through+human+kinome+data&doi=10.1186%2Fs12859-016-1433-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">KinMap: a web-based tool for interactive navigation through human kinome data</span></div><div class="casAuthors">Eid, Sameh; Turk, Samo; Volkamer, Andrea; Rippmann, Friedrich; Fulle, Simone</div><div class="citationInfo"><span class="NLM_cas:title">BMC Bioinformatics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16/1-16/6</span>CODEN:
                <span class="NLM_cas:coden">BBMIC4</span>;
        ISSN:<span class="NLM_cas:issn">1471-2105</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Annotations of the phylogenetic tree of the human kinome is an intuitive way to visualize compd. profiling data, structural features of kinases or functional relationships within this important class of proteins.  The increasing vol. and complexity of kinase-related data underlines the need for a tool that enables complex queries pertaining to kinase disease involvement and potential therapeutic uses of kinase inhibitors.  Results: Here, we present KinMap, a user-friendly online tool that facilitates the interactive navigation through kinase knowledge by linking biochem., structural, and disease assocn. data to the human kinome tree.  To this end, preprocessed data from freely-available sources, such as ChEMBL, the Protein Data Bank, and the Center for Therapeutic Target Validation platform are integrated into KinMap and can easily be complemented by proprietary data.  The value of KinMap will be exemplarily demonstrated for uncovering new therapeutic indications of known kinase inhibitors and for prioritizing kinases for drug development efforts.  Conclusions: KinMap represents a new generation of kinome tree viewers which facilitates interactive exploration of the human kinome.  KinMap enables generation of high-quality annotated images of the human kinome tree as well as exchange of kinome-related data in scientific communications.  Furthermore, KinMap supports multiple input and output formats and recognizes alternative kinase names and links them to a unified naming scheme, which makes it a useful tool across different disciplines and applications.  A web-service of KinMap is freely available at http://www.kinhub.org/kinmap/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1M2aa8fuKALVg90H21EOLACvtfcHk0ljKIKxEkp5-Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCjtLc%253D&md5=29737c7cda8d9caf75018e0d29e9a459</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1186%2Fs12859-016-1433-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12859-016-1433-7%26sid%3Dliteratum%253Aachs%26aulast%3DEid%26aufirst%3DS.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DVolkamer%26aufirst%3DA.%26aulast%3DRippmann%26aufirst%3DF.%26aulast%3DFulle%26aufirst%3DS.%26atitle%3DKinMap%253A%2520a%2520web-based%2520tool%2520for%2520interactive%2520navigation%2520through%2520human%2520kinome%2520data%26jtitle%3DBMC%2520Bioinf.%26date%3D2017%26volume%3D18%26spage%3D16%26doi%3D10.1186%2Fs12859-016-1433-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 38 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jakob Bouton, Ludmila Ferreira de Almeida Fiuza, Camila Cardoso Santos, Maria Angela Mazzarella, Maria de Nazaré Correia Soeiro, Louis Maes, Izet Karalic, Guy Caljon, <span class="NLM_string-name hlFld-ContribAuthor">Serge Van Calenbergh</span>. </span><span class="cited-content_cbyCitation_article-title">Revisiting Pyrazolo[3,4-d]pyrimidine Nucleosides as Anti-Trypanosoma cruzi and Antileishmanial Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 4206-4238. <a href="https://doi.org/10.1021/acs.jmedchem.1c00135" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00135%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRevisiting%252BPyrazolo%25255B3%25252C4-d%25255Dpyrimidine%252BNucleosides%252Bas%252BAnti-Trypanosoma%252Bcruzi%252Band%252BAntileishmanial%252BAgents%26aulast%3DBouton%26aufirst%3DJakob%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D24012021%26date%3D30032021%26volume%3D64%26issue%3D7%26spage%3D4206%26epage%3D4238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sherlin Rosita Arokiaraj, Nargis Begum Tajuddin, Karthikeyan Muthusamy, John Marshal Jayaraj, <span class="NLM_string-name hlFld-ContribAuthor">Manikandan Alagumuthu</span>. </span><span class="cited-content_cbyCitation_article-title">TRAF2 and NCK-Interacting Kinase Inhibitors for Colorectal Cancer: In Vitro and Theoretical Validations. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2020,</strong> <em>22 </em>
                                    (11)
                                     , 608-616. <a href="https://doi.org/10.1021/acscombsci.0c00027" title="DOI URL">https://doi.org/10.1021/acscombsci.0c00027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.0c00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.0c00027%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DTRAF2%252Band%252BNCK-Interacting%252BKinase%252BInhibitors%252Bfor%252BColorectal%252BCancer%25253A%252BIn%252BVitro%252Band%252BTheoretical%252BValidations%26aulast%3DArokiaraj%26aufirst%3DSherlin%2BRosita%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14022020%26date%3D19092020%26date%3D29092020%26date%3D22092020%26volume%3D22%26issue%3D11%26spage%3D608%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jeffery D. Zwicker, David Smith, Alfredo J. Guerra, Jacob R. Hitchens, Nicole Haug, Steve Vander Roest, Pil Lee, Bo Wen, Duxin Sun, Lu Wang, Richard F. Keep, Jianming Xiang, Vern B. Carruthers, <span class="NLM_string-name hlFld-ContribAuthor">Scott D. Larsen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of Triazine Nitrile Inhibitors of Toxoplasma gondii Cathepsin L for the Potential Treatment of Chronic Toxoplasmosis in the CNS. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (16)
                                     , 2450-2463. <a href="https://doi.org/10.1021/acschemneuro.9b00674" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00674%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BTriazine%252BNitrile%252BInhibitors%252Bof%252BToxoplasma%252Bgondii%252BCathepsin%252BL%252Bfor%252Bthe%252BPotential%252BTreatment%252Bof%252BChronic%252BToxoplasmosis%252Bin%252Bthe%252BCNS%26aulast%3DZwicker%26aufirst%3DJeffery%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D17122019%26date%3D06022020%26date%3D18022020%26date%3D06022020%26volume%3D11%26issue%3D16%26spage%3D2450%26epage%3D2463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">James W. Janetka, Allen T. Hopper, Ziping Yang, Jennifer Barks, Mary Savari Dhason, Qiuling Wang, <span class="NLM_string-name hlFld-ContribAuthor">L. David Sibley</span>. </span><span class="cited-content_cbyCitation_article-title">Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 6144-6163. <a href="https://doi.org/10.1021/acs.jmedchem.0c00419" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00419</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00419%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimizing%252BPyrazolopyrimidine%252BInhibitors%252Bof%252BCalcium%252BDependent%252BProtein%252BKinase%252B1%252Bfor%252BTreatment%252Bof%252BAcute%252Band%252BChronic%252BToxoplasmosis%26aulast%3DJanetka%26aufirst%3DJames%2BW.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11032020%26date%3D01062020%26date%3D18052020%26volume%3D63%26issue%3D11%26spage%3D6144%26epage%3D6163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christian Kersten, Edmond Fleischer, Josef Kehrein, Christoph Borek, Elmar Jaenicke, Christoph Sotriffer, <span class="NLM_string-name hlFld-ContribAuthor">Ruth Brenk</span>. </span><span class="cited-content_cbyCitation_article-title">How To Design Selective Ligands for Highly Conserved Binding Sites: A Case Study Using N-Myristoyltransferases as a Model System. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2095-2113. <a href="https://doi.org/10.1021/acs.jmedchem.9b00586" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00586</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00586%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHow%252BTo%252BDesign%252BSelective%252BLigands%252Bfor%252BHighly%252BConserved%252BBinding%252BSites%25253A%252BA%252BCase%252BStudy%252BUsing%252BN-Myristoyltransferases%252Bas%252Ba%252BModel%252BSystem%26aulast%3DKersten%26aufirst%3DChristian%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D05042019%26date%3D19082019%26volume%3D63%26issue%3D5%26spage%3D2095%26epage%3D2113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandhya  Kortagere</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Molecules To Treat Chronic Central Nervous System Toxoplasmosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (24)
                                     , 9974-9975. <a href="https://doi.org/10.1021/acs.jmedchem.7b01663" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01663%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BMolecules%252BTo%252BTreat%252BChronic%252BCentral%252BNervous%252BSystem%252BToxoplasmosis%26aulast%3DKortagere%26aufirst%3DSandhya%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10112017%26date%3D04122017%26date%3D28122017%26volume%3D60%26issue%3D24%26spage%3D9974%26epage%3D9975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumit K.  Matta</span>, <span class="hlFld-ContribAuthor ">Nicholas  Rinkenberger</span>, <span class="hlFld-ContribAuthor ">Ildiko R.  Dunay</span>, <span class="hlFld-ContribAuthor ">L. David  Sibley</span>. </span><span class="cited-content_cbyCitation_article-title">Toxoplasma gondii infection and its implications within the central nervous system. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Microbiology</span><span> <strong>2021,</strong> <em>19 </em>
                                    (7)
                                     , 467-480. <a href="https://doi.org/10.1038/s41579-021-00518-7" title="DOI URL">https://doi.org/10.1038/s41579-021-00518-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41579-021-00518-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41579-021-00518-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Microbiology%26atitle%3DToxoplasma%252Bgondii%252Binfection%252Band%252Bits%252Bimplications%252Bwithin%252Bthe%252Bcentral%252Bnervous%252Bsystem%26aulast%3DMatta%26aufirst%3DSumit%2BK.%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D7%26spage%3D467%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajshekhar Y.  Gaji</span>, <span class="hlFld-ContribAuthor ">Amanda K.  Sharp</span>, <span class="hlFld-ContribAuthor ">Anne M.  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Protein kinases in Toxoplasma gondii. </span><span class="cited-content_cbyCitation_journal-name">International Journal for Parasitology</span><span> <strong>2021,</strong> <em>51 </em>
                                    (6)
                                     , 415-429. <a href="https://doi.org/10.1016/j.ijpara.2020.11.006" title="DOI URL">https://doi.org/10.1016/j.ijpara.2020.11.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpara.2020.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpara.2020.11.006%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520for%2520Parasitology%26atitle%3DProtein%252Bkinases%252Bin%252BToxoplasma%252Bgondii%26aulast%3DGaji%26aufirst%3DRajshekhar%2BY.%26date%3D2021%26volume%3D51%26issue%3D6%26spage%3D415%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas C.  Smith</span>, <span class="hlFld-ContribAuthor ">Cibelly  Goulart</span>, <span class="hlFld-ContribAuthor ">Jenni A.  Hayward</span>, <span class="hlFld-ContribAuthor ">Andreas  Kupz</span>, <span class="hlFld-ContribAuthor ">Catherine M.  Miller</span>, <span class="hlFld-ContribAuthor ">Giel G.  van Dooren</span>. </span><span class="cited-content_cbyCitation_article-title">Control of human toxoplasmosis. </span><span class="cited-content_cbyCitation_journal-name">International Journal for Parasitology</span><span> <strong>2021,</strong> <em>51 </em>
                                    (2-3)
                                     , 95-121. <a href="https://doi.org/10.1016/j.ijpara.2020.11.001" title="DOI URL">https://doi.org/10.1016/j.ijpara.2020.11.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpara.2020.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpara.2020.11.001%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520for%2520Parasitology%26atitle%3DControl%252Bof%252Bhuman%252Btoxoplasmosis%26aulast%3DSmith%26aufirst%3DNicholas%2BC.%26date%3D2021%26volume%3D51%26issue%3D2-3%26spage%3D95%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaolong  Zhao</span>, <span class="hlFld-ContribAuthor ">Hongyan  Wang</span>, <span class="hlFld-ContribAuthor ">Yongfeng  Sun</span>, . </span><span class="cited-content_cbyCitation_article-title">Establishment and Analysis of Spatiotemporal Variation Hydrological Model of Distributed Rainfall and Evaporation in Biliu River Basin. </span><span class="cited-content_cbyCitation_journal-name">Complexity</span><span> <strong>2021,</strong> <em>2021 </em>, 1-10. <a href="https://doi.org/10.1155/2021/6639691" title="DOI URL">https://doi.org/10.1155/2021/6639691</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2021/6639691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2021%2F6639691%26sid%3Dliteratum%253Aachs%26jtitle%3DComplexity%26atitle%3DEstablishment%252Band%252BAnalysis%252Bof%252BSpatiotemporal%252BVariation%252BHydrological%252BModel%252Bof%252BDistributed%252BRainfall%252Band%252BEvaporation%252Bin%252BBiliu%252BRiver%252BBasin%26aulast%3DLiu%26aufirst%3DQi%26date%3D2021%26volume%3D2021%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eddie L  Myers</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5–6 Systems: Other Four Heteroatoms 2:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00056-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00056-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00056-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00056-1%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5%2525E2%252580%2525936%252BSystems%25253A%252BOther%252BFour%252BHeteroatoms%252B2%25253A2%26aulast%3DMyers%26aufirst%3DEddie%2BL%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amir Med  Kezai</span>, <span class="hlFld-ContribAuthor ">Cécile  Lecoeur</span>, <span class="hlFld-ContribAuthor ">David  Hot</span>, <span class="hlFld-ContribAuthor ">Mustapha  Bounechada</span>, <span class="hlFld-ContribAuthor ">Med Lamine  Alouani</span>, <span class="hlFld-ContribAuthor ">Sabrina  Marion</span>. </span><span class="cited-content_cbyCitation_article-title">Association between schizophrenia and Toxoplasma gondii infection in Algeria. </span><span class="cited-content_cbyCitation_journal-name">Psychiatry Research</span><span> <strong>2020,</strong> <em>291 </em>, 113293. <a href="https://doi.org/10.1016/j.psychres.2020.113293" title="DOI URL">https://doi.org/10.1016/j.psychres.2020.113293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.psychres.2020.113293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.psychres.2020.113293%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychiatry%2520Research%26atitle%3DAssociation%252Bbetween%252Bschizophrenia%252Band%252BToxoplasma%252Bgondii%252Binfection%252Bin%252BAlgeria%26aulast%3DKezai%26aufirst%3DAmir%2BMed%26date%3D2020%26volume%3D291%26spage%3D113293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. Stone  Doggett</span>, <span class="hlFld-ContribAuthor ">Tracey  Schultz</span>, <span class="hlFld-ContribAuthor ">Alyssa J.  Miller</span>, <span class="hlFld-ContribAuthor ">Igor  Bruzual</span>, <span class="hlFld-ContribAuthor ">Sovitj  Pou</span>, <span class="hlFld-ContribAuthor ">Rolf  Winter</span>, <span class="hlFld-ContribAuthor ">Rozalia  Dodean</span>, <span class="hlFld-ContribAuthor ">Lev N.  Zakharov</span>, <span class="hlFld-ContribAuthor ">Aaron  Nilsen</span>, <span class="hlFld-ContribAuthor ">Michael K.  Riscoe</span>, <span class="hlFld-ContribAuthor ">Vern B.  Carruthers</span>. </span><span class="cited-content_cbyCitation_article-title">Orally Bioavailable Endochin-Like Quinolone Carbonate Ester Prodrug Reduces Toxoplasma gondii Brain Cysts. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>64 </em>
                                    (9)
                                     <a href="https://doi.org/10.1128/AAC.00535-20" title="DOI URL">https://doi.org/10.1128/AAC.00535-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00535-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00535-20%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DOrally%252BBioavailable%252BEndochin-Like%252BQuinolone%252BCarbonate%252BEster%252BProdrug%252BReduces%252BToxoplasma%252Bgondii%252BBrain%252BCysts%26aulast%3DDoggett%26aufirst%3DJ.%2BStone%26date%3D2020%26volume%3D64%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian  Cai</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Ullmann‐Ma
              Reaction: Development, Scope and Applications in Organic Synthesis
              †. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2020,</strong> <em>38 </em>
                                    (8)
                                     , 879-893. <a href="https://doi.org/10.1002/cjoc.202000075" title="DOI URL">https://doi.org/10.1002/cjoc.202000075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.202000075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.202000075%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DUllmann%2525E2%252580%252590Ma%252BReaction%25253A%252BDevelopment%25252C%252BScope%252Band%252BApplications%252Bin%252BOrganic%252BSynthesis%252B%2525E2%252580%2525A0%26aulast%3DCai%26aufirst%3DQian%26date%3D2020%26date%3D2020%26volume%3D38%26issue%3D8%26spage%3D879%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hermann AM  Mucke</span>. </span><span class="cited-content_cbyCitation_article-title">Patent highlights February–March 2020. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2020,</strong> <em>9 </em>
                                    (4)
                                     , 125-132. <a href="https://doi.org/10.4155/ppa-2020-0010" title="DOI URL">https://doi.org/10.4155/ppa-2020-0010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa-2020-0010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa-2020-0010%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DPatent%252Bhighlights%252BFebruary%2525E2%252580%252593March%252B2020%26aulast%3DMucke%26aufirst%3DHermann%2BAM%26date%3D2020%26volume%3D9%26issue%3D4%26spage%3D125%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. Nishanth  Rao</span>, <span class="hlFld-ContribAuthor ">Kaushik  Chanda</span>. </span><span class="cited-content_cbyCitation_article-title">An assessment study of known pyrazolopyrimidines: Chemical methodology and cellular activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103801. <a href="https://doi.org/10.1016/j.bioorg.2020.103801" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103801</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103801%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAn%252Bassessment%252Bstudy%252Bof%252Bknown%252Bpyrazolopyrimidines%25253A%252BChemical%252Bmethodology%252Band%252Bcellular%252Bactivity%26aulast%3DRao%26aufirst%3DR.%2BNishanth%26date%3D2020%26volume%3D99%26spage%3D103801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aude  Cerutti</span>, <span class="hlFld-ContribAuthor ">Nicolas  Blanchard</span>, <span class="hlFld-ContribAuthor ">Sébastien  Besteiro</span>. </span><span class="cited-content_cbyCitation_article-title">The Bradyzoite: A Key Developmental Stage for the Persistence and Pathogenesis of Toxoplasmosis. </span><span class="cited-content_cbyCitation_journal-name">Pathogens</span><span> <strong>2020,</strong> <em>9 </em>
                                    (3)
                                     , 234. <a href="https://doi.org/10.3390/pathogens9030234" title="DOI URL">https://doi.org/10.3390/pathogens9030234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pathogens9030234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpathogens9030234%26sid%3Dliteratum%253Aachs%26jtitle%3DPathogens%26atitle%3DThe%252BBradyzoite%25253A%252BA%252BKey%252BDevelopmental%252BStage%252Bfor%252Bthe%252BPersistence%252Band%252BPathogenesis%252Bof%252BToxoplasmosis%26aulast%3DCerutti%26aufirst%3DAude%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D3%26spage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiuling  Wang</span>, <span class="hlFld-ContribAuthor ">L. David  Sibley</span>. </span><span class="cited-content_cbyCitation_article-title">Assays for Monitoring Toxoplasma gondii Infectivity in the Laboratory Mouse. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 99-116. <a href="https://doi.org/10.1007/978-1-4939-9857-9_5" title="DOI URL">https://doi.org/10.1007/978-1-4939-9857-9_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-9857-9_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-9857-9_5%26sid%3Dliteratum%253Aachs%26atitle%3DAssays%252Bfor%252BMonitoring%252BToxoplasma%252Bgondii%252BInfectivity%252Bin%252Bthe%252BLaboratory%252BMouse%26aulast%3DWang%26aufirst%3DQiuling%26date%3D2020%26date%3D2019%26spage%3D99%26epage%3D116%26pub%3DSpringer%2520US%26atitle%3DToxoplasma%252Bgondii%26aulast%3DTonkin%26aufirst%3DChristopher%2BJ.%26date%3D2020%26volume%3D2071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rima  McLeod</span>, <span class="hlFld-ContribAuthor ">William  Cohen</span>, <span class="hlFld-ContribAuthor ">Samantha  Dovgin</span>, <span class="hlFld-ContribAuthor ">Lauren  Finkelstein</span>, <span class="hlFld-ContribAuthor ">Kenneth M.  Boyer</span>. </span><span class="cited-content_cbyCitation_article-title">Human Toxoplasma infection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 117-227. <a href="https://doi.org/10.1016/B978-0-12-815041-2.00004-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-815041-2.00004-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-815041-2.00004-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-815041-2.00004-9%26sid%3Dliteratum%253Aachs%26atitle%3DHuman%252BToxoplasma%252Binfection%26aulast%3DMcLeod%26aufirst%3DRima%26date%3D2020%26spage%3D117%26epage%3D227%26pub%3DElsevier%26atitle%3DToxoplasma%252Bgondii%26date%3D2020%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin M.  Brown</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Tonkin</span>, <span class="hlFld-ContribAuthor ">Oliver  Billker</span>, <span class="hlFld-ContribAuthor ">L. David  Sibley</span>. </span><span class="cited-content_cbyCitation_article-title">Calcium and cyclic nucleotide signaling networks in Toxoplasma gondii. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 577-605. <a href="https://doi.org/10.1016/B978-0-12-815041-2.00013-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-815041-2.00013-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-815041-2.00013-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-815041-2.00013-X%26sid%3Dliteratum%253Aachs%26atitle%3DCalcium%252Band%252Bcyclic%252Bnucleotide%252Bsignaling%252Bnetworks%252Bin%252BToxoplasma%252Bgondii%26aulast%3DBrown%26aufirst%3DKevin%2BM.%26date%3D2020%26spage%3D577%26epage%3D605%26pub%3DElsevier%26atitle%3DToxoplasma%252Bgondii%26date%3D2020%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Deng</span>, <span class="hlFld-ContribAuthor ">Tao  Wu</span>, <span class="hlFld-ContribAuthor ">Shao-Qin  Zhai</span>, <span class="hlFld-ContribAuthor ">Cheng-Hong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>183 </em>, 111711. <a href="https://doi.org/10.1016/j.ejmech.2019.111711" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111711%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bon%252Banti-Toxoplasma%252Bdrugs%252Bdiscovery%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bscreening%26aulast%3DDeng%26aufirst%3DYu%26date%3D2019%26volume%3D183%26spage%3D111711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula J.  Lapinskas</span>, <span class="hlFld-ContribAuthor ">Ruben R.  Ben-Harari</span>. </span><span class="cited-content_cbyCitation_article-title">Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis. </span><span class="cited-content_cbyCitation_journal-name">Postgraduate Medicine</span><span> <strong>2019,</strong> <em>131 </em>
                                    (8)
                                     , 589-596. <a href="https://doi.org/10.1080/00325481.2019.1655258" title="DOI URL">https://doi.org/10.1080/00325481.2019.1655258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00325481.2019.1655258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00325481.2019.1655258%26sid%3Dliteratum%253Aachs%26jtitle%3DPostgraduate%2520Medicine%26atitle%3DPerspective%252Bon%252Bcurrent%252Band%252Bemerging%252Bdrugs%252Bin%252Bthe%252Btreatment%252Bof%252Bacute%252Band%252Bchronic%252Btoxoplasmosis%26aulast%3DLapinskas%26aufirst%3DPaula%2BJ.%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D8%26spage%3D589%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoana D.  Petrova</span>, <span class="hlFld-ContribAuthor ">Katty  Wadda</span>, <span class="hlFld-ContribAuthor ">Amit  Nathubhai</span>, <span class="hlFld-ContribAuthor ">Maksims  Yevglevskis</span>, <span class="hlFld-ContribAuthor ">Paul J.  Mitchell</span>, <span class="hlFld-ContribAuthor ">Tony D.  James</span>, <span class="hlFld-ContribAuthor ">Michael D.  Threadgill</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Woodman</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel small-molecule inhibitors of α-methylacyl-CoA racemase (AMACR; P504S) and structure-activity relationships. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>92 </em>, 103264. <a href="https://doi.org/10.1016/j.bioorg.2019.103264" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103264%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DIdentification%252Bof%252Bnovel%252Bsmall-molecule%252Binhibitors%252Bof%252B%2525CE%2525B1-methylacyl-CoA%252Bracemase%252B%252528AMACR%25253B%252BP504S%252529%252Band%252Bstructure-activity%252Brelationships%26aulast%3DPetrova%26aufirst%3DYoana%2BD.%26date%3D2019%26volume%3D92%26spage%3D103264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Burgess B.  Freeman</span>, <span class="hlFld-ContribAuthor ">Lei  Yang</span>, <span class="hlFld-ContribAuthor ">Zoran  Rankovic</span>. </span><span class="cited-content_cbyCitation_article-title">Practical approaches to evaluating and optimizing brain exposure in early drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111643. <a href="https://doi.org/10.1016/j.ejmech.2019.111643" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111643%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPractical%252Bapproaches%252Bto%252Bevaluating%252Band%252Boptimizing%252Bbrain%252Bexposure%252Bin%252Bearly%252Bdrug%252Bdiscovery%26aulast%3DFreeman%26aufirst%3DBurgess%2BB.%26date%3D2019%26volume%3D182%26spage%3D111643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanan Abd  Elgawad</span>, <span class="hlFld-ContribAuthor ">Samar M.  Alhusseiny</span>, <span class="hlFld-ContribAuthor ">Amira  Taman</span>, <span class="hlFld-ContribAuthor ">Mona Younis  Youssef</span>, <span class="hlFld-ContribAuthor ">Basem  Mansour</span>, <span class="hlFld-ContribAuthor ">Mohammed  Massoud</span>, <span class="hlFld-ContribAuthor ">Aya  Handousa</span>. </span><span class="cited-content_cbyCitation_article-title">Biological evaluation of newly synthesized quinoline–based compound PPQ-8 in acute and chronic toxoplasmosis: An experimental study. </span><span class="cited-content_cbyCitation_journal-name">Experimental Parasitology</span><span> <strong>2019,</strong> <em>206 </em>, 107756. <a href="https://doi.org/10.1016/j.exppara.2019.107756" title="DOI URL">https://doi.org/10.1016/j.exppara.2019.107756</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.exppara.2019.107756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.exppara.2019.107756%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Parasitology%26atitle%3DBiological%252Bevaluation%252Bof%252Bnewly%252Bsynthesized%252Bquinoline%2525E2%252580%252593based%252Bcompound%252BPPQ-8%252Bin%252Bacute%252Band%252Bchronic%252Btoxoplasmosis%25253A%252BAn%252Bexperimental%252Bstudy%26aulast%3DElgawad%26aufirst%3DHanan%2BAbd%26date%3D2019%26volume%3D206%26spage%3D107756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael P.  Barrett</span>, <span class="hlFld-ContribAuthor ">Dennis E.  Kyle</span>, <span class="hlFld-ContribAuthor ">L. David  Sibley</span>, <span class="hlFld-ContribAuthor ">Joshua B.  Radke</span>, <span class="hlFld-ContribAuthor ">Rick L.  Tarleton</span>. </span><span class="cited-content_cbyCitation_article-title">Protozoan persister-like cells and drug treatment failure. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Microbiology</span><span> <strong>2019,</strong> <em>17 </em>
                                    (10)
                                     , 607-620. <a href="https://doi.org/10.1038/s41579-019-0238-x" title="DOI URL">https://doi.org/10.1038/s41579-019-0238-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41579-019-0238-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41579-019-0238-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Microbiology%26atitle%3DProtozoan%252Bpersister-like%252Bcells%252Band%252Bdrug%252Btreatment%252Bfailure%26aulast%3DBarrett%26aufirst%3DMichael%2BP.%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D10%26spage%3D607%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hugo  Bisio</span>, <span class="hlFld-ContribAuthor ">Dominique  Soldati-Favre</span>. </span><span class="cited-content_cbyCitation_article-title">Signaling Cascades Governing Entry into and Exit from Host Cells by
              Toxoplasma gondii. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Microbiology</span><span> <strong>2019,</strong> <em>73 </em>
                                    (1)
                                     , 579-599. <a href="https://doi.org/10.1146/annurev-micro-020518-120235" title="DOI URL">https://doi.org/10.1146/annurev-micro-020518-120235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-micro-020518-120235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-micro-020518-120235%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Microbiology%26atitle%3DSignaling%252BCascades%252BGoverning%252BEntry%252Binto%252Band%252BExit%252Bfrom%252BHost%252BCells%252Bby%252BToxoplasma%252Bgondii%26aulast%3DBisio%26aufirst%3DHugo%26date%3D2019%26volume%3D73%26issue%3D1%26spage%3D579%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neda  Konstantinovic</span>, <span class="hlFld-ContribAuthor ">Hélène  Guegan</span>, <span class="hlFld-ContribAuthor ">Tijana  Stäjner</span>, <span class="hlFld-ContribAuthor ">Sorya  Belaz</span>, <span class="hlFld-ContribAuthor ">Florence  Robert-Gangneux</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of toxoplasmosis: Current options and future perspectives. </span><span class="cited-content_cbyCitation_journal-name">Food and Waterborne Parasitology</span><span> <strong>2019,</strong> <em>15 </em>, e00036. <a href="https://doi.org/10.1016/j.fawpar.2019.e00036" title="DOI URL">https://doi.org/10.1016/j.fawpar.2019.e00036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fawpar.2019.e00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fawpar.2019.e00036%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520and%2520Waterborne%2520Parasitology%26atitle%3DTreatment%252Bof%252Btoxoplasmosis%25253A%252BCurrent%252Boptions%252Band%252Bfuture%252Bperspectives%26aulast%3DKonstantinovic%26aufirst%3DNeda%26date%3D2019%26volume%3D15%26spage%3De00036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew A  Hulverson</span>, <span class="hlFld-ContribAuthor ">Igor  Bruzual</span>, <span class="hlFld-ContribAuthor ">Erin V  McConnell</span>, <span class="hlFld-ContribAuthor ">Wenlin  Huang</span>, <span class="hlFld-ContribAuthor ">Rama S R  Vidadala</span>, <span class="hlFld-ContribAuthor ">Ryan  Choi</span>, <span class="hlFld-ContribAuthor ">Samuel L M  Arnold</span>, <span class="hlFld-ContribAuthor ">Grant R  Whitman</span>, <span class="hlFld-ContribAuthor ">Molly C  McCloskey</span>, <span class="hlFld-ContribAuthor ">Lynn K  Barrett</span>, <span class="hlFld-ContribAuthor ">Kasey L  Rivas</span>, <span class="hlFld-ContribAuthor ">Suzanne  Scheele</span>, <span class="hlFld-ContribAuthor ">Amy E  DeRocher</span>, <span class="hlFld-ContribAuthor ">Marilyn  Parsons</span>, <span class="hlFld-ContribAuthor ">Kayode K  Ojo</span>, <span class="hlFld-ContribAuthor ">Dustin J  Maly</span>, <span class="hlFld-ContribAuthor ">Erkang  Fan</span>, <span class="hlFld-ContribAuthor ">Wesley C  Van Voorhis</span>, <span class="hlFld-ContribAuthor ">J Stone  Doggett</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Infectious Diseases</span><span> <strong>2019,</strong> <em>219 </em>
                                    (9)
                                     , 1464-1473. <a href="https://doi.org/10.1093/infdis/jiy664" title="DOI URL">https://doi.org/10.1093/infdis/jiy664</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/infdis/jiy664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Finfdis%2Fjiy664%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Infectious%2520Diseases%26atitle%3DPharmacokinetics%252Band%252BIn%252BVivo%252BEfficacy%252Bof%252BPyrazolopyrimidine%25252C%252BPyrrolopyrimidine%25252C%252Band%252B5-Aminopyrazole-4-Carboxamide%252BBumped%252BKinase%252BInhibitors%252Bagainst%252BToxoplasmosis%26aulast%3DHulverson%26aufirst%3DMatthew%2BA%26date%3D2019%26date%3D2018%26volume%3D219%26issue%3D9%26spage%3D1464%26epage%3D1473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clinton G. L.  Veale</span>. </span><span class="cited-content_cbyCitation_article-title">Unpacking the Pathogen Box—An Open Source Tool for Fighting Neglected Tropical Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (4)
                                     , 386-453. <a href="https://doi.org/10.1002/cmdc.201800755" title="DOI URL">https://doi.org/10.1002/cmdc.201800755</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800755%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DUnpacking%252Bthe%252BPathogen%252BBox%2525E2%252580%252594An%252BOpen%252BSource%252BTool%252Bfor%252BFighting%252BNeglected%252BTropical%252BDisease%26aulast%3DVeale%26aufirst%3DClinton%2BG.%2BL.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D4%26spage%3D386%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agata  Paneth</span>, <span class="hlFld-ContribAuthor ">Lidia  Węglińska</span>, <span class="hlFld-ContribAuthor ">Adrian  Bekier</span>, <span class="hlFld-ContribAuthor ">Edyta  Stefaniszyn</span>, <span class="hlFld-ContribAuthor ">Monika  Wujec</span>, <span class="hlFld-ContribAuthor ">Nazar  Trotsko</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Dzitko</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic Identification of Thiosemicarbazides for Inhibition of Toxoplasma gondii Growth In Vitro. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (3)
                                     , 614. <a href="https://doi.org/10.3390/molecules24030614" title="DOI URL">https://doi.org/10.3390/molecules24030614</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24030614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24030614%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSystematic%252BIdentification%252Bof%252BThiosemicarbazides%252Bfor%252BInhibition%252Bof%252BToxoplasma%252Bgondii%252BGrowth%252BIn%252BVitro%26aulast%3DPaneth%26aufirst%3DAgata%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D3%26spage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodrigo  Ochoa</span>, <span class="hlFld-ContribAuthor ">Cristian  Rocha-Roa</span>, <span class="hlFld-ContribAuthor ">Marcel  Marín-Villa</span>, <span class="hlFld-ContribAuthor ">Sara  Robledo</span>, <span class="hlFld-ContribAuthor ">Rubén  Varela-M</span>. </span><span class="cited-content_cbyCitation_article-title">Search of Allosteric Inhibitors and Associated Proteins of an AKT-like Kinase from Trypanosoma cruzi. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (12)
                                     , 3951. <a href="https://doi.org/10.3390/ijms19123951" title="DOI URL">https://doi.org/10.3390/ijms19123951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19123951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19123951%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSearch%252Bof%252BAllosteric%252BInhibitors%252Band%252BAssociated%252BProteins%252Bof%252Ban%252BAKT-like%252BKinase%252Bfrom%252BTrypanosoma%252Bcruzi%26aulast%3DOchoa%26aufirst%3DRodrigo%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D12%26spage%3D3951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miryam Andrea  Hortua Triana</span>, <span class="hlFld-ContribAuthor ">Karla M.  Márquez-Nogueras</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Vella</span>, <span class="hlFld-ContribAuthor ">Silvia N.J.  Moreno</span>. </span><span class="cited-content_cbyCitation_article-title">Calcium signaling and the lytic cycle of the Apicomplexan parasite Toxoplasma gondii. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</span><span> <strong>2018,</strong> <em>1865 </em>
                                    (11)
                                     , 1846-1856. <a href="https://doi.org/10.1016/j.bbamcr.2018.08.004" title="DOI URL">https://doi.org/10.1016/j.bbamcr.2018.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamcr.2018.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamcr.2018.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520Cell%2520Research%26atitle%3DCalcium%252Bsignaling%252Band%252Bthe%252Blytic%252Bcycle%252Bof%252Bthe%252BApicomplexan%252Bparasite%252BToxoplasma%252Bgondii%26aulast%3DHortua%2BTriana%26aufirst%3DMiryam%2BAndrea%26date%3D2018%26volume%3D1865%26issue%3D11%26spage%3D1846%26epage%3D1856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahbobeh  Montazeri</span>, <span class="hlFld-ContribAuthor ">Saeed  Mehrzadi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Sharif</span>, <span class="hlFld-ContribAuthor ">Shahabeddin  Sarvi</span>, <span class="hlFld-ContribAuthor ">Shayesteh  Shahdin</span>, <span class="hlFld-ContribAuthor ">Ahmad  Daryani</span>. </span><span class="cited-content_cbyCitation_article-title">Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review. </span><span class="cited-content_cbyCitation_journal-name">Parasitology Research</span><span> <strong>2018,</strong> <em>117 </em>
                                    (10)
                                     , 3045-3057. <a href="https://doi.org/10.1007/s00436-018-6027-z" title="DOI URL">https://doi.org/10.1007/s00436-018-6027-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00436-018-6027-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00436-018-6027-z%26sid%3Dliteratum%253Aachs%26jtitle%3DParasitology%2520Research%26atitle%3DActivities%252Bof%252Banti-Toxoplasma%252Bdrugs%252Band%252Bcompounds%252Bagainst%252Btissue%252Bcysts%252Bin%252Bthe%252Blast%252Bthree%252Bdecades%252B%2525281987%252Bto%252B2017%252529%25252C%252Ba%252Bsystematic%252Breview%26aulast%3DMontazeri%26aufirst%3DMahbobeh%26date%3D2018%26date%3D2018%26volume%3D117%26issue%3D10%26spage%3D3045%26epage%3D3057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ildiko Rita  Dunay</span>, <span class="hlFld-ContribAuthor ">Kiran  Gajurel</span>, <span class="hlFld-ContribAuthor ">Reshika  Dhakal</span>, <span class="hlFld-ContribAuthor ">Oliver  Liesenfeld</span>, <span class="hlFld-ContribAuthor ">Jose G.  Montoya</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice. </span><span class="cited-content_cbyCitation_journal-name">Clinical Microbiology Reviews</span><span> <strong>2018,</strong> <em>31 </em>
                                    (4)
                                     <a href="https://doi.org/10.1128/CMR.00057-17" title="DOI URL">https://doi.org/10.1128/CMR.00057-17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/CMR.00057-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FCMR.00057-17%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Microbiology%2520Reviews%26atitle%3DTreatment%252Bof%252BToxoplasmosis%25253A%252BHistorical%252BPerspective%25252C%252BAnimal%252BModels%25252C%252Band%252BCurrent%252BClinical%252BPractice%26aulast%3DDunay%26aufirst%3DIldiko%2BRita%26date%3D2018%26volume%3D31%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Espérance  Moine</span>, <span class="hlFld-ContribAuthor ">Nathalie  Moiré</span>, <span class="hlFld-ContribAuthor ">Isabelle  Dimier-Poisson</span>, <span class="hlFld-ContribAuthor ">Kévin  Brunet</span>, <span class="hlFld-ContribAuthor ">William  Couet</span>, <span class="hlFld-ContribAuthor ">Cyril  Colas</span>, <span class="hlFld-ContribAuthor ">Nathalie  Van Langendonck</span>, <span class="hlFld-ContribAuthor ">Cécile  Enguehard-Gueiffier</span>, <span class="hlFld-ContribAuthor ">Alain  Gueiffier</span>, <span class="hlFld-ContribAuthor ">Bruno  Héraut</span>, <span class="hlFld-ContribAuthor ">Caroline  Denevault-Sabourin</span>, <span class="hlFld-ContribAuthor ">Françoise  Debierre-Grockiego</span>. </span><span class="cited-content_cbyCitation_article-title">Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosis. </span><span class="cited-content_cbyCitation_journal-name">International Journal for Parasitology</span><span> <strong>2018,</strong> <em>48 </em>
                                    (7)
                                     , 561-568. <a href="https://doi.org/10.1016/j.ijpara.2017.12.006" title="DOI URL">https://doi.org/10.1016/j.ijpara.2017.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpara.2017.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpara.2017.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520for%2520Parasitology%26atitle%3DImidazo%25255B1%25252C2-b%25255Dpyridazines%252Btargeting%252BToxoplasma%252Bgondii%252Bcalcium-dependent%252Bprotein%252Bkinase%252B1%252Bdecrease%252Bthe%252Bparasite%252Bburden%252Bin%252Bmice%252Bwith%252Bacute%252Btoxoplasmosis%26aulast%3DMoine%26aufirst%3DEsp%25C3%25A9rance%26date%3D2018%26volume%3D48%26issue%3D7%26spage%3D561%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suzanne  Scheele</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  Geiger</span>, <span class="hlFld-ContribAuthor ">Amy E.  DeRocher</span>, <span class="hlFld-ContribAuthor ">Ryan  Choi</span>, <span class="hlFld-ContribAuthor ">Tess R.  Smith</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Hulverson</span>, <span class="hlFld-ContribAuthor ">Rama Subba Rao  Vidadala</span>, <span class="hlFld-ContribAuthor ">Lynn K.  Barrett</span>, <span class="hlFld-ContribAuthor ">Dustin J.  Maly</span>, <span class="hlFld-ContribAuthor ">Ethan A.  Merritt</span>, <span class="hlFld-ContribAuthor ">Kayode K.  Ojo</span>, <span class="hlFld-ContribAuthor ">Wesley C.  Van Voorhis</span>, <span class="hlFld-ContribAuthor ">Marilyn  Parsons</span>. </span><span class="cited-content_cbyCitation_article-title">Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift Assays. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2018,</strong> <em>62 </em>
                                    (6)
                                     <a href="https://doi.org/10.1128/AAC.00051-18" title="DOI URL">https://doi.org/10.1128/AAC.00051-18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00051-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00051-18%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DToxoplasma%252BCalcium-Dependent%252BProtein%252BKinase%252B1%252BInhibitors%25253A%252BProbing%252BActivity%252Band%252BResistance%252BUsing%252BCellular%252BThermal%252BShift%252BAssays%26aulast%3DScheele%26aufirst%3DSuzanne%26date%3D2018%26volume%3D62%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) R<sub>1</sub>OH, copper iodide, <i>N</i>,<i>N</i>-dimethylglycine, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 120 °C, 18 h; (ii) R<sub>1</sub>NH<sub>2</sub>, BrettPhosPd G3, KOtBu, dioxane, 90 °C, 18 h; (iii) R<sub>1</sub>SH, copper iodide, ethylene glycol, 2-propanol, K<sub>2</sub>CO<sub>3</sub>, 130 °C, 1 h. Positions on the PP scaffold are labeled numerically in blue italics.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure–activity profile of initial CDPK1 inhibitor series. (A) Structures of initial CDPK1 inhibitors highlighting modifications at R<sub>1</sub> and heteroatom linkages of R<sub>1</sub> to the pyrazolopyrimidine core are shown in tabular form with associated biochemical inhibition (IC<sub>50</sub>) of CDPK1, inhibition of parasite growth (EC<sub>50</sub>), off-target biochemical inhibition (IC<sub>50</sub>) of Src, metabolic stability in rat microsomes (half-life in minutes), and calculated clogP values. IC<sub>50</sub> and EC<sub>50</sub> values are the average of 2 or more biological replicates. (B) Compound <b>1</b> binds within the CDPK1 active site forming hydrogen bonds (black dashes) to the CDPK1 hinge and extends its R<sub>1</sub> substituent into the CDPK1 hydrophobic pocket. Amino acids in close proximity to compound <b>1</b> are labeled as well as the glycine gatekeeper (green). The orange map shows the 2<i>F</i><sub>0</sub> – <i>F</i><sub>c</sub> simulated annealing map of compound <b>1</b> contoured at 1σ. (C) An overlay of compounds <b>1</b>, <b>2</b>, <b>3</b>, and <b>4</b> shows similar binding poses for inhibitors possessing heteroatom linkages. Interacting residues are labeled as well as methionine 112 (yellow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Exploration of R<sub>2</sub> with ether linked substituent. (A) Structures of CDPK1 inhibitors highlighting modifications at R<sub>2</sub> with <i>meta</i> chloro and ether linkage to the pyrazolopyrimidine core are shown in tabular form with associated biochemical inhibition (IC<sub>50</sub>) of CDPK1, inhibition of parasite growth (EC<sub>50</sub>), off-target biochemical inhibition (IC<sub>50</sub>) of Src, metabolic stability in rat microsomes (half-life in minutes), and calculated clogP values. IC<sub>50</sub> and EC<sub>50</sub> values are the average of 2 or more biological replicates. (B) Compound <b>13</b> binds within the CDPK1 active site maintaining hinge binding to the CDPK1 hinge and forms an additional hydrogen bond with E135 within the CDPK1 ribose binding region.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Exploration of methylpiperidine at R<sub>2</sub> for enhanced metabolic stability. (A) Structures of CDPK1 inhibitors highlighting modifications at R<sub>1</sub> with methylpiperidine at R<sub>2</sub> of a pyrazolopyrimidine core are shown in the top section, while modification of one compound to contain a pyrrolopyrimidine core is shown between the dotted lines. Structures of CDPK1 inhibitors highlighting modifications at R<sub>2</sub> on a pyrazolopyrimidine core that were generated in attempts to reduce cellular efflux are shown in the bottom section of the table. Biochemical inhibition (IC<sub>50</sub>) of CDPK1, inhibition of parasite growth (EC<sub>50</sub>), off-target biochemical inhibition (IC<sub>50</sub>) of Src, metabolic stability in rat microsomes (half-life in minutes), and calculated clogP values. IC<sub>50</sub> and EC<sub>50</sub> values are the average of 2 or more biological replicates assays. (B) Homology model of compound <b>24</b> based on the cocrystal structure of compound <b>13</b> and CDPK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Activity of PP analogs against tachyzoites and bradyzoites and PK studies in mice. (A) Comparison of enzyme inhibition vs parasite growth inhibition by PP analogs. Values for IC<sub>50</sub> for inhibition of CDPK1 enzyme activity were plotted vs EC<sub>50</sub> values for inhibition of parasite growth. The plot was analyzed by linear regression (solid line), shown with 95% confidence interval (dotted lines), <i>r</i><sup>2</sup> = 0.58. Highlighted are potent inhibitors that were further profiled in the following studies. (B) Ex vivo treatment of bradyzoites with PP analogs. (top) Schematic for isolation of tissue cysts containing bradyzoites, shown for PRU-GFP strain. Following Percoll enrichment of mouse-brain derived cysts, bradyzoites were liberated by acid-pepsin treatment, followed by neutralization. Liberated bradyzoites were used to infect HFF monolayers. Compounds were used to treat parallel cultures either with continuous treatment or following 4 h treatment and washing to remove extracellular parasites and compounds. (bottom) Following isolation of bradyzoites from the ME49Δ<i>hx</i>::FLUC line, compounds were used to treat cultures as described in top panel. Plaque forming units were enumerated in triplicate from three independent experiments. Compounds <b>1</b>, <b>13</b>, and <b>24</b> were used at 2.5 μM, while pyrimethamine (Pyr) was used at 3 μM. Mean ± SEM, <i>n</i> = 3 independent biological replicates with three technical replicates each. Two-way ANOVA with Dunnett’s correction: *<i>P</i> ≤ 0.05; **<i>P</i> ≤ 0.01, ***<i>P</i> ≤ 0.001. (C) Pharmacokinetic analysis of compound FUR7-27 in mice. Dose dependent kinetics of serum levels of compound following oral administration. Compound <b>24</b> suspended in 25%-PEG-400–PBS with 5% DMSO was administered by oral gavage; <i>n</i> = 3 animals per time point. Reference lines shows the free serum level of compound <b>24</b> that would correspond to the EC<sub>50</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Human kinome profiling of compounds to determine inhibitor selectivity. Selectivity of compounds toward a panel of kinases in the ThermoFisher ACCESS program that are inhibited (red) by more than 50% or show greater than 50% tracer displacement (blue). Circle size reflects percent inhibition or displacement in the presence of inhibitor, and percentages are the mean of 2 data points. The % inhibition value for Src is shown as a yellow triangle and is emphasized by a dashed line connecting an * to the yellow triangle. Kinome tree images were generated using KinMap<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and the kinase tree illustration is reproduced courtesy of Cell Signaling Technology, Inc. (<a href="http://www.cellsignal.com" class="extLink">www.cellsignal.com</a>). Inhibitors were screened at 1 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo treatment of acute toxoplasmosis with compound <b>24</b>. (A) Survival curve of mice infected with ME49-FLUC strain parasites and treated with compound <b>24</b> (treated) vs vehicle control (control) as monitored for 30 days. Animals were infected with 5000 tachyzoites by ip injection on day 0. At 24 h postinfection, animals were given compound <b>24</b> at 50 mg/kg or vehicle control, followed by a second dose of 25 mg/kg 12 h later, and then treated with 25 mg/kg BID for 5 additional days. Mantel–Cox test, <i>P</i> ≤ 0.05. (B) Weight loss of infected animals shown in panel B. Values are reported as % Control, which refers to the average weight at day 0 for each group treated separately. (C) Bioluminescence imaging of parasite numbers in animals shown in panel A. Whole body imaging was used to determine the mean intensity of luciferase signal, which is expressed as relative light units (RLU). Individual animals shown by symbols; median values graphed in the lines. Student’s <i>t</i> test with Holm–Sidak correction for multiple tests, ***<i>P</i> ≤ 0.001. (D) The number of cysts in surviving animals from panel A were determined by counting aliquots of brain homogenate. Means ± SD, <i>n</i> = 6–9. Threshold for detection = 40 cysts. Red triangle denotes animal where bioassay was negative indicating it was cured. Mann–Whitney nonparametric test, **<i>P</i> ≤ 0.01. (E) Bioluminescence imaging of representative control and treated mice from panel A imaged at day 8. (F) Bioluminescence imaging of control and treated mice from panel A imaged at day 18.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/medium/jm-2017-01192g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vivo treatment of reactivation of CNS toxoplasmosis. (A) Schematic for treatment during reactivation in an immunocompromised mouse. Ifngr1<sup>–/–</sup> mice were infected with 10 cysts of the ME49-FLUC strain and treated from day 2–22 with sulfadiazine in the drinking water. Two days (48 h) after removal of sulfadiazine, animals were treated po with compound <b>24</b> or vehicle control (control, <i>n</i> = 6) for 8 days. Animals in one group (<i>n</i> = 9) received a loading dose of 50 mg/kg followed by 25 mg/kg 12 h later and then 25 mg/kg BID for seven additional days. A second group of animals (<i>n</i> = 5) received 40 mg/kg BID for 8 days. (B) Animals were evaluated for survival and imaged for bioluminescence over a period of 30 days. Treated mice survived significantly longer than controls, log-rank, Mantel–Cox test, <i>P</i> < 0.001 (***). Animals that survived in the treated groups (red triangles) were negative by bioassay, indicating they were cured. (C) Bioluminescence imaging at day 6 indicates that a number of control animals that have perished (red X) and remaining animals show a positive signal in the head and upper thorax. In contrast, all treated mice were alive and mice treated with 25 mg/kg show reduced signals while those treated with 40 mg/kg showed no sign of activation. Animals marked * were determined to be cured based on bioassay at the end of the experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01192/20171221/images/large/jm-2017-01192g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01192&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67615" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67615" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 51 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Montoya, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesenfeld, O.</span><span> </span><span class="NLM_article-title">Toxoplasmosis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1965</span><span class="NLM_x">–</span> <span class="NLM_lpage">1976</span><span class="refDoi"> DOI: 10.1016/S0140-6736(04)16412-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2FS0140-6736%2804%2916412-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=15194258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVemuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2004&pages=1965-1976&author=J.+G.+Montoyaauthor=O.+Liesenfeld&title=Toxoplasmosis&doi=10.1016%2FS0140-6736%2804%2916412-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasmosis</span></div><div class="casAuthors">Montoya, J. G.; Liesenfeld, O.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">9425</span>),
    <span class="NLM_cas:pages">1965-1976</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Toxoplasma gondii is a protozoan parasite that infects up to a third of the world's population.  Infection is mainly acquired by ingestion of food or water that is contaminated with oocysts shed by cats or by eating undercooked or raw meat contg. tissue cysts.  Primary infection is usually subclin. but in some patients cervical lymphadenopathy or ocular disease can be present.  Infection acquired during pregnancy may cause severe damage to the fetus.  In immunocompromised patients, reactivation of latent disease can cause life-threatening encephalitis.  Diagnosis of toxoplasmosis can be established by direct detection of the parasite or by serol. techniques.  The most commonly used therapeutic regimen, and probably the most effective, is the combination of pyrimethamine with sulfadiazine and folinic acid.  This Seminar provides an overview and update on management of patients with acute infection, pregnant women who acquire infection during gestation, fetuses or infants who are congenitally infected, those with ocular disease, and immunocompromised individuals.  Controversy about the effectiveness of primary and secondary prevention in pregnant women is discussed.  Important topics of current and future research are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjtqSI8fuY4rVg90H21EOLACvtfcHk0liZQLcJ5x8ppg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVemuro%253D&md5=7fe37d0af87e4bbff2e087b416dcf5c0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2804%2916412-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252804%252916412-X%26sid%3Dliteratum%253Aachs%26aulast%3DMontoya%26aufirst%3DJ.%2BG.%26aulast%3DLiesenfeld%26aufirst%3DO.%26atitle%3DToxoplasmosis%26jtitle%3DLancet%26date%3D2004%26volume%3D363%26spage%3D1965%26epage%3D1976%26doi%3D10.1016%2FS0140-6736%2804%2916412-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Dennis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napravnik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sena, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eron, J. J.</span><span> </span><span class="NLM_article-title">Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span><span class="refDoi"> DOI: 10.1093/cid/cir434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1093%2Fcid%2Fcir434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=21844031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADC%252BC3MjmsF2kuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2011&pages=480-487&author=A.+M.+Dennisauthor=S.+Napravnikauthor=A.+C.+Senaauthor=J.+J.+Eron&title=Late+entry+to+HIV+care+among+Latinos+compared+with+non-Latinos+in+a+southeastern+US+cohort&doi=10.1093%2Fcid%2Fcir434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort</span></div><div class="casAuthors">Dennis Ann M; Napravnik Sonia; Sena Arlene C; Eron Joseph J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">480-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Late diagnosis of human immunodeficiency virus (HIV) infection remains common despite advances in therapy and prognosis.  The southeastern United States is a rapidly growing Latino settlement area where ethnic disparities may contribute to late presentation to care.  METHODS:  We assessed demographic and clinical factors between racial/ethnic groups at the time of HIV care initiation in the University of North Carolina Center for AIDS Research Clinical Cohort.  We identified independent predictors of late presentation, defined as a CD4(+) T lymphocyte (CD4) count <350 cells/mm(3) or an AIDS-defining event (ADE), using log-linear binomial regression.  RESULTS:  During the period 1999-2009, 853 patients initiated HIV care, of whom 11% were Latino, 28% were white, and 61% were black.  Median initial CD4 counts were lower for Latino patients (186 cells/mm(3)) than white patients (292 cells/mm(3); P = .006) and black patients (302 cells/mm(3); P = .02).  Latino persons were more likely to be late presenters than white or black persons (76% vs 58%; P < .001) and accounted for 86%, 75%, and 50% of all presenting cases of active tuberculosis, histoplasmosis, and toxoplasmosis, respectively.  Latino ethnicity, older age, male sex, and earlier entry year were independently associated with late presentation (P < .05 for all).  In multivariable analyses, Latino persons were 1.29 times more likely to present to care late than white or black persons (95% confidence interval, 1.15-1.45).  CONCLUSIONS:  Latinos are more likely to initiate HIV care later in the course of illness than are black and white persons and account for a majority of several ADEs.  Strategies to improve earlier HIV testing among Latinos in new settlement areas are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnoJeuH0wzSWxpATR2EQURfW6udTcc2ebqzcZgtKSb1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjmsF2kuw%253D%253D&md5=8953553d1fc7a52123825a6d7eab4a0c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcir434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcir434%26sid%3Dliteratum%253Aachs%26aulast%3DDennis%26aufirst%3DA.%2BM.%26aulast%3DNapravnik%26aufirst%3DS.%26aulast%3DSena%26aufirst%3DA.%2BC.%26aulast%3DEron%26aufirst%3DJ.%2BJ.%26atitle%3DLate%2520entry%2520to%2520HIV%2520care%2520among%2520Latinos%2520compared%2520with%2520non-Latinos%2520in%2520a%2520southeastern%2520US%2520cohort%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2011%26volume%3D53%26spage%3D480%26epage%3D487%26doi%3D10.1093%2Fcid%2Fcir434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kiderlen, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesenfeld, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schurmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T.</span><span> </span><span class="NLM_article-title">Toxoplasmic encephalitis in AIDS-patients before and after the introduction of highly active antiretroviral therapy (HAART)</span> <span class="citation_source-journal">Eur. J. Clin. Microbiol. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1521</span><span class="NLM_x">–</span> <span class="NLM_lpage">1525</span><span class="refDoi"> DOI: 10.1007/s10096-011-1254-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1007%2Fs10096-011-1254-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=1521-1525&author=T.+R.+Kiderlenauthor=O.+Liesenfeldauthor=D.+Schurmannauthor=T.+Schneider&title=Toxoplasmic+encephalitis+in+AIDS-patients+before+and+after+the+introduction+of+highly+active+antiretroviral+therapy+%28HAART%29&doi=10.1007%2Fs10096-011-1254-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs10096-011-1254-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10096-011-1254-6%26sid%3Dliteratum%253Aachs%26aulast%3DKiderlen%26aufirst%3DT.%2BR.%26aulast%3DLiesenfeld%26aufirst%3DO.%26aulast%3DSchurmann%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DT.%26atitle%3DToxoplasmic%2520encephalitis%2520in%2520AIDS-patients%2520before%2520and%2520after%2520the%2520introduction%2520of%2520highly%2520active%2520antiretroviral%2520therapy%2520%2528HAART%2529%26jtitle%3DEur.%2520J.%2520Clin.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2011%26volume%3D30%26spage%3D1521%26epage%3D1525%26doi%3D10.1007%2Fs10096-011-1254-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Oliveira, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greco, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christo, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimaraes, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, R. C.</span><span> </span><span class="NLM_article-title">Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience</span> <span class="citation_source-journal">Rev. Soc. Bras. Med. Trop.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1590/S0037-86822006000200002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1590%2FS0037-86822006000200002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=16699639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADC%252BD283ntVyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=146-151&author=J.+F.+Oliveiraauthor=D.+B.+Grecoauthor=G.+C.+Oliveiraauthor=P.+P.+Christoauthor=M.+D.+Guimaraesauthor=R.+C.+Oliveira&title=Neurological+disease+in+HIV-infected+patients+in+the+era+of+highly+active+antiretroviral+treatment%3A+a+Brazilian+experience&doi=10.1590%2FS0037-86822006000200002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience</span></div><div class="casAuthors">Oliveira Jacqueline Ferreira de; Greco Dirceu Bartolomeu; Oliveira Guilherme Correa; Christo Paulo Pereira; Guimaraes Mark Drew Crosland; Oliveira Rodrigo Correa</div><div class="citationInfo"><span class="NLM_cas:title">Revista da Sociedade Brasileira de Medicina Tropical</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-51</span>
        ISSN:<span class="NLM_cas:issn">0037-8682</span>.
    </div><div class="casAbstract">To study characteristics of neurological disorders in HIV/AIDS patients and their relationship to highly active antiretroviral treatment, a cross-sectional study was conducted in an infectious disease public hospital in Belo Horizonte, Brazil, between February 1999 and March 2000.  Of the 417 patients enrolled, neurological disease was observed in 194 (46.5%) and a new AIDS-defining neurological event developed in 23.7% of individuals.  Toxoplasmosis (42.3%), cryptococcosis meningitis (12.9%) and tuberculosis (10.8%) were the most common causes of neurological complications.  The majority (79.3%) of patients were on highly active antiretroviral treatment and these individuals using HAART showed higher CD4 cell counts (p = 0.014) and presented stable neurological disease (p = 0.0001), although no difference was found with respect to the profile of neurological complications.  The neurological diseases continue to be a frequent complication of HIV/AIDS and infections are still its main causes in Brazil, even in the highly active antiretroviral treatment era.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQqARn0gZHl4kFb3mqPUYDfW6udTcc2ebqzcZgtKSb1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283ntVyrsQ%253D%253D&md5=d2f7eb299c21df3f7f11949193c05717</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1590%2FS0037-86822006000200002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0037-86822006000200002%26sid%3Dliteratum%253Aachs%26aulast%3DOliveira%26aufirst%3DJ.%2BF.%26aulast%3DGreco%26aufirst%3DD.%2BB.%26aulast%3DOliveira%26aufirst%3DG.%2BC.%26aulast%3DChristo%26aufirst%3DP.%2BP.%26aulast%3DGuimaraes%26aufirst%3DM.%2BD.%26aulast%3DOliveira%26aufirst%3DR.%2BC.%26atitle%3DNeurological%2520disease%2520in%2520HIV-infected%2520patients%2520in%2520the%2520era%2520of%2520highly%2520active%2520antiretroviral%2520treatment%253A%2520a%2520Brazilian%2520experience%26jtitle%3DRev.%2520Soc.%2520Bras.%2520Med.%2520Trop.%26date%3D2006%26volume%3D39%26spage%3D146%26epage%3D151%26doi%3D10.1590%2FS0037-86822006000200002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Palella, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorman, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loveless, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satten, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmberg, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">The HIV Outpatient Study Investigators</span><span> </span><span class="NLM_article-title">Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span><span class="refDoi"> DOI: 10.1056/NEJM199803263381301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1056%2FNEJM199803263381301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=9516219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADyaK1c7mslyjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1998&pages=853-860&author=F.+J.+Palellaauthor=K.+M.+Delaneyauthor=A.+C.+Moormanauthor=M.+O.+Lovelessauthor=J.+Fuhrerauthor=G.+A.+Sattenauthor=D.+J.+Aschmanauthor=S.+D.+Holmbergauthor=The+HIV+Outpatient+Study+Investigators&title=Declining+morbidity+and+mortality+among+patients+with+advanced+human+immunodeficiency+virus+infection&doi=10.1056%2FNEJM199803263381301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators</span></div><div class="casAuthors">Palella F J Jr; Delaney K M; Moorman A C; Loveless M O; Fuhrer J; Satten G A; Aschman D J; Holmberg S D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">853-60</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND AND METHODS:  National surveillance data show recent, marked reductions in morbidity and mortality associated with the acquired immunodeficiency syndrome (AIDS).  To evaluate these declines, we analyzed data on 1255 patients, each of whom had at least one CD4+ count below 100 cells per cubic millimeter, who were seen at nine clinics specializing in the treatment of human immunodeficiency virus (HIV) infection in eight U.S. cities from January 1994 through June 1997.  RESULTS:  Mortality among the patients declined from 29.4 per 100 person-years in the first quarter of 1995 to 8.8 per 100 in the second quarter of 1997.  There were reductions in mortality regardless of sex, race, age, and risk factors for transmission of HIV.  The incidence of any of three major opportunistic infections (Pneumocystis carinii pneumonia, Mycobacterium avium complex disease, and cytomegalovirus retinitis) declined from 21.9 per 100 person-years in 1994 to 3.7 per 100 person-years by mid-1997.  In a failure-rate model, increases in the intensity of antiretroviral therapy (classified as none, monotherapy, combination therapy without a protease inhibitor, and combination therapy with a protease inhibitor) were associated with stepwise reductions in morbidity and mortality.  Combination antiretroviral therapy was associated with the most benefit; the inclusion of protease inhibitors in such regimens conferred additional benefit.  Patients with private insurance were more often prescribed protease inhibitors and had lower mortality rates than those insured by Medicare or Medicaid.  CONCLUSIONS:  The recent declines in morbidity and mortality due to AIDS are attributable to the use of more intensive antiretroviral therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6uVwzPlrzo4IRAdBLKY41fW6udTcc2eZ04Sx-VbdkD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7mslyjuw%253D%253D&md5=63bd6978cc957517f4bcfae251adc3ef</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJM199803263381301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199803263381301%26sid%3Dliteratum%253Aachs%26aulast%3DPalella%26aufirst%3DF.%2BJ.%26aulast%3DDelaney%26aufirst%3DK.%2BM.%26aulast%3DMoorman%26aufirst%3DA.%2BC.%26aulast%3DLoveless%26aufirst%3DM.%2BO.%26aulast%3DFuhrer%26aufirst%3DJ.%26aulast%3DSatten%26aufirst%3DG.%2BA.%26aulast%3DAschman%26aufirst%3DD.%2BJ.%26aulast%3DHolmberg%26aufirst%3DS.%2BD.%26aulast%3D%26atitle%3DDeclining%2520morbidity%2520and%2520mortality%2520among%2520patients%2520with%2520advanced%2520human%2520immunodeficiency%2520virus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D338%26spage%3D853%26epage%3D860%26doi%3D10.1056%2FNEJM199803263381301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Israelski, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remington, J. S.</span><span> </span><span class="NLM_article-title">Toxoplasmosis in the non-AIDS immunocompromised host</span> <span class="citation_source-journal">Curr. Clin. Top. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=8397917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADyaK2c%252FgtVGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=322-356&author=D.+M.+Israelskiauthor=J.+S.+Remington&title=Toxoplasmosis+in+the+non-AIDS+immunocompromised+host"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasmosis in the non-AIDS immunocompromised host</span></div><div class="casAuthors">Israelski D M; Remington J S</div><div class="citationInfo"><span class="NLM_cas:title">Current clinical topics in infectious diseases</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">322-56</span>
        ISSN:<span class="NLM_cas:issn">0195-3842</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTywXsaUPD8jYMcDoIzZtNkfW6udTcc2eZ04Sx-VbdkD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FgtVGjsQ%253D%253D&md5=3406defb6b29dc6140e9eb0a1ada956c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsraelski%26aufirst%3DD.%2BM.%26aulast%3DRemington%26aufirst%3DJ.%2BS.%26atitle%3DToxoplasmosis%2520in%2520the%2520non-AIDS%2520immunocompromised%2520host%26jtitle%3DCurr.%2520Clin.%2520Top.%2520Infect.%2520Dis.%26date%3D1993%26volume%3D13%26spage%3D322%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Arantes, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silveira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muccioli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldhardt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belfort, R.,  Jr.</span><span> </span><span class="NLM_article-title">Ocular involvement following postnatally acquired <i>Toxoplasma gondii</i> infection in southern Brazil: A 28-year experience</span> <span class="citation_source-journal">Am. J. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">1002</span><span class="refDoi"> DOI: 10.1016/j.ajo.2015.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2Fj.ajo.2015.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=25743338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADC%252BC2Mnht1ensw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2015&pages=1002&author=T.+E.+Arantesauthor=C.+Silveiraauthor=G.+N.+Hollandauthor=C.+Muccioliauthor=F.+Yuauthor=J.+L.+Jonesauthor=R.+Goldhardtauthor=K.+G.+Lewisauthor=R.+Belfort&title=Ocular+involvement+following+postnatally+acquired+Toxoplasma+gondii+infection+in+southern+Brazil%3A+A+28-year+experience&doi=10.1016%2Fj.ajo.2015.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Ocular Involvement Following Postnatally Acquired Toxoplasma gondii Infection in Southern Brazil: A 28-Year Experience</span></div><div class="casAuthors">Arantes Tiago E F; Silveira Claudio; Holland Gary N; Muccioli Cristina; Belfort Rubens Jr; Yu Fei; Goldhardt Raquel; Lewis Kevan G; Jones Jeffrey L</div><div class="citationInfo"><span class="NLM_cas:title">American journal of ophthalmology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1002-1012.e2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To determine the incidence of, and risk factors for, ocular involvement among people known to have postnatally acquired Toxoplasma gondii infection in a region of southern Brazil where there is a high prevalence of endemic disease.  DESIGN:  Retrospective longitudinal cohort study.  METHODS:  Records of 302 patients with serologic evidence of recent T gondii infection (a positive anti-T gondii IgM antibody test) from Erechim, Rio Grande do Sul state, Brazil (1974-2002) were analyzed.  The incidence of ocular involvement was calculated in terms of person-years (PY) of follow-up.  Risk factors for ocular involvement were analyzed using log-rank and Fisher exact tests.  RESULTS:  At initial ocular examination (baseline), 30 patients (9.9%) had intraocular inflammation only (anterior chamber cells and flare, vitreous inflammatory reactions, retinal whitening), without clinically apparent necrotizing retinochoroiditis.  At baseline, men were more likely to have ocular involvement (P = .043) and antiparasitic treatment was associated with less ocular involvement (P = .015).  Follow-up examinations were performed on 255 patients (median follow-up, 13.7 months [range 0.4-261.9 months]).  Among those without ocular involvement at baseline, the incidence of necrotizing retinochoroiditis was 6.4/100 PY.  Patients >40 years of age at first IgM test had a greater risk of incident necrotizing retinochoroiditis (hazard ratio = 4.47, 95% CI = 1.67-11.93, P = .003) than younger patients.  The incidence of recurrent necrotizing retinochoroiditis was 10.5/100 PY.  CONCLUSION:  Isolated intraocular inflammatory reactions can be an initial manifestation of T gondii infection, with necrotizing retinochoroiditis occurring months or years later.  Male sex and older age are risk factors for toxoplasmic retinochoroiditis.  Antitoxoplasmic treatment may protect against early ocular involvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgOsPLFPhvd8KL0FlyGHDofW6udTcc2eZ04Sx-VbdkD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mnht1ensw%253D%253D&md5=7012af4f07b5e4017c49a434a135e634</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ajo.2015.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajo.2015.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DArantes%26aufirst%3DT.%2BE.%26aulast%3DSilveira%26aufirst%3DC.%26aulast%3DHolland%26aufirst%3DG.%2BN.%26aulast%3DMuccioli%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DJones%26aufirst%3DJ.%2BL.%26aulast%3DGoldhardt%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DK.%2BG.%26aulast%3DBelfort%26aufirst%3DR.%26atitle%3DOcular%2520involvement%2520following%2520postnatally%2520acquired%2520Toxoplasma%2520gondii%2520infection%2520in%2520southern%2520Brazil%253A%2520A%252028-year%2520experience%26jtitle%3DAm.%2520J.%2520Ophthalmol.%26date%3D2015%26volume%3D159%26spage%3D1002%26doi%3D10.1016%2Fj.ajo.2015.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Jacobson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rainey, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raasch, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, B. J.</span><span> </span><span class="NLM_article-title">Pyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for <i>Toxoplasma gondii</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1360</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=1360-1365&author=J.+M.+Jacobsonauthor=M.+Davidianauthor=P.+M.+Raineyauthor=R.+Hafnerauthor=R.+H.+Raaschauthor=B.+J.+Luft&title=Pyrimethamine+pharmacokinetics+in+human+immunodeficiency+virus-positive+patients+seropositive+for+Toxoplasma+gondii"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DJ.%2BM.%26aulast%3DDavidian%26aufirst%3DM.%26aulast%3DRainey%26aufirst%3DP.%2BM.%26aulast%3DHafner%26aufirst%3DR.%26aulast%3DRaasch%26aufirst%3DR.%2BH.%26aulast%3DLuft%26aufirst%3DB.%2BJ.%26atitle%3DPyrimethamine%2520pharmacokinetics%2520in%2520human%2520immunodeficiency%2520virus-positive%2520patients%2520seropositive%2520for%2520Toxoplasma%2520gondii%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1996%26volume%3D40%26spage%3D1360%26epage%3D1365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">McCabe, R. E.</span><span> </span><span class="NLM_article-title">Antitoxoplasma chemotherapy</span>. In  <span class="citation_source-book">Toxoplasmosis: a Comprehensive Clinical Guide</span>; <span class="NLM_contrib-group">Joynson, D. H. M.; Wreghitt, T. G.</span>, Eds.; <span class="NLM_publisher-name">Cambridge Univ. Press</span>: <span class="NLM_publisher-loc">Cambridge</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1017%2FCBO9780511527005.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=319-359&author=R.+E.+McCabeauthor=D.+H.+M.+Joynson&author=T.+G.+Wreghitt&title=Toxoplasmosis%3A+a+Comprehensive+Clinical+Guide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1017%2FCBO9780511527005.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1017%252FCBO9780511527005.015%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DR.%2BE.%26atitle%3DAntitoxoplasma%2520chemotherapy%26btitle%3DToxoplasmosis%253A%2520a%2520Comprehensive%2520Clinical%2520Guide%26aulast%3DJoynson%26aufirst%3DD.%2BH.%2BM.%26pub%3DCambridge%2520Univ.%2520Press%26date%3D2001%26spage%3D319%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Weiss, L. M.; Kim, K.</span><span> </span><span class="NLM_article-title">Bradyzoite development</span>. In  <span class="citation_source-book">Toxoplasma gondii the Model Apicomplexan: Perspectives and Methods</span>; <span class="NLM_contrib-group">Weiss, L. M.; Kim, K.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2FB978-012369542-0%2F50015-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=341-366&author=L.+M.+Weiss&author=K.+Kimauthor=L.+M.+Weiss&author=K.+Kim&title=Toxoplasma+gondii+the+Model+Apicomplexan%3A+Perspectives+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FB978-012369542-0%2F50015-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-012369542-0%252F50015-5%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DL.%2BM.%26atitle%3DBradyzoite%2520development%26btitle%3DToxoplasma%2520gondii%2520the%2520Model%2520Apicomplexan%253A%2520Perspectives%2520and%2520Methods%26aulast%3DWeiss%26aufirst%3DL.%2BM.%26pub%3DAcademic%2520Press%26date%3D2007%26spage%3D341%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Watts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patwardhan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinai, A. P.</span><span> </span><span class="NLM_article-title">Novel approaches reveal that <i>Toxoplasma gondii</i> bradyzoites within tissue cysts are dynamic and replicating entities in vivo</span> <span class="citation_source-journal">mBio</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e01155-15</span><span class="refDoi"> DOI: 10.1128/mBio.01155-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FmBio.01155-15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=e01155-15&author=E.+Wattsauthor=Y.+Zhaoauthor=A.+Dharaauthor=B.+Ellerauthor=A.+Patwardhanauthor=A.+P.+Sinai&title=Novel+approaches+reveal+that+Toxoplasma+gondii+bradyzoites+within+tissue+cysts+are+dynamic+and+replicating+entities+in+vivo&doi=10.1128%2FmBio.01155-15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FmBio.01155-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01155-15%26sid%3Dliteratum%253Aachs%26aulast%3DWatts%26aufirst%3DE.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DDhara%26aufirst%3DA.%26aulast%3DEller%26aufirst%3DB.%26aulast%3DPatwardhan%26aufirst%3DA.%26aulast%3DSinai%26aufirst%3DA.%2BP.%26atitle%3DNovel%2520approaches%2520reveal%2520that%2520Toxoplasma%2520gondii%2520bradyzoites%2520within%2520tissue%2520cysts%2520are%2520dynamic%2520and%2520replicating%2520entities%2520in%2520vivo%26jtitle%3DmBio%26date%3D2015%26volume%3D6%26spage%3De01155-15%26doi%3D10.1128%2FmBio.01155-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lourido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span> </span><span class="NLM_article-title">Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span><span class="refDoi"> DOI: 10.1038/nature09022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1038%2Fnature09022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=20485436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1Oisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=359-362&author=S.+Louridoauthor=J.+Shumanauthor=C.+Zhangauthor=K.+M.+Shokatauthor=R.+Huiauthor=L.+D.+Sibley&title=Calcium-dependent+protein+kinase+1+is+an+essential+regulator+of+exocytosis+in+Toxoplasma&doi=10.1038%2Fnature09022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma</span></div><div class="casAuthors">Lourido, Sebastian; Shuman, Joel; Zhang, Chao; Shokat, Kevan M.; Hui, Raymond; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7296</span>),
    <span class="NLM_cas:pages">359-362</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calcium-regulated exocytosis is a ubiquitous process in eukaryotes, whereby secretory vesicles fuse with the plasma membrane and release their contents in response to an intracellular calcium surge.  This process regulates various cellular functions such as plasma membrane repair in plants and animals, the discharge of defensive spikes in Paramecium, and the secretion of insulin from pancreatic cells, immune modulators from lymphocytes, and chem. transmitters from neurons.  In animal cells, serine/threonine kinases including cAMP-dependent protein kinase, protein kinase C and calmodulin kinases have been implicated in calcium-signal transduction leading to regulated secretion.  Although plants and protozoa also regulate secretion by means of intracellular calcium, the method by which these signals are relayed has not been explained.  Here we show that the Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) is an essential regulator of calcium-dependent exocytosis in this opportunistic human pathogen.  Conditional suppression of TgCDPK1 revealed that it controls calcium-dependent secretion of specialized organelles called micronemes, resulting in a block of essential phenotypes including parasite motility, host-cell invasion, and egress.  These phenotypes were recapitulated by using a chem. biol. approach in which pyrazolopyrimidine-derived compds. specifically inhibited TgCDPK1 and disrupted the parasite's life cycle at stages dependent on microneme secretion.  Inhibition was specific to TgCDPK1, because expression of a resistant mutant kinase reversed sensitivity to the inhibitor.  TgCDPK1 is conserved among apicomplexans and belongs to a family of kinases shared with plants and ciliates, suggesting that related CDPKs may have a function in calcium-regulated secretion in other organisms.  Because this kinase family is absent from mammalian hosts, it represents a validated target that may be exploitable for chemotherapy against T. gondii and related apicomplexans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5sWOGpkZQn7Vg90H21EOLACvtfcHk0ljqHJizAup-Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1Oisr0%253D&md5=750f6bf5c933759605574d4a2ab5accc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature09022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09022%26sid%3Dliteratum%253Aachs%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DShuman%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DHui%26aufirst%3DR.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DCalcium-dependent%2520protein%2520kinase%25201%2520is%2520an%2520essential%2520regulator%2520of%2520exocytosis%2520in%2520Toxoplasma%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D359%26epage%3D362%26doi%3D10.1038%2Fnature09022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyloun, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaneda, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRocher, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inampudi, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakaki, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napuli, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hol, W. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, C.</span><span> </span><span class="NLM_article-title"><i>Toxoplasma gondii</i> calcium-dependent protein kinase 1 is a target for selective kinase inhibitors</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">602</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span><span class="refDoi"> DOI: 10.1038/nsmb.1818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1038%2Fnsmb.1818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=20436472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVyiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=602-607&author=K.+K.+Ojoauthor=E.+T.+Larsonauthor=K.+R.+Keylounauthor=L.+J.+Castanedaauthor=A.+E.+DeRocherauthor=K.+K.+Inampudiauthor=J.+E.+Kimauthor=T.+L.+Arakakiauthor=R.+C.+Murphyauthor=L.+Zhangauthor=A.+J.+Napuliauthor=D.+J.+Malyauthor=C.+L.+M.+J.+Verlindeauthor=F.+S.+Bucknerauthor=M.+Parsonsauthor=W.+G.+J.+Holauthor=E.+A.+Merrittauthor=C.+Van+Voorhis&title=Toxoplasma+gondii+calcium-dependent+protein+kinase+1+is+a+target+for+selective+kinase+inhibitors&doi=10.1038%2Fnsmb.1818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors</span></div><div class="casAuthors">Ojo, Kayode K.; Larson, Eric T.; Keyloun, Katelyn R.; Castaneda, Lisa J.; De Rocher, Amy E.; Inampudi, Krishna K.; Kim, Jessica E.; Arakaki, Tracy L.; Murphy, Ryan C.; Zhang, Li; Napuli, Alberto J.; Maly, Dustin J.; Verlinde, Christophe L. M. J.; Buckner, Frederick S.; Parsons, Marilyn; Hol, Wim G. J.; Merritt, Ethan A.; Van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">602-607</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">New drugs are needed to treat toxoplasmosis.  Toxoplasma gondii calcium-dependent protein kinases (TgCDPKs) are attractive targets because they are absent in mammals.  We show that TgCDPK1 is inhibited by low nanomolar levels of bumped kinase inhibitors (BKIs), compds. inactive against mammalian kinases.  Cocrystal structures of TgCDPK1 with BKIs confirm that the structural basis for selectivity is due to the unique glycine gatekeeper residue in the ATP-binding site.  We show that BKIs interfere with an early step in T. gondii infection of human cells in culture.  Furthermore, we show that TgCDPK1 is the in vivo target of BKIs because T. gondii expressing a glycine to methionine gatekeeper mutant enzyme show significantly decreased sensitivity to BKIs.  Thus, design of selective TgCDPK1 inhibitors with low host toxicity may be achievable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiGhHqXpYi-7Vg90H21EOLACvtfcHk0li_sOhADNvUog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVyiurk%253D&md5=f1630eba0dd5dec19e8a095c041996b1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1818%26sid%3Dliteratum%253Aachs%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DKeyloun%26aufirst%3DK.%2BR.%26aulast%3DCastaneda%26aufirst%3DL.%2BJ.%26aulast%3DDeRocher%26aufirst%3DA.%2BE.%26aulast%3DInampudi%26aufirst%3DK.%2BK.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DArakaki%26aufirst%3DT.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNapuli%26aufirst%3DA.%2BJ.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%2BM.%2BJ.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DVan%2BVoorhis%26aufirst%3DC.%26atitle%3DToxoplasma%2520gondii%2520calcium-dependent%2520protein%2520kinase%25201%2520is%2520a%2520target%2520for%2520selective%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D602%26epage%3D607%26doi%3D10.1038%2Fnsmb.1818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wernimont, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finerty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allali-Hassani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">senisterra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lourido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, R.</span><span> </span><span class="NLM_article-title">Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span><span class="refDoi"> DOI: 10.1038/nsmb.1795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1038%2Fnsmb.1795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=20436473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVyhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=596-601&author=A.+K.+Wernimontauthor=J.+D.+Artzauthor=P.+Finertyauthor=Y.+Linauthor=M.+Amaniauthor=A.+Allali-Hassaniauthor=G.+senisterraauthor=M.+Vedadiauthor=W.+Tempelauthor=F.+Mackenzieauthor=I.+Chauauthor=S.+Louridoauthor=L.+D.+Sibleyauthor=R.+Hui&title=Structures+of+apicomplexan+calcium-dependent+protein+kinases+reveal+mechanism+of+activation+by+calcium&doi=10.1038%2Fnsmb.1795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium</span></div><div class="casAuthors">Wernimont, Amy K.; Artz, Jennifer D.; Finerty, Patrick, Jr.; Lin, Yu-Hui; Amani, Mehrnaz; Allali-Hassani, Abdellah; Senisterra, Guillermo; Vedadi, Masoud; Tempel, Wolfram; MacKenzie, Farrell; Chau, Irene; Lourido, Sebastian; Sibley, L. David; Hui, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calcium-dependent protein kinases (CDPKs) have pivotal roles in the calcium-signaling pathway in plants, ciliates and apicomplexan parasites and comprise a calmodulin-dependent kinase (CaMK)-like kinase domain regulated by a calcium-binding domain in the C terminus.  To understand this intramol. mechanism of activation, we solved the structures of the autoinhibited (apo) and activated (calcium-bound) conformations of CDPKs from the apicomplexan parasites Toxoplasma gondii and Cryptosporidium parvum.  In the apo form, the C-terminal CDPK activation domain (CAD) resembles a calmodulin protein with an unexpected long helix in the N terminus that inhibits the kinase domain in the same manner as CaMKII.  Calcium binding triggers the reorganization of the CAD into a highly intricate fold, leading to its relocation around the base of the kinase domain to a site remote from the substrate binding site.  This large conformational change constitutes a distinct mechanism in calcium signal-transduction pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPNbf5csvAT7Vg90H21EOLACvtfcHk0li_sOhADNvUog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVyhsr0%253D&md5=7e34915b35107e30227a6a786f397da7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1795%26sid%3Dliteratum%253Aachs%26aulast%3DWernimont%26aufirst%3DA.%2BK.%26aulast%3DArtz%26aufirst%3DJ.%2BD.%26aulast%3DFinerty%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DAmani%26aufirst%3DM.%26aulast%3DAllali-Hassani%26aufirst%3DA.%26aulast%3Dsenisterra%26aufirst%3DG.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DTempel%26aufirst%3DW.%26aulast%3DMackenzie%26aufirst%3DF.%26aulast%3DChau%26aufirst%3DI.%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26aulast%3DHui%26aufirst%3DR.%26atitle%3DStructures%2520of%2520apicomplexan%2520calcium-dependent%2520protein%2520kinases%2520reveal%2520mechanism%2520of%2520activation%2520by%2520calcium%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D596%26epage%3D601%26doi%3D10.1038%2Fnsmb.1795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span><span class="refDoi"> DOI: 10.1126/science.1075762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome&doi=10.1126%2Fscience.1075762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0ljGW4zvgvoc_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934%26doi%3D10.1126%2Fscience.1075762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Bakkouri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span> </span><span class="NLM_article-title">Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span><span class="refDoi"> DOI: 10.1016/j.tips.2015.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2Fj.tips.2015.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=26002073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVWitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=452-460&author=R.+Huiauthor=M.+El+Bakkouriauthor=L.+D.+Sibley&title=Designing+selective+inhibitors+for+calcium-dependent+protein+kinases+in+apicomplexans&doi=10.1016%2Fj.tips.2015.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans</span></div><div class="casAuthors">Hui, Raymond; El Bakkouri, Majida; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">452-460</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Apicomplexan parasites cause some of the most severe human diseases, including malaria (caused by Plasmodium), toxoplasmosis, and cryptosporidiosis.  Treatments are limited by the lack of effective drugs and development of resistance to available agents.  By exploiting novel features of protein kinases in these parasites, it may be possible to develop new treatments.  We summarize here recent advances in identifying small mol. inhibitors against a novel family of plant-like, calcium-dependent kinases that are uniquely expanded in apicomplexan parasites.  Anal. of the 3D structure, activation mechanism, and sensitivity to small mols. had identified several attractive chem. scaffolds that are potent and selective inhibitors of these parasite kinases.  Further optimization of these leads may yield promising new drugs for treatment of these parasitic infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-4M4FEBeFQrVg90H21EOLACvtfcHk0lhzSlr3_HjQYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVWitLk%253D&md5=0081edfce5d381c6a34c396b011c24b8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DR.%26aulast%3DEl%2BBakkouri%26aufirst%3DM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DDesigning%2520selective%2520inhibitors%2520for%2520calcium-dependent%2520protein%2520kinases%2520in%2520apicomplexans%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D452%26epage%3D460%26doi%3D10.1016%2Fj.tips.2015.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bishop, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witucki, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Design of allele-specific inhibitors to probe protein kinase signaling</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span><span class="refDoi"> DOI: 10.1016/S0960-9822(98)70198-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2FS0960-9822%2898%2970198-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=9501066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADyaK1cXhvVWqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=257-266&author=A.+C.+Bishopauthor=K.+Shahauthor=Y.+Liuauthor=L.+Wituckiauthor=C.+Kungauthor=K.+M.+Shokat&title=Design+of+allele-specific+inhibitors+to+probe+protein+kinase+signaling&doi=10.1016%2FS0960-9822%2898%2970198-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Design of allele-specific inhibitors to probe protein kinase signaling</span></div><div class="casAuthors">Bishop, Anthony C.; Shah, Kavita; Liu, Yi; Witucki, Laurie; Kung, Chi-yun; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">257-266</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">Deconvoluting protein kinase signaling pathways using conventional genetic and biochem. approaches has been difficult because of the overwhelming no. of closely related kinases.  If cell-permeable inhibitors of individual kinases could be designed, the role of each kinase could be systematically assessed.  The authors have devised an approach combining chem. and genetics to develop the first highly specific cell-permeable inhibitor of the oncogenic tyrosine kinase v-Src.  A functionally silent active-site mutation was made in v-Src to distinguish it from all other cellular kinases.  A tight-binding cell-permeable inhibitor of this mutant kinase that does not inhibit wild-type kinases was designed and synthesized.  In vitro and whole-cell assays established the unique specificity of the mutant v-Src-inhibitor pair.  The inhibitor reversed cell transformation by the engineered but not the 'wild type' v-Src, establishing that changes in cellular signaling can be attributed to specific inhibition of the engineered kinase.  The generality of the method was tested by engineering another tyrosine kinase, Fyn, to contain the corresponding active-site mutation to the one in v-Src.  The same compd. that inhibited mutant v-Src could also potently inhibit the engineered Fyn kinase.  Thus allele-specific cell-permeable inhibitors of individual Src family kinases can be rapidly developed in an approach that should be applicable to all kinases.  This approach will be useful for the deconvolution of kinase-mediated cellular pathways and for validating novel kinases as good targets for drug discovery both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLSMWJloQ0rbVg90H21EOLACvtfcHk0lhzSlr3_HjQYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvVWqtb0%253D&md5=5bceaa956d196318db19f20250b85f7d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2898%2970198-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252898%252970198-8%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DA.%2BC.%26aulast%3DShah%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWitucki%26aufirst%3DL.%26aulast%3DKung%26aufirst%3DC.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DDesign%2520of%2520allele-specific%2520inhibitors%2520to%2520probe%2520protein%2520kinase%2520signaling%26jtitle%3DCurr.%2520Biol.%26date%3D1998%26volume%3D8%26spage%3D257%26epage%3D266%26doi%3D10.1016%2FS0960-9822%2898%2970198-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witucki, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraybill, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubersax, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blethrow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Structural basis for selective inhibition of Src family kinases by PP1</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span><span class="refDoi"> DOI: 10.1016/S1074-5521(99)80118-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2FS1074-5521%2899%2980118-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10467133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFaqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=671-678&author=Y.+Liuauthor=A.+Bishopauthor=L.+Wituckiauthor=B.+Kraybillauthor=E.+Shimizuauthor=J.+Tsienauthor=J.+Ubersaxauthor=J.+Blethrowauthor=D.+O.+Morganauthor=K.+M.+Shokat&title=Structural+basis+for+selective+inhibition+of+Src+family+kinases+by+PP1&doi=10.1016%2FS1074-5521%2899%2980118-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for selective inhibition of Src family kinases by PP1</span></div><div class="casAuthors">Liu, Yi; Bishop, Anthony; Witucki, Laurie; Kraybill, Brian; Shimizu, Eiji; Tsien, Joe; Ubersax, Jeff; Blethrow, Justin; Morgan, David O.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">671-678</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that can target individual kinases are powerful tools for use in signal transduction research.  It is difficult to find such compds. because of the enormous no. of protein kinases and the highly conserved nature of their catalytic domains.  Recently, a novel, potent, Src family selective tyrosine kinase inhibitor was reported (PP1).  Here, we study the structural basis for this inhibitor's specificity for Src family kinases.  A single residue corresponding to Ile338 (v-Src numbering; Thr338 in c-Src) in Src family tyrosine kinases largely controls PP1's ability to inhibit protein kinases.  Mutation of Ile338 to a larger residue such as methionine or phenylalanine in v-Src makes this inhibitor less potent.  Conversely, mutation of Ile338 to alanine or glycine increases PP1's potency.  PP1 can inhibit Ser/Thr kinases if the residue corresponding to Ile338 in v-Src is mutated to glycine.  We have accurately predicted several non-Src family kinases that are moderately (IC50 ∼1 μM) inhibited by PP1, including c-Abl and the MAP kinase p38.  Our mutagenesis studies of the ATP-binding site in both tyrosine kinases and Ser/Thr kinases explain why PP1 is a specific inhibitor of Src family tyrosine kinases.  Detn. of the structural basis of inhibitor specificity will aid in the design of more potent and more selective protein kinase inhibitors.  The ability to desensitize a particular kinase to PP1 inhibition of residue 338 or conversely to sensitize a kinase to PP1 inhibition by mutation should provide a useful basis for chem. genetic studies of kinase signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC8HNYPVy4RLVg90H21EOLACvtfcHk0lhzSlr3_HjQYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFaqur4%253D&md5=4d09cc5fb95c2ed5d538c02f356c0842</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980118-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980118-5%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DBishop%26aufirst%3DA.%26aulast%3DWitucki%26aufirst%3DL.%26aulast%3DKraybill%26aufirst%3DB.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DTsien%26aufirst%3DJ.%26aulast%3DUbersax%26aufirst%3DJ.%26aulast%3DBlethrow%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DStructural%2520basis%2520for%2520selective%2520inhibition%2520of%2520Src%2520family%2520kinases%2520by%2520PP1%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D671%26epage%3D678%26doi%3D10.1016%2FS1074-5521%2899%2980118-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Johnson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geiger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRocher, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maly, D. J.</span><span> </span><span class="NLM_article-title">Development of <i>Toxoplasma gondii</i> calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2416</span><span class="NLM_x">–</span> <span class="NLM_lpage">2426</span><span class="refDoi"> DOI: 10.1021/jm201713h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201713h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVeksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2416-2426&author=S.+M.+Johnsonauthor=R.+C.+Murphyauthor=J.+A.+Geigerauthor=A.+E.+DeRocherauthor=Z.+Zhangauthor=K.+K.+Ojoauthor=E.+T.+Larsonauthor=B.+G.+Pereraauthor=E.+J.+Daleauthor=P.+Heauthor=M.+C.+Reidauthor=A.+M.+Foxauthor=N.+R.+Muellerauthor=E.+A.+Merrittauthor=E.+Fanauthor=M.+Parsonsauthor=W.+C.+Van+Voorhisauthor=D.+J.+Maly&title=Development+of+Toxoplasma+gondii+calcium-dependent+protein+kinase+1+%28TgCDPK1%29+inhibitors+with+potent+anti-toxoplasma+activity&doi=10.1021%2Fjm201713h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitors with Potent Anti-Toxoplasma Activity</span></div><div class="casAuthors">Johnson, Steven M.; Murphy, Ryan C.; Geiger, Jennifer A.; DeRocher, Amy E.; Zhang, Zhongsheng; Ojo, Kayode K.; Larson, Eric T.; Perera, B. Gayani K.; Dale, Edward J.; He, Panqing; Reid, Molly C.; Fox, Anna M. W.; Mueller, Natascha R.; Merritt, Ethan A.; Fan, Erkang; Parsons, Marilyn; Van Voorhis, Wesley C.; Maly, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2416-2426</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toxoplasmosis is a disease of prominent health concern that is caused by the protozoan parasite Toxoplasma gondii.  Proliferation of T. gondii is dependent on its ability to invade host cells, which is mediated in part by calcium-dependent protein kinase 1 (CDPK1).  We have developed ATP competitive inhibitors of TgCDPK1 that block invasion of parasites into host cells, preventing their proliferation.  The presence of a unique glycine gatekeeper residue in TgCDPK1 permits selective inhibition of the parasite enzyme over human kinases.  These potent TgCDPK1 inhibitors do not inhibit the growth of human cell lines and represent promising candidates as toxoplasmosis therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxuYszPit90rVg90H21EOLACvtfcHk0lj4qm0QowL54A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVeksb8%253D&md5=862ac0e5066f60d7eeaccc723c2c4e75</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm201713h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201713h%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BM.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DGeiger%26aufirst%3DJ.%2BA.%26aulast%3DDeRocher%26aufirst%3DA.%2BE.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DPerera%26aufirst%3DB.%2BG.%26aulast%3DDale%26aufirst%3DE.%2BJ.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DReid%26aufirst%3DM.%2BC.%26aulast%3DFox%26aufirst%3DA.%2BM.%26aulast%3DMueller%26aufirst%3DN.%2BR.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3DDevelopment%2520of%2520Toxoplasma%2520gondii%2520calcium-dependent%2520protein%2520kinase%25201%2520%2528TgCDPK1%2529%2520inhibitors%2520with%2520potent%2520anti-toxoplasma%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2416%26epage%3D2426%26doi%3D10.1021%2Fjm201713h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Larson, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leibly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hol, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, E. A.</span><span> </span><span class="NLM_article-title">Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2803</span><span class="NLM_x">–</span> <span class="NLM_lpage">2810</span><span class="refDoi"> DOI: 10.1021/jm201725v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201725v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2803-2810&author=E.+T.+Larsonauthor=K.+K.+Ojoauthor=R.+C.+Murphyauthor=S.+M.+Johnsonauthor=Z.+Zhangauthor=J.+E.+Kimauthor=D.+J.+Leiblyauthor=A.+M.+Foxauthor=M.+C.+Reidauthor=E.+J.+Daleauthor=B.+G.+Pereraauthor=J.+Kimauthor=S.+N.+Hewittauthor=W.+G.+Holauthor=C.+L.+Verlindeauthor=E.+Fanauthor=W.+C.+Van+Voorhisauthor=D.+J.+Malyauthor=E.+A.+Merritt&title=Multiple+determinants+for+selective+inhibition+of+apicomplexan+calcium-dependent+protein+kinase+CDPK1&doi=10.1021%2Fjm201725v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Determinants for Selective Inhibition of Apicomplexan Calcium-Dependent Protein Kinase CDPK1</span></div><div class="casAuthors">Larson, Eric T.; Ojo, Kayode K.; Murphy, Ryan C.; Johnson, Steven M.; Zhang, Zhongsheng; Kim, Jessica E.; Leibly, David J.; Fox, Anna M. W.; Reid, Molly C.; Dale, Edward J.; Perera, B. Gayani K.; Kim, Jae; Hewitt, Stephen N.; Hol, Wim G. J.; Verlinde, Christophe L. M. J.; Fan, Erkang; Van Voorhis, Wesley C.; Maly, Dustin J.; Merritt, Ethan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2803-2810</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Diseases caused by the apicomplexan protozoans Toxoplasma gondii and Cryptosporidium parvum are a major health concern.  The life cycle of these parasites is regulated by a family of calcium-dependent protein kinases (CDPKs) that have no direct homologs in the human host.  Fortuitously, CDPK1 from both parasites contains a rare glycine gatekeeper residue adjacent to the ATP-binding pocket.  This has allowed creation of a series of C3-substituted pyrazolopyrimidine compds. that are potent inhibitors selective for CDPK1 over a panel of human kinases.  Here we demonstrate that selectivity is further enhanced by modification of the scaffold at the C1 position.  The explanation for this unexpected result is provided by crystal structures of the inhibitors bound to CDPK1 and the human kinase c-SRC.  Furthermore, the insight gained from these studies was applied to transform an alternative ATP-competitive scaffold lacking potency and selectivity for CDPK1 into a low nanomolar inhibitor of this enzyme with no activity against SRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxAUMMe3qUybVg90H21EOLACvtfcHk0lj4qm0QowL54A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOgsLo%253D&md5=c8aae3a6d1811aaa2d1316eb98fa8251</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm201725v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201725v%26sid%3Dliteratum%253Aachs%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DJohnson%26aufirst%3DS.%2BM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DLeibly%26aufirst%3DD.%2BJ.%26aulast%3DFox%26aufirst%3DA.%2BM.%26aulast%3DReid%26aufirst%3DM.%2BC.%26aulast%3DDale%26aufirst%3DE.%2BJ.%26aulast%3DPerera%26aufirst%3DB.%2BG.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHewitt%26aufirst%3DS.%2BN.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26atitle%3DMultiple%2520determinants%2520for%2520selective%2520inhibition%2520of%2520apicomplexan%2520calcium-dependent%2520protein%2520kinase%2520CDPK1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2803%26epage%3D2810%26doi%3D10.1021%2Fjm201725v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Murphy, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellanos-Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyloun, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhandari, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinde, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maly, D. J.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of calcium-dependent protein kinase 1 (CDPK1) from <i>C.ryptosporidium parvum</i> and <i>Toxoplasma gondii</i></span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span><span class="refDoi"> DOI: 10.1021/ml100096t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100096t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=331-335&author=R.+C.+Murphyauthor=K.+K.+Ojoauthor=E.+T.+Larsonauthor=A.+Castellanos-Gonzalezauthor=B.+G.+Pereraauthor=K.+R.+Keylounauthor=J.+E.+Kimauthor=J.+G.+Bhandariauthor=N.+R.+Mullerauthor=C.+L.+Verlindeauthor=A.+C.+Whiteauthor=E.+A.+Merrittauthor=W.+C.+Van+Voorhisauthor=D.+J.+Maly&title=Discovery+of+potent+and+selective+inhibitors+of+calcium-dependent+protein+kinase+1+%28CDPK1%29+from+C.ryptosporidium+parvum+and+Toxoplasma+gondii&doi=10.1021%2Fml100096t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fml100096t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100096t%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DLarson%26aufirst%3DE.%2BT.%26aulast%3DCastellanos-Gonzalez%26aufirst%3DA.%26aulast%3DPerera%26aufirst%3DB.%2BG.%26aulast%3DKeyloun%26aufirst%3DK.%2BR.%26aulast%3DKim%26aufirst%3DJ.%2BE.%26aulast%3DBhandari%26aufirst%3DJ.%2BG.%26aulast%3DMuller%26aufirst%3DN.%2BR.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DWhite%26aufirst%3DA.%2BC.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520calcium-dependent%2520protein%2520kinase%25201%2520%2528CDPK1%2529%2520from%2520C.ryptosporidium%2520parvum%2520and%2520Toxoplasma%2520gondii%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D331%26epage%3D335%26doi%3D10.1021%2Fml100096t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Doggett, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span> </span><span class="NLM_article-title">Bumped kinase inhibitor 1294 treats established <i>Toxoplasma gondii</i> infection</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3547</span><span class="NLM_x">–</span> <span class="NLM_lpage">3549</span><span class="refDoi"> DOI: 10.1128/AAC.01823-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FAAC.01823-13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=3547-3549&author=J.+S.+Doggettauthor=K.+K.+Ojoauthor=E.+Fanauthor=D.+J.+Malyauthor=W.+C.+Van+Voorhis&title=Bumped+kinase+inhibitor+1294+treats+established+Toxoplasma+gondii+infection&doi=10.1128%2FAAC.01823-13"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FAAC.01823-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01823-13%26sid%3Dliteratum%253Aachs%26aulast%3DDoggett%26aufirst%3DJ.%2BS.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DBumped%2520kinase%2520inhibitor%25201294%2520treats%2520established%2520Toxoplasma%2520gondii%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D3547%26epage%3D3549%26doi%3D10.1128%2FAAC.01823-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lourido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barks, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wildman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span> </span><span class="NLM_article-title">Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by <i>Toxoplasma gondii</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3068</span><span class="NLM_x">–</span> <span class="NLM_lpage">3077</span><span class="refDoi"> DOI: 10.1021/jm4001314</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001314" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslSgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3068-3077&author=S.+Louridoauthor=C.+Zhangauthor=M.+S.+Lopezauthor=K.+Tangauthor=J.+Barksauthor=Q.+Wangauthor=S.+A.+Wildmanauthor=K.+M.+Shokatauthor=L.+D.+Sibley&title=Optimizing+small+molecule+inhibitors+of+calcium-dependent+protein+kinase+1+to+prevent+infection+by+Toxoplasma+gondii&doi=10.1021%2Fjm4001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Small Molecule Inhibitors of Calcium-Dependent Protein Kinase 1 to Prevent Infection by Toxoplasma gondii</span></div><div class="casAuthors">Lourido, Sebastian; Zhang, Chao; Lopez, Michael S.; Tang, Keliang; Barks, Jennifer; Wang, Qiuling; Wildman, Scott A.; Shokat, Kevan M.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3068-3077</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toxoplasma gondii is sensitive to bulky pyrazolo [3,4-d] pyrimidine (PP) inhibitors due to the presence of a Gly gatekeeper in the essential calcium dependent protein kinase 1 (CDPK1).  Here we synthesized a no. of new derivs. of 3-methyl-benzyl-PP (3-MB-PP, or 1).  The potency of PP analogs in inhibiting CDPK1 enzyme activity in vitro (low nM IC50 values) and blocking parasite growth in host cell monolayers in vivo (low μM EC50 values) were highly correlated and occurred in a CDPK1-specific manner.  Chem. modification of the PP scaffold to increase half-life in the presence of microsomes in vitro led to identification of compds. with enhanced stability while retaining activity.  Several of these more potent compds. were able to prevent lethal infection with T. gondii in the mouse model.  Collectively, the strategies outlined here provide a route for development of more effective compds. for treatment of toxoplasmosis and perhaps related parasitic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBcv37M-6fobVg90H21EOLACvtfcHk0licbHI6494Iig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslSgt78%253D&md5=352bb9e5b5304656aab52da763202b68</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm4001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001314%26sid%3Dliteratum%253Aachs%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DTang%26aufirst%3DK.%26aulast%3DBarks%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DOptimizing%2520small%2520molecule%2520inhibitors%2520of%2520calcium-dependent%2520protein%2520kinase%25201%2520to%2520prevent%2520infection%2520by%2520Toxoplasma%2520gondii%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3068%26epage%3D3077%26doi%3D10.1021%2Fjm4001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Vidadala, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivas, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojo, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulverson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zambriski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzual, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRocher, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddaramaiah, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hol, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merritt, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freiberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempf, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isoherranen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doggett, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maly, D. J.</span><span> </span><span class="NLM_article-title">Development of an orally available and central nervous system (CNS) renetrant <i>Toxoplasma gondii</i> calcium-dependent protein kinase 1 (TgCDPK1) inhibitor with minimal human ether-a-go-go-related gene (hERG) activity for the treatment of toxoplasmosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">6531</span><span class="NLM_x">–</span> <span class="NLM_lpage">6546</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00760</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6531-6546&author=R.+S.+Vidadalaauthor=K.+L.+Rivasauthor=K.+K.+Ojoauthor=M.+A.+Hulversonauthor=J.+A.+Zambriskiauthor=I.+Bruzualauthor=T.+L.+Schultzauthor=W.+Huangauthor=Z.+Zhangauthor=S.+Scheeleauthor=A.+E.+DeRocherauthor=R.+Choiauthor=L.+K.+Barrettauthor=L.+K.+Siddaramaiahauthor=W.+G.+Holauthor=E.+Fanauthor=E.+A.+Merrittauthor=M.+Parsonsauthor=G.+Freibergauthor=K.+Marshauthor=D.+J.+Kempfauthor=V.+B.+Carruthersauthor=N.+Isoherranenauthor=J.+S.+Doggettauthor=W.+C.+Van+Voorhisauthor=D.+J.+Maly&title=Development+of+an+orally+available+and+central+nervous+system+%28CNS%29+renetrant+Toxoplasma+gondii+calcium-dependent+protein+kinase+1+%28TgCDPK1%29+inhibitor+with+minimal+human+ether-a-go-go-related+gene+%28hERG%29+activity+for+the+treatment+of+toxoplasmosis&doi=10.1021%2Facs.jmedchem.6b00760"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00760%26sid%3Dliteratum%253Aachs%26aulast%3DVidadala%26aufirst%3DR.%2BS.%26aulast%3DRivas%26aufirst%3DK.%2BL.%26aulast%3DOjo%26aufirst%3DK.%2BK.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DZambriski%26aufirst%3DJ.%2BA.%26aulast%3DBruzual%26aufirst%3DI.%26aulast%3DSchultz%26aufirst%3DT.%2BL.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DScheele%26aufirst%3DS.%26aulast%3DDeRocher%26aufirst%3DA.%2BE.%26aulast%3DChoi%26aufirst%3DR.%26aulast%3DBarrett%26aufirst%3DL.%2BK.%26aulast%3DSiddaramaiah%26aufirst%3DL.%2BK.%26aulast%3DHol%26aufirst%3DW.%2BG.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DMerritt%26aufirst%3DE.%2BA.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DFreiberg%26aufirst%3DG.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DCarruthers%26aufirst%3DV.%2BB.%26aulast%3DIsoherranen%26aufirst%3DN.%26aulast%3DDoggett%26aufirst%3DJ.%2BS.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DMaly%26aufirst%3DD.%2BJ.%26atitle%3DDevelopment%2520of%2520an%2520orally%2520available%2520and%2520central%2520nervous%2520system%2520%2528CNS%2529%2520renetrant%2520Toxoplasma%2520gondii%2520calcium-dependent%2520protein%2520kinase%25201%2520%2528TgCDPK1%2529%2520inhibitor%2520with%2520minimal%2520human%2520ether-a-go-go-related%2520gene%2520%2528hERG%2529%2520activity%2520for%2520the%2520treatment%2520of%2520toxoplasmosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6531%26epage%3D6546%26doi%3D10.1021%2Facs.jmedchem.6b00760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hanefeld, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. J.</span><span> </span><span class="NLM_article-title">One-pot synthesis of tetrasubstituted pyrazoles - proof of regiochemistry</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">0</span><span class="NLM_x">, </span> <span class="NLM_fpage">1545</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span><span class="refDoi"> DOI: 10.1039/P19960001545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1039%2FP19960001545" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=0&publication_year=1996&pages=1545-1552&author=U.+Hanefeldauthor=C.+W.+Reesauthor=A.+J.+P.+Whiteauthor=D.+J.+Williams&title=One-pot+synthesis+of+tetrasubstituted+pyrazoles+-+proof+of+regiochemistry&doi=10.1039%2FP19960001545"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FP19960001545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FP19960001545%26sid%3Dliteratum%253Aachs%26aulast%3DHanefeld%26aufirst%3DU.%26aulast%3DRees%26aufirst%3DC.%2BW.%26aulast%3DWhite%26aufirst%3DA.%2BJ.%2BP.%26aulast%3DWilliams%26aufirst%3DD.%2BJ.%26atitle%3DOne-pot%2520synthesis%2520of%2520tetrasubstituted%2520pyrazoles%2520-%2520proof%2520of%2520regiochemistry%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1996%26volume%3D0%26spage%3D1545%26epage%3D1552%26doi%3D10.1039%2FP19960001545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Schenone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musumeci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brullo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: an old scaffold as a new tool for medicinal chemistry and chemical biology studies</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">7189</span><span class="NLM_x">–</span> <span class="NLM_lpage">7238</span><span class="refDoi"> DOI: 10.1021/cr400270z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400270z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=7189-7238&author=S.+Schenoneauthor=M.+Radiauthor=F.+Musumeciauthor=C.+Brulloauthor=M.+Botta&title=Biologically+driven+synthesis+of+pyrazolo%5B3%2C4-d%5Dpyrimidines+as+protein+kinase+inhibitors%3A+an+old+scaffold+as+a+new+tool+for+medicinal+chemistry+and+chemical+biology+studies&doi=10.1021%2Fcr400270z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: An old scaffold as a new tool for medicinal chemistry and chemical biology studies</span></div><div class="casAuthors">Schenone, Silvia; Radi, Marco; Musumeci, Francesca; Brullo, Chiara; Botta, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7189-7238</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review was given on the design, synthesis, and biol. activity of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVe-x33MLF37Vg90H21EOLACvtfcHk0lgo3k-gckAehg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWhsLo%253D&md5=ee2dcea73afb5841bffe333fead3485a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fcr400270z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400270z%26sid%3Dliteratum%253Aachs%26aulast%3DSchenone%26aufirst%3DS.%26aulast%3DRadi%26aufirst%3DM.%26aulast%3DMusumeci%26aufirst%3DF.%26aulast%3DBrullo%26aufirst%3DC.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DBiologically%2520driven%2520synthesis%2520of%2520pyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520protein%2520kinase%2520inhibitors%253A%2520an%2520old%2520scaffold%2520as%2520a%2520new%2520tool%2520for%2520medicinal%2520chemistry%2520and%2520chemical%2520biology%2520studies%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D7189%26epage%3D7238%26doi%3D10.1021%2Fcr400270z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kwong, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">A general, efficient, and inexpensive catalyst system for the coupling of aryl iodides and thiols</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3517</span><span class="NLM_x">–</span> <span class="NLM_lpage">3520</span><span class="refDoi"> DOI: 10.1021/ol0266673</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0266673" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvVGntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=3517-3520&author=F.+Y.+Kwongauthor=S.+L.+Buchwald&title=A+general%2C+efficient%2C+and+inexpensive+catalyst+system+for+the+coupling+of+aryl+iodides+and+thiols&doi=10.1021%2Fol0266673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A General, Efficient, and Inexpensive Catalyst System for the Coupling of Aryl Iodides and Thiols</span></div><div class="casAuthors">Kwong, Fuk Yee; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3517-3520</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient copper-catalyzed carbon-sulfur bond formation reaction was developed.  This method is particularly noteworthy given its exptl. simplicity, high generality, and exceptional level of functional group toleration and the low cost of the catalyst system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph2Qp54FuzDbVg90H21EOLACvtfcHk0lgo3k-gckAehg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvVGntLk%253D&md5=2c54c4b4c4d34f7ae67ae44d2d8cd6c2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fol0266673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0266673%26sid%3Dliteratum%253Aachs%26aulast%3DKwong%26aufirst%3DF.%2BY.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DA%2520general%252C%2520efficient%252C%2520and%2520inexpensive%2520catalyst%2520system%2520for%2520the%2520coupling%2520of%2520aryl%2520iodides%2520and%2520thiols%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D3517%26epage%3D3520%26doi%3D10.1021%2Fol0266673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ley, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. W.</span><span> </span><span class="NLM_article-title">Modern synthetic methods for copper-mediated C(aryl)-O, C(aryl)-N, and C(aryl)-S bond formation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5400</span><span class="NLM_x">–</span> <span class="NLM_lpage">5449</span><span class="refDoi"> DOI: 10.1002/anie.200300594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1002%2Fanie.200300594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=14618572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFOqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=5400-5449&author=S.+V.+Leyauthor=A.+W.+Thomas&title=Modern+synthetic+methods+for+copper-mediated+C%28aryl%29-O%2C+C%28aryl%29-N%2C+and+C%28aryl%29-S+bond+formation&doi=10.1002%2Fanie.200300594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Modern synthetic methods for copper-mediated C(aryl)-O, C(aryl)-N, and C(aryl)-S bond formation</span></div><div class="casAuthors">Ley, Steven V.; Thomas, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">5400-5449</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The copper-mediated C(aryl)-N, C(aryl)-O, and C(aryl)-S bond formation is an important transformation and was developed to include a wide range of substrates.  This review highlights the recent developments in the copper-mediated (both stoichiometric and catalytic) reactions of aryl boronic acids, aryl halides, iodonium salts, siloxanes, stannanes, plumbanes, bismuthates, and trifluoroborate salts as aryl donors.  In particular, the recent introduction of boronic acids as reaction partners in both O- and N-arylation was a significant discovery and will occupy center-stage in this review.  Clear improvements can be obtained by the correct choice of copper source, base, ligands, and other additives.  Mechanistic investigations should provide insight into the catalytically active species, which would aid in the development of milder, more-efficient methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFt6Vxw-Bls7Vg90H21EOLACvtfcHk0lgo3k-gckAehg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFOqtbk%253D&md5=b90d9ab6ac33d286ca570aeb9ef6a10b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fanie.200300594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200300594%26sid%3Dliteratum%253Aachs%26aulast%3DLey%26aufirst%3DS.%2BV.%26aulast%3DThomas%26aufirst%3DA.%2BW.%26atitle%3DModern%2520synthetic%2520methods%2520for%2520copper-mediated%2520C%2528aryl%2529-O%252C%2520C%2528aryl%2529-N%252C%2520and%2520C%2528aryl%2529-S%2520bond%2520formation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D5400%26epage%3D5449%26doi%3D10.1002%2Fanie.200300594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Q.</span><span> </span><span class="NLM_article-title">N,N-dimethyl glycine-promoted ullmann coupling reaction of phenols and aryl halides</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3799</span><span class="NLM_x">–</span> <span class="NLM_lpage">3802</span><span class="refDoi"> DOI: 10.1021/ol0350947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0350947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsFyrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=3799-3802&author=D.+Maauthor=Q.+Cai&title=N%2CN-dimethyl+glycine-promoted+ullmann+coupling+reaction+of+phenols+and+aryl+halides&doi=10.1021%2Fol0350947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">N,N-Dimethyl Glycine-Promoted Ullmann Coupling Reaction of Phenols and Aryl Halides</span></div><div class="casAuthors">Ma, Dawei; Cai, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3799-3802</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ullmann-type diaryl ether synthesis can be performed at 90 °C using either aryl iodides or aryl bromides as the substrates under the assistance of N,N-dimethylglycine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-5F2Dl8PWTbVg90H21EOLACvtfcHk0lgo3k-gckAehg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsFyrurs%253D&md5=9d63bfcef4d0f32e18514874d5bd752f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fol0350947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0350947%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DQ.%26atitle%3DN%252CN-dimethyl%2520glycine-promoted%2520ullmann%2520coupling%2520reaction%2520of%2520phenols%2520and%2520aryl%2520halides%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D3799%26epage%3D3802%26doi%3D10.1021%2Fol0350947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Prim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagne, J.-m.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrioletti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, D.</span><span> </span><span class="NLM_article-title">Palladium-catalysed reactions of aryl halides with soft, non-organometallic nucleophiles</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2041</span><span class="NLM_x">–</span> <span class="NLM_lpage">2075</span><span class="refDoi"> DOI: 10.1016/S0040-4020(02)00076-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1016%2FS0040-4020%2802%2900076-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsFSjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=2041-2075&author=D.+Primauthor=J.-m.+Campagneauthor=B.+Andriolettiauthor=D.+Joseph&title=Palladium-catalysed+reactions+of+aryl+halides+with+soft%2C+non-organometallic+nucleophiles&doi=10.1016%2FS0040-4020%2802%2900076-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed reactions of aryl halides with soft, non-organometallic nucleophiles</span></div><div class="casAuthors">Prim, Damien; Campagne, Jean-Marc; Joseph, Delphine; Andrioletti, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2041-2075</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review including N-, O-, B-, Si-, P-, S-, and C-based nucleophiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrafl_sFfa04LVg90H21EOLACvtfcHk0liZtqz72ZTRlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsFSjt7w%253D&md5=47fee3fe9b0df2ac65a38d3a1bb94b71</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2802%2900076-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252802%252900076-5%26sid%3Dliteratum%253Aachs%26aulast%3DPrim%26aufirst%3DD.%26aulast%3DCampagne%26aufirst%3DJ.-m.%26aulast%3DAndrioletti%26aufirst%3DB.%26aulast%3DJoseph%26aufirst%3DD.%26atitle%3DPalladium-catalysed%2520reactions%2520of%2520aryl%2520halides%2520with%2520soft%252C%2520non-organometallic%2520nucleophiles%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D2041%26epage%3D2075%26doi%3D10.1016%2FS0040-4020%2802%2900076-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Zaretzki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matlock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swamidass, S. J.</span><span> </span><span class="NLM_article-title">XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3373</span><span class="NLM_x">–</span> <span class="NLM_lpage">3383</span><span class="refDoi"> DOI: 10.1021/ci400518g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci400518g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslKks77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=3373-3383&author=J.+Zaretzkiauthor=M.+Matlockauthor=S.+J.+Swamidass&title=XenoSite%3A+accurately+predicting+CYP-mediated+sites+of+metabolism+with+neural+networks&doi=10.1021%2Fci400518g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">XenoSite: Accurately Predicting CYP-Mediated Sites of Metabolism with Neural Networks</span></div><div class="casAuthors">Zaretzki, Jed; Matlock, Matthew; Swamidass, S. Joshua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3373-3383</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding how xenobiotic mols. are metabolized is important because it influences the safety, efficacy, and dose of medicines and how they can be modified to improve these properties.  The cytochrome P450s (CYPs) are proteins responsible for metabolizing 90% of drugs on the market, and many computational methods can predict which at. sites of a mol.-sites of metab. (SOMs)-are modified during CYP-mediated metab.  This study improves on prior methods of predicting CYP-mediated SOMs by using new descriptors and machine learning based on neural networks.  The new method, XenoSite, is faster to train and more accurate by as much as 4% or 5% for some isoenzymes.  Furthermore, some "incorrect" predictions made by XenoSite were subsequently validated as correct predictions by revaluation of the source literature.  Moreover, XenoSite output is interpretable as a probability, which reflects both the confidence of the model that a particular atom is metabolized and the statistical likelihood that its prediction for that atom is correct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlZ_8YN3XASbVg90H21EOLACvtfcHk0liZtqz72ZTRlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslKks77E&md5=1de6321b1500c9571db548006767e708</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fci400518g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400518g%26sid%3Dliteratum%253Aachs%26aulast%3DZaretzki%26aufirst%3DJ.%26aulast%3DMatlock%26aufirst%3DM.%26aulast%3DSwamidass%26aufirst%3DS.%2BJ.%26atitle%3DXenoSite%253A%2520accurately%2520predicting%2520CYP-mediated%2520sites%2520of%2520metabolism%2520with%2520neural%2520networks%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D3373%26epage%3D3383%26doi%3D10.1021%2Fci400518g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Bohm, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendels, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obst-Sander, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span><span class="refDoi"> DOI: 10.1002/cbic.200301023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1002%2Fcbic.200301023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=15122635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=637-643&author=H.+J.+Bohmauthor=D.+Bannerauthor=S.+Bendelsauthor=M.+Kansyauthor=B.+Kuhnauthor=K.+Mullerauthor=U.+Obst-Sanderauthor=M.+Stahl&title=Fluorine+in+medicinal+chemistry&doi=10.1002%2Fcbic.200301023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry</span></div><div class="casAuthors">Bohm Hans-Joachim; Banner David; Bendels Stefanie; Kansy Manfred; Kuhn Bernd; Muller Klaus; Obst-Sander Ulrike; Stahl Martin</div><div class="citationInfo"><span class="NLM_cas:title">Chembiochem : a European journal of chemical biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">637-43</span>
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    </div><div class="casAbstract">Fluorinated compounds are synthesized in pharmaceutical research on a routine basis and many marketed compounds contain fluorine.  The present review summarizes some of the most frequently employed strategies for using fluorine substituents in medicinal chemistry.  Quite often, fluorine is introduced to improve the metabolic stability by blocking metabolically labile sites.  However, fluorine can also be used to modulate the physicochemical properties, such as lipophilicity or basicity.  It may exert a substantial effect on the conformation of a molecule.  Increasingly, fluorine is used to enhance the binding affinity to the target protein.  Recent 3D-structure determinations of protein complexes with bound fluorinated ligands have led to an improved understanding of the nonbonding protein-ligand interactions that involve fluorine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4zDG_wo1YGtts4TFFB11gfW6udTcc2ebIkk-Tj0D7gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D&md5=fa5ca2cfc278b83c80d5c96b18dfe312</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200301023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200301023%26sid%3Dliteratum%253Aachs%26aulast%3DBohm%26aufirst%3DH.%2BJ.%26aulast%3DBanner%26aufirst%3DD.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DObst-Sander%26aufirst%3DU.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D637%26epage%3D643%26doi%3D10.1002%2Fcbic.200301023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Barnes-Seeman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatsis, P.</span><span> </span><span class="NLM_article-title">Metabolically stable tert-butyl replacement</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">514</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span><span class="refDoi"> DOI: 10.1021/ml400045j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400045j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1ymt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=514-516&author=D.+Barnes-Seemanauthor=M.+Jainauthor=L.+Bellauthor=S.+Ferreiraauthor=S.+Cohenauthor=X.+H.+Chenauthor=J.+Aminauthor=B.+Snodgrassauthor=P.+Hatsis&title=Metabolically+stable+tert-butyl+replacement&doi=10.1021%2Fml400045j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolically Stable tert-Butyl Replacement</span></div><div class="casAuthors">Barnes-Seeman, David; Jain, Monish; Bell, Leslie; Ferreira, Suzie; Cohen, Scott; Chen, Xiao-Hui; Amin, Jakal; Snodgrass, Brad; Hatsis, Panos</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">514-516</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Susceptibility to metab. is a common issue with the tert-Bu group on compds. of medicinal interest.  The authors demonstrate an approach of removing all the fully Sp3 C-Hs from a tert-Bu group: replacing some C-Hs with C-Fs and increasing the s-character of the remaining C-Hs.  This approach gave a trifluoromethylcyclopropyl group, which increased metabolic stability.  Trifluoromethylcyclopropyl-contg. analogs had consistently higher metabolic stability in vitro and in vivo compared to their tert-butyl-contg. counterparts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrao2I5ukFsTrVg90H21EOLACvtfcHk0lgmYuI9kWmQWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1ymt78%253D&md5=156572485ea3a48f5e1b6ea7409f1f61</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fml400045j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400045j%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes-Seeman%26aufirst%3DD.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DBell%26aufirst%3DL.%26aulast%3DFerreira%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DX.%2BH.%26aulast%3DAmin%26aufirst%3DJ.%26aulast%3DSnodgrass%26aufirst%3DB.%26aulast%3DHatsis%26aufirst%3DP.%26atitle%3DMetabolically%2520stable%2520tert-butyl%2520replacement%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D514%26epage%3D516%26doi%3D10.1021%2Fml400045j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Hicken, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmsater, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlachter, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topalov, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarlton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callejo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klopfenstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woessner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">Discovery of a novel class of imidazo[1,2-a]pyridines with potent PDGFR activity and oral bioavailability</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span><span class="refDoi"> DOI: 10.1021/ml4003953</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4003953" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=78-83&author=E.+J.+Hickenauthor=F.+P.+Marmsaterauthor=M.+C.+Munsonauthor=S.+T.+Schlachterauthor=J.+E.+Robinsonauthor=S.+Allenauthor=L.+E.+Burgessauthor=R.+K.+Delisleauthor=J.+P.+Rizziauthor=G.+T.+Topalovauthor=Q.+Zhaoauthor=J.+M.+Hicksauthor=N.+C.+Kallanauthor=E.+Tarltonauthor=A.+Allenauthor=M.+Callejoauthor=A.+Coxauthor=S.+Ranaauthor=N.+Klopfensteinauthor=R.+Woessnerauthor=J.+P.+Lyssikatos&title=Discovery+of+a+novel+class+of+imidazo%5B1%2C2-a%5Dpyridines+with+potent+PDGFR+activity+and+oral+bioavailability&doi=10.1021%2Fml4003953"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fml4003953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4003953%26sid%3Dliteratum%253Aachs%26aulast%3DHicken%26aufirst%3DE.%2BJ.%26aulast%3DMarmsater%26aufirst%3DF.%2BP.%26aulast%3DMunson%26aufirst%3DM.%2BC.%26aulast%3DSchlachter%26aufirst%3DS.%2BT.%26aulast%3DRobinson%26aufirst%3DJ.%2BE.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DBurgess%26aufirst%3DL.%2BE.%26aulast%3DDelisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DTopalov%26aufirst%3DG.%2BT.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DHicks%26aufirst%3DJ.%2BM.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DTarlton%26aufirst%3DE.%26aulast%3DAllen%26aufirst%3DA.%26aulast%3DCallejo%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKlopfenstein%26aufirst%3DN.%26aulast%3DWoessner%26aufirst%3DR.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520imidazo%255B1%252C2-a%255Dpyridines%2520with%2520potent%2520PDGFR%2520activity%2520and%2520oral%2520bioavailability%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D78%26epage%3D83%26doi%3D10.1021%2Fml4003953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Shim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. T.</span><span> </span><span class="NLM_article-title">The associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation</span> <span class="citation_source-journal">Oncol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1469</span><span class="refDoi"> DOI: 10.3892/ol.2017.5564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.3892%2Fol.2017.5564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=28454278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADC%252BC1crit12hsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=1463-1469&author=H.+J.+Shimauthor=H.+I.+Kimauthor=S.+T.+Lee&title=The+associated+pyrazolopyrimidines+PP1+and+PP2+inhibit+protein+tyrosine+kinase+6+activity+and+suppress+breast+cancer+cell+proliferation&doi=10.3892%2Fol.2017.5564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation</span></div><div class="casAuthors">Shim Hyun Jae; Kim Han Ie; Lee Seung-Taek</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1463-1469</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">Protein tyrosine kinase (PTK)6, also known as breast tumor kinase, is a non-receptor tyrosine kinase.  It is closely associated with, but evolutionarily distinct from, the Src family members.  PTK6 has a role in proliferation, migration and invasion in various cancers, and therefore has been suggested as a potentially valuable therapeutic target.  In an attempt to develop PTK6 inhibitors, chemicals known to inhibit various kinases were screened for their ability to inhibit PTK6.  Pyrazolopyrimidine (PP)1, PP2 and a lymphocyte-specific protein tyrosine kinase inhibitor strongly inhibited the catalytic activity of PTK6 in vitro.  These chemicals suppressed the phosphorylation of PTK6 substrate proteins, including signal transducer and activator of transcription 3, in human embryonic kidney (HEK) 293 cells expressing hyperactive PTK6.  They also expressed selectivity towards PTK6 over other PTK members in HEK 293 cells.  PP1 and PP2 specifically inhibited the PTK6-dependent proliferation of human breast carcinoma T-47D cells.  PP1 and PP2 were more selective for PTK6 than for Src family kinases, and may be useful for the treatment of PTK6-positive malignant diseases such as breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrSOuOV6FyA5QHPYJuLg8TfW6udTcc2eZE4SLABhIB2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crit12hsA%253D%253D&md5=1d0e97970d72830939270cfe7c0538a2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3892%2Fol.2017.5564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2017.5564%26sid%3Dliteratum%253Aachs%26aulast%3DShim%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BI.%26aulast%3DLee%26aufirst%3DS.%2BT.%26atitle%3DThe%2520associated%2520pyrazolopyrimidines%2520PP1%2520and%2520PP2%2520inhibit%2520protein%2520tyrosine%2520kinase%25206%2520activity%2520and%2520suppress%2520breast%2520cancer%2520cell%2520proliferation%26jtitle%3DOncol.%2520Lett.%26date%3D2017%26volume%3D13%26spage%3D1463%26epage%3D1469%26doi%3D10.3892%2Fol.2017.5564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Lourido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeschke, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span> </span><span class="NLM_article-title">Exploiting the unique ATP-binding pocket of toxoplasma calcium-dependent protein kinase 1 to identify its substrates</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1155</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span><span class="refDoi"> DOI: 10.1021/cb400115y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400115y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1155-1162&author=S.+Louridoauthor=G.+R.+Jeschkeauthor=B.+E.+Turkauthor=L.+D.+Sibley&title=Exploiting+the+unique+ATP-binding+pocket+of+toxoplasma+calcium-dependent+protein+kinase+1+to+identify+its+substrates&doi=10.1021%2Fcb400115y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcb400115y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400115y%26sid%3Dliteratum%253Aachs%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DJeschke%26aufirst%3DG.%2BR.%26aulast%3DTurk%26aufirst%3DB.%2BE.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DExploiting%2520the%2520unique%2520ATP-binding%2520pocket%2520of%2520toxoplasma%2520calcium-dependent%2520protein%2520kinase%25201%2520to%2520identify%2520its%2520substrates%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1155%26epage%3D1162%26doi%3D10.1021%2Fcb400115y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Yap, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sher, A.</span><span> </span><span class="NLM_article-title">Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha- dependent host resistance to the intracellular pathogen</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1091</span><span class="refDoi"> DOI: 10.1084/jem.189.7.1083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1084%2Fjem.189.7.1083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=1999&pages=1083-1091&author=G.+S.+Yapauthor=A.+Sher&title=Effector+cells+of+both+nonhemopoietic+and+hemopoietic+origin+are+required+for+interferon+%28IFN%29-gamma-+and+tumor+necrosis+factor+%28TNF%29-alpha-+dependent+host+resistance+to+the+intracellular+pathogen&doi=10.1084%2Fjem.189.7.1083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1084%2Fjem.189.7.1083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.189.7.1083%26sid%3Dliteratum%253Aachs%26aulast%3DYap%26aufirst%3DG.%2BS.%26aulast%3DSher%26aufirst%3DA.%26atitle%3DEffector%2520cells%2520of%2520both%2520nonhemopoietic%2520and%2520hemopoietic%2520origin%2520are%2520required%2520for%2520interferon%2520%2528IFN%2529-gamma-%2520and%2520tumor%2520necrosis%2520factor%2520%2528TNF%2529-alpha-%2520dependent%2520host%2520resistance%2520to%2520the%2520intracellular%2520pathogen%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1999%26volume%3D189%26spage%3D1083%26epage%3D1091%26doi%3D10.1084%2Fjem.189.7.1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Dunay, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimesaat, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushrab, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasteh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesenfeld, O.</span><span> </span><span class="NLM_article-title">Atovaquone maintenance therapy prevents reactivation of toxopasmic encepahalitis in the murine model of reactivated toxoplasmosis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4848</span><span class="NLM_x">–</span> <span class="NLM_lpage">4854</span><span class="refDoi"> DOI: 10.1128/AAC.48.12.4848-4854.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FAAC.48.12.4848-4854.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=15561866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKmt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=4848-4854&author=I.+R.+Dunayauthor=M.+M.+Heimesaatauthor=F.+N.+Bushrabauthor=R.+H.+Mullerauthor=H.+Stockerauthor=K.+Arastehauthor=M.+Kurowskiauthor=R.+Fitznerauthor=K.+Bornerauthor=O.+Liesenfeld&title=Atovaquone+maintenance+therapy+prevents+reactivation+of+toxopasmic+encepahalitis+in+the+murine+model+of+reactivated+toxoplasmosis&doi=10.1128%2FAAC.48.12.4848-4854.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis</span></div><div class="casAuthors">Dunay, Ildiko R.; Heimesaat, Markus M.; Bushrab, Faris Nadiem; Mueller, Rainer H.; Stocker, Hartmut; Arasteh, Keikawus; Kurowski, Michael; Fitzner, Rudolf; Borner, Klaus; Liesenfeld, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4848-4854</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Acute therapy with pyrimethamine plus sulfadiazine is the treatment of choice for reactivated toxoplasmic encephalitis (TE).  Acute therapy is followed by lifelong maintenance therapy (secondary prophylaxis) with the same drugs at lower dosages.  The use of pyrimethamine plus sulfadiazine is hampered by severe side effects including allergic reactions and hematotoxicity.  Alternative treatment regimens with pyrimethamine plus clindamycin or other antiparasitic drugs are less efficacious.  Atovaquone nanosuspensions show excellent therapeutic effects for "acute" i.v. treatment of reactivated TE in a murine model.  In the present study, the therapeutic efficacy of atovaquone for oral "maintenance" therapy was investigated.  Mice with a targeted mutation in the interferon regulatory factor 8 gene were latently infected with Toxoplasma gondii, developed reactivated TE, and received acute i.v. therapy with atovaquone nanosuspensions.  Mice were then treated orally with atovaquone suspension or other antiparasitic drugs to prevent relapse of TE.  Maintenance therapy with atovaquone at daily doses of 50 or 100 mg/kg (body wt.) protected mice against reactivated TE and death.  This maintenance treatment was superior to std. therapy with pyrimethamine plus sulfadiazine.  The latter combination was superior to the combination of pyrimethamine plus clindamycin.  Inflammatory changes in the brain parenchyma and meninges, as well as parasite nos., in the brains of mice confirmed the therapeutic efficacy of atovaquone for maintenance therapy.  Atovaquone was detectable in sera, brains, livers, and lungs of infected mice by high-performance liq. chromatog. and/or mass spectrometry.  In conclusion, atovaquone appears to be superior to the std. maintenance therapy regimens in a murine model of reactivated TE.  The therapeutic efficacy of atovaquone for maintenance therapy against TE should be further investigated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKPKQMmt7eL7Vg90H21EOLACvtfcHk0li7fbVRVhTtYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKmt7vJ&md5=3a5c765f82509aa8b1121dbb28720c33</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.12.4848-4854.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.12.4848-4854.2004%26sid%3Dliteratum%253Aachs%26aulast%3DDunay%26aufirst%3DI.%2BR.%26aulast%3DHeimesaat%26aufirst%3DM.%2BM.%26aulast%3DBushrab%26aufirst%3DF.%2BN.%26aulast%3DMuller%26aufirst%3DR.%2BH.%26aulast%3DStocker%26aufirst%3DH.%26aulast%3DArasteh%26aufirst%3DK.%26aulast%3DKurowski%26aufirst%3DM.%26aulast%3DFitzner%26aufirst%3DR.%26aulast%3DBorner%26aufirst%3DK.%26aulast%3DLiesenfeld%26aufirst%3DO.%26atitle%3DAtovaquone%2520maintenance%2520therapy%2520prevents%2520reactivation%2520of%2520toxopasmic%2520encepahalitis%2520in%2520the%2520murine%2520model%2520of%2520reactivated%2520toxoplasmosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D4848%26epage%3D4854%26doi%3D10.1128%2FAAC.48.12.4848-4854.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkbeiner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Structure-guided inhibitor design expands the scope of analog-sensitive kinase technology</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1931</span><span class="NLM_x">–</span> <span class="NLM_lpage">1938</span><span class="refDoi"> DOI: 10.1021/cb400376p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400376p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVOksbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1931-1938&author=C.+Zhangauthor=M.+S.+Lopezauthor=A.+C.+Darauthor=E.+Ladowauthor=S.+Finkbeinerauthor=C.+H.+Yunauthor=M.+J.+Eckauthor=K.+M.+Shokat&title=Structure-guided+inhibitor+design+expands+the+scope+of+analog-sensitive+kinase+technology&doi=10.1021%2Fcb400376p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Inhibitor Design Expands the Scope of Analog-Sensitive Kinase Technology</span></div><div class="casAuthors">Zhang, Chao; Lopez, Michael S.; Dar, Arvin C.; LaDow, Eva; Finkbeiner, Steven; Yun, Cai-Hong; Eck, Michael J.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1931-1938</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Engineered analog-sensitive (AS) protein kinases have emerged as powerful tools for dissecting phospho-signaling pathways, for elucidating the cellular function of individual kinases, and for deciphering unanticipated effects of clin. therapeutics.  A crucial and necessary feature of this technol. is a bioorthogonal small mol. that is innocuous toward native cellular systems but potently inhibits the engineered kinase.  In order to generalize this method, we sought a mol. capable of targeting divergent AS-kinases.  Here we employ x-ray crystallog. and medicinal chem. to unravel the mechanism of current inhibitors and use these insights to design the most potent, selective, and general AS-kinase inhibitors reported to date.  We use large-scale kinase inhibitor profiling to characterize the selectivity of these mols. as well as examine the consequences of potential off-target effects in chem. genetic expts.  The mols. reported here will serve as powerful tools in efforts to extend AS-kinase technol. to the entire kinome and the principles discovered may help in the design of other engineered enzyme/ligand pairs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNjAOxjjP0vLVg90H21EOLACvtfcHk0li7fbVRVhTtYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVOksbfK&md5=678113c290dfa3b3df691cf272595260</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcb400376p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400376p%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DDar%26aufirst%3DA.%2BC.%26aulast%3DLadow%26aufirst%3DE.%26aulast%3DFinkbeiner%26aufirst%3DS.%26aulast%3DYun%26aufirst%3DC.%2BH.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DStructure-guided%2520inhibitor%2520design%2520expands%2520the%2520scope%2520of%2520analog-sensitive%2520kinase%2520technology%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1931%26epage%3D1938%26doi%3D10.1021%2Fcb400376p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Long, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">Structural basis for the potent and selective inhibition of casein kinase 1 epsilon</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10307</span><span class="NLM_x">–</span> <span class="NLM_lpage">10311</span><span class="refDoi"> DOI: 10.1021/jm301336n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301336n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10307-10311&author=A.+M.+Longauthor=H.+Zhaoauthor=X.+Huang&title=Structural+basis+for+the+potent+and+selective+inhibition+of+casein+kinase+1+epsilon&doi=10.1021%2Fjm301336n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm301336n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301336n%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DA.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DStructural%2520basis%2520for%2520the%2520potent%2520and%2520selective%2520inhibition%2520of%2520casein%2520kinase%25201%2520epsilon%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10307%26epage%3D10311%26doi%3D10.1021%2Fjm301336n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Dunay, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span> </span><span class="NLM_article-title">Artemisone and artemiside control acute and reactivated toxoplasmosis in the murine model</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4450</span><span class="NLM_x">–</span> <span class="NLM_lpage">4456</span><span class="refDoi"> DOI: 10.1128/AAC.00502-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FAAC.00502-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=19635951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KkurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=4450-4456&author=I.+R.+Dunayauthor=W.+C.+Chanauthor=R.+K.+Haynesauthor=L.+D.+Sibley&title=Artemisone+and+artemiside+control+acute+and+reactivated+toxoplasmosis+in+the+murine+model&doi=10.1128%2FAAC.00502-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model</span></div><div class="casAuthors">Dunay, Ildiko R.; Chan, Wing Chi; Haynes, Richard K.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4450-4456</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Immunocompromised patients are at risk of developing toxoplasmosis, and although chemotherapy is available, std. treatments are often complicated by severe side effects.  Artemisinin is a new highly potent antimalarial drug that has activity against Toxoplasma gondii in vitro.  However, artemisinin derivs. have previously been ineffective in vivo using a rat model of toxoplasmosis.  In the present study, the efficacy of several new artemisinin derivates was investigated for treatment of mice infected with the parasite Toxoplasma gondii.  Artemiside and artemisone displayed better inhibition than either artemisinin or artesunate against the parasite in vitro.  Artemiside and artemisone treatment controlled parasite replication in vivo, and mice survived the acute infection.  In a murine model of reactivated toxoplasmosis, both drugs increased survival, although artemiside was more effective.  These results indicate that these newer derivs. of artemisinin may have potential for treatment of toxoplasmosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2MtmJjyOHtbVg90H21EOLACvtfcHk0li7fbVRVhTtYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KkurjJ&md5=e86b366adcbd75b40fc3101344613137</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FAAC.00502-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00502-09%26sid%3Dliteratum%253Aachs%26aulast%3DDunay%26aufirst%3DI.%2BR.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DHaynes%26aufirst%3DR.%2BK.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DArtemisone%2520and%2520artemiside%2520control%2520acute%2520and%2520reactivated%2520toxoplasmosis%2520in%2520the%2520murine%2520model%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D4450%26epage%3D4456%26doi%3D10.1128%2FAAC.00502-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Minor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cymborowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chruszcz, M.</span><span> </span><span class="NLM_article-title">HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">866</span><span class="refDoi"> DOI: 10.1107/S0907444906019949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1107%2FS0907444906019949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=16855301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVWksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=859-866&author=W.+Minorauthor=M.+Cymborowskiauthor=Z.+Otwinowskiauthor=M.+Chruszcz&title=HKL-3000%3A+the+integration+of+data+reduction+and+structure+solution%2D%2Dfrom+diffraction+images+to+an+initial+model+in+minutes&doi=10.1107%2FS0907444906019949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">HKL-3000: the integration of data reduction and structure solution - from diffraction images to an initial model in minutes</span></div><div class="casAuthors">Minor, Wladek; Cymborowski, Marcin; Otwinowski, Zbyszek; Chruszcz, Maksymilian</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">859-866</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A new approach that integrates data collection, data redn., phasing and model building significantly accelerates the process of structure detn. and on av. minimizes the no. of data sets and synchrotron time required for structure soln.  Initial testing of the HKL-3000 system (the beta version was named HKL-2000_ph) with more than 140 novel structure detns. has proven its high value for MAD/SAD expts.  The heuristics for choosing the best computational strategy at different data resoln. limits of phasing signal and crystal diffraction are being optimized.  The typical end result is an interpretable electron-d. map with a partially built structure and, in some cases, an almost complete refined model.  The current development is oriented towards very fast structure soln. in order to provide feedback during the diffraction expt.  Work is also proceeding towards improving the quality of phasing calcn. and model building.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0c0DYtjFP7rVg90H21EOLACvtfcHk0ljV9sg4TIBESQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVWksL8%253D&md5=2cd2fe288f954837abb4acae4c008a2f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444906019949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444906019949%26sid%3Dliteratum%253Aachs%26aulast%3DMinor%26aufirst%3DW.%26aulast%3DCymborowski%26aufirst%3DM.%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DChruszcz%26aufirst%3DM.%26atitle%3DHKL-3000%253A%2520the%2520integration%2520of%2520data%2520reduction%2520and%2520structure%2520solution--from%2520diffraction%2520images%2520to%2520an%2520initial%2520model%2520in%2520minutes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D859%26epage%3D866%26doi%3D10.1107%2FS0907444906019949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; W, P.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span> BUSTER version 2.10.0. <span class="NLM_publisher-name">Global Phasing Ltd</span>, <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>.<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bricogne%2C+G.%3B+Blanc%2C+E.%3B+Brandl%2C+M.%3B+Flensburg%2C+C.%3B+Keller%2C+P.%3B+W%2C+P.%3B+Roversi%2C+P.%3B+Sharff%2C+A.%3B+Smart%2C+O.+S.%3B+Vonrhein%2C+C.%3B+Womack%2C+T.+O.+BUSTER+version+2.10.0.+Global+Phasing+Ltd%2C+Cambridge%2C+United+Kingdom.+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0ljV9sg4TIBESQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0ljV9sg4TIBESQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaver-Fay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendall, W. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snoeyink, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span> </span><span class="NLM_article-title">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">W375</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span><span class="refDoi"> DOI: 10.1093/nar/gkm216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1093%2Fnar%2Fgkm216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=17452350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W375-383&author=I.+W.+Davisauthor=A.+Leaver-Fayauthor=V.+B.+Chenauthor=J.+N.+Blockauthor=G.+J.+Kapralauthor=X.+Wangauthor=L.+W.+Murrayauthor=W.+B.+Arendallauthor=J.+Snoeyinkauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+contacts+and+structure+validation+for+proteins+and+nucleic+acids&doi=10.1093%2Fnar%2Fgkm216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span></div><div class="casAuthors">Davis Ian W; Leaver-Fay Andrew; Chen Vincent B; Block Jeremy N; Kapral Gary J; Wang Xueyi; Murray Laura W; Arendall W Bryan 3rd; Snoeyink Jack; Richardson Jane S; Richardson David C</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W375-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MolProbity is a general-purpose web server offering quality validation for 3D structures of proteins, nucleic acids and complexes.  It provides detailed all-atom contact analysis of any steric problems within the molecules as well as updated dihedral-angle diagnostics, and it can calculate and display the H-bond and van der Waals contacts in the interfaces between components.  An integral step in the process is the addition and full optimization of all hydrogen atoms, both polar and nonpolar.  New analysis functions have been added for RNA, for interfaces, and for NMR ensembles.  Additionally, both the web site and major component programs have been rewritten to improve speed, convenience, clarity and integration with other resources.  MolProbity results are reported in multiple forms: as overall numeric scores, as lists or charts of local problems, as downloadable PDB and graphics files, and most notably as informative, manipulable 3D kinemage graphics shown online in the KiNG viewer.  This service is available free to all users at http://molprobity.biochem.duke.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuyhuetoNS59bHMBt0mMIXfW6udTcc2eb0-MW8Vtqn5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D&md5=726ca1e7e162ab2a4a05048f493731fb</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm216%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DLeaver-Fay%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DBlock%26aufirst%3DJ.%2BN.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DSnoeyink%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520contacts%2520and%2520structure%2520validation%2520for%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW375%26epage%3D383%26doi%3D10.1093%2Fnar%2Fgkm216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Molecular Operating Environment (MOE)</span><span class="NLM_x">, 2013.08. </span><span class="NLM_publisher-name">Chemical Computing Group ULC</span>: <span class="NLM_publisher-loc">Montreal, QC, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE%29%2C+2013.08.+Chemical+Computing+Group+ULC%3A+Montreal%2C+QC%2C+Canada%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3D%26pub%3DChemical%2520Computing%2520Group%2520ULC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Fox, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommereim, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigley, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesbron-Delauw, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzik, D. J.</span><span> </span><span class="NLM_article-title">Type II <i>Toxoplasma gondii</i> KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection</span> <span class="citation_source-journal">Eukaryotic Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span><span class="refDoi"> DOI: 10.1128/EC.00297-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FEC.00297-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=21531875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2hs7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=1193-1206&author=B.+A.+Foxauthor=A.+Fallaauthor=L.+M.+Rommereimauthor=T.+Tomitaauthor=J.+P.+Gigleyauthor=C.+Mercierauthor=M.+F.+Cesbron-Delauwauthor=L.+M.+Weissauthor=D.+J.+Bzik&title=Type+II+Toxoplasma+gondii+KU80+knockout+strains+enable+functional+analysis+of+genes+required+for+cyst+development+and+latent+infection&doi=10.1128%2FEC.00297-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection</span></div><div class="casAuthors">Fox, Barbara A.; Falla, Alejandra; Rommereim, Leah M.; Tomita, Tadakimi; Gigley, Jason P.; Mercier, Corinne; Cesbron-Delauw, Marie-France; Weiss, Louis M.; Bzik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Eukaryotic Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1193-1206</span>CODEN:
                <span class="NLM_cas:coden">ECUEA2</span>;
        ISSN:<span class="NLM_cas:issn">1535-9786</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Type II Toxoplasma gondii KU80 knockouts (Δku80) deficient in nonhomologous en joining were developed to delete the dominant pathway mediating random integration of targeting episomes.  Gene targeting frequency in the type II Δku80 Δhxgprt strain measured at the orotate (OPRT) and the uracil (UPRT) phosphoribosyltransferase loci was highly efficient.  To assess the potential of the type II Δku80 Δhxgprt strain to examine gene function affecting cyst biol. and latent stages of infection, we targeted the deletion of four parasite antigen genes (GRA4, GRA6, ROP7, and tgd057) that encode characterized CD8+ T cell epitopes that elicit corresponding antigen-specific CD8+ T cell populations assocd. with control of infection.  Cyst development in these type II mutant strains was not found to be strictly dependent on antigen-specific CD8+ T cell host responses.  In contrast, a significant biol. role was revealed for the dense granule proteins GRA4 and GRA6 in cyst development since brain tissue cyst burdens were drastically reduced specifically in mutant strains with GRA4 and/or GRA6 deleted.  Complementation of the Δgra4 and Δgra6 mutant strains using a functional allele of the deleted GRA coding region placed under the control of the endogenous UPRT locus was found to significantly restore brain cyst burdens.  These results reveal that GRA proteins play a functional role in establishing cyst burdens and latent infection.  Collectively, our results suggest that a type II Δku80 Δhxgprt genetic background enables a higher-throughput functional anal. of the parasite genome to reveal fundamental aspects of parasite biol. controlling virulence, pathogenesis, and transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtmNlE9c1rtLVg90H21EOLACvtfcHk0lgXi2_pfqcXgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2hs7vL&md5=97d29ee067ffaccc82c5dbd04ede19b8</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1128%2FEC.00297-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FEC.00297-10%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DB.%2BA.%26aulast%3DFalla%26aufirst%3DA.%26aulast%3DRommereim%26aufirst%3DL.%2BM.%26aulast%3DTomita%26aufirst%3DT.%26aulast%3DGigley%26aufirst%3DJ.%2BP.%26aulast%3DMercier%26aufirst%3DC.%26aulast%3DCesbron-Delauw%26aufirst%3DM.%2BF.%26aulast%3DWeiss%26aufirst%3DL.%2BM.%26aulast%3DBzik%26aufirst%3DD.%2BJ.%26atitle%3DType%2520II%2520Toxoplasma%2520gondii%2520KU80%2520knockout%2520strains%2520enable%2520functional%2520analysis%2520of%2520genes%2520required%2520for%2520cyst%2520development%2520and%2520latent%2520infection%26jtitle%3DEukaryotic%2520Cell%26date%3D2011%26volume%3D10%26spage%3D1193%26epage%3D1206%26doi%3D10.1128%2FEC.00297-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Tobin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, L. J.</span><span> </span><span class="NLM_article-title">A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1128/IAI.05543-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FIAI.05543-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=22006568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=55-61&author=C.+M.+Tobinauthor=L.+J.+Knoll&title=A+patatin-like+protein+protects+Toxoplasma+gondii+from+degradation+in+a+nitric+oxide-dependent+manner&doi=10.1128%2FIAI.05543-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner</span></div><div class="casAuthors">Tobin, Crystal M.; Knoll, Laura J.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toxoplasma gondii is an obligate intracellular parasite that uses immune cells to disseminate throughout its host.  T. gondii can persist and even slowly replicate in activated host macrophages by reducing the antimicrobial effects of mols. such as nitric oxide (NO).  A T. gondii patatin-like protein called TgPL1 was previously shown to be important for survival in activated macrophages.  Here we show that a T. gondii mutant with a deletion of the TgPL1 gene (ΔTgPL1) is degraded in activated macrophages.  This degrdn. phenotype is abolished by the removal of NO by the use of an inducible NO synthase (iNOS) inhibitor or iNOS-deficient macrophages.  The exogenous addn. of NO to macrophages results in reduced parasite growth but not the degrdn. of ΔTgPL1 parasites.  These results suggest that NO is necessary but not sufficient for the degrdn. of ΔTgPL1 parasites in activated macrophages.  While some patatin-like proteins have phospholipase A2 (PLA2) activity, recombinant TgPL1 purified from Escherichia coli does not have phospholipase activity.  This result was not surprising, as TgPL1 contains a G-to-S change at the predicted catalytic serine residue.  An epitope-tagged version of TgPL1 partially colocalized with a dense granule protein in the parasitophorous vacuole space.  These results may suggest that TgPL1 moves to the parasitophorous vacuole to protect parasites from nitric oxide by an undetd. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU1uPDCKZvk7Vg90H21EOLACvtfcHk0lgXi2_pfqcXgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlGitw%253D%253D&md5=4adbe39d3ed61bdd9d57a539cbe58e5f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FIAI.05543-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.05543-11%26sid%3Dliteratum%253Aachs%26aulast%3DTobin%26aufirst%3DC.%2BM.%26aulast%3DKnoll%26aufirst%3DL.%2BJ.%26atitle%3DA%2520patatin-like%2520protein%2520protects%2520Toxoplasma%2520gondii%2520from%2520degradation%2520in%2520a%2520nitric%2520oxide-dependent%2520manner%26jtitle%3DInfect.%2520Immun.%26date%3D2012%26volume%3D80%26spage%3D55%26epage%3D61%26doi%3D10.1128%2FIAI.05543-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Wang, Z. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, L. D.</span><span> </span><span class="NLM_article-title">Reassessment of the role of aromatic amino acid hydroxylases and the effect of infection by <i>Toxoplasma gondii</i> on host dopamine</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span><span class="refDoi"> DOI: 10.1128/IAI.02465-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1128%2FIAI.02465-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=25547791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFKrtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2015&pages=1039-1047&author=Z.+T.+Wangauthor=S.+Harmonauthor=K.+L.+O%E2%80%99Malleyauthor=L.+D.+Sibley&title=Reassessment+of+the+role+of+aromatic+amino+acid+hydroxylases+and+the+effect+of+infection+by+Toxoplasma+gondii+on+host+dopamine&doi=10.1128%2FIAI.02465-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Reassessment of the role of aromatic amino acid hydroxylases and the effect of infection by Toxoplasma gondii on host dopamine</span></div><div class="casAuthors">Wang, Zi T.; Harmon, Steve; O'Malley, Karen L.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1039-1047, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">1098-5522</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toxoplasma gondii infection has been described previously to cause infected mice to lose their fear of cat urine.  This behavioral manipulation has been proposed to involve alterations of host dopamine pathways due to parasite-encoded arom. amino acid hydroxylases.  Here, we report successful knockout and complementation of the arom. amino acid hydroxylase AAH2 gene, with no observable phenotype in parasite growth or differentiation in vitro and in vivo.  Addnl., expression levels of the two arom. amino acid hydroxylases were negligible both in tachyzoites and in bradyzoites.  Finally, we were unable to confirm previously described effects of parasite infection on host dopamine either in vitro or in vivo, even when AAH2 was overexpressed using the BAG1 promoter.  Together, these data indicate that AAH enzymes in the parasite do not cause global or regional alterations of dopamine in the host brain; although, they may affect this pathway locally.  Addnl., our findings suggest alternative roles for the AHH enzymes in T. gondii, since AAH1 is essential for growth in nondopaminergic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQLlcjGlRoV7Vg90H21EOLACvtfcHk0lgU22Ryd7Bdjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFKrtr8%253D&md5=e641c4048811b23c61689578c1da1d37</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1128%2FIAI.02465-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.02465-14%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%2BT.%26aulast%3DHarmon%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DK.%2BL.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DReassessment%2520of%2520the%2520role%2520of%2520aromatic%2520amino%2520acid%2520hydroxylases%2520and%2520the%2520effect%2520of%2520infection%2520by%2520Toxoplasma%2520gondii%2520on%2520host%2520dopamine%26jtitle%3DInfect.%2520Immun.%26date%3D2015%26volume%3D83%26spage%3D1039%26epage%3D1047%26doi%3D10.1128%2FIAI.02465-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Eid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rippmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulle, S.</span><span> </span><span class="NLM_article-title">KinMap: a web-based tool for interactive navigation through human kinome data</span> <span class="citation_source-journal">BMC Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="refDoi"> DOI: 10.1186/s12859-016-1433-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=10.1186%2Fs12859-016-1433-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=28056780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=16&author=S.+Eidauthor=S.+Turkauthor=A.+Volkamerauthor=F.+Rippmannauthor=S.+Fulle&title=KinMap%3A+a+web-based+tool+for+interactive+navigation+through+human+kinome+data&doi=10.1186%2Fs12859-016-1433-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">KinMap: a web-based tool for interactive navigation through human kinome data</span></div><div class="casAuthors">Eid, Sameh; Turk, Samo; Volkamer, Andrea; Rippmann, Friedrich; Fulle, Simone</div><div class="citationInfo"><span class="NLM_cas:title">BMC Bioinformatics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16/1-16/6</span>CODEN:
                <span class="NLM_cas:coden">BBMIC4</span>;
        ISSN:<span class="NLM_cas:issn">1471-2105</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Annotations of the phylogenetic tree of the human kinome is an intuitive way to visualize compd. profiling data, structural features of kinases or functional relationships within this important class of proteins.  The increasing vol. and complexity of kinase-related data underlines the need for a tool that enables complex queries pertaining to kinase disease involvement and potential therapeutic uses of kinase inhibitors.  Results: Here, we present KinMap, a user-friendly online tool that facilitates the interactive navigation through kinase knowledge by linking biochem., structural, and disease assocn. data to the human kinome tree.  To this end, preprocessed data from freely-available sources, such as ChEMBL, the Protein Data Bank, and the Center for Therapeutic Target Validation platform are integrated into KinMap and can easily be complemented by proprietary data.  The value of KinMap will be exemplarily demonstrated for uncovering new therapeutic indications of known kinase inhibitors and for prioritizing kinases for drug development efforts.  Conclusions: KinMap represents a new generation of kinome tree viewers which facilitates interactive exploration of the human kinome.  KinMap enables generation of high-quality annotated images of the human kinome tree as well as exchange of kinome-related data in scientific communications.  Furthermore, KinMap supports multiple input and output formats and recognizes alternative kinase names and links them to a unified naming scheme, which makes it a useful tool across different disciplines and applications.  A web-service of KinMap is freely available at http://www.kinhub.org/kinmap/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1M2aa8fuKALVg90H21EOLACvtfcHk0lgU22Ryd7Bdjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCjtLc%253D&md5=29737c7cda8d9caf75018e0d29e9a459</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1186%2Fs12859-016-1433-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12859-016-1433-7%26sid%3Dliteratum%253Aachs%26aulast%3DEid%26aufirst%3DS.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DVolkamer%26aufirst%3DA.%26aulast%3DRippmann%26aufirst%3DF.%26aulast%3DFulle%26aufirst%3DS.%26atitle%3DKinMap%253A%2520a%2520web-based%2520tool%2520for%2520interactive%2520navigation%2520through%2520human%2520kinome%2520data%26jtitle%3DBMC%2520Bioinf.%26date%3D2017%26volume%3D18%26spage%3D16%26doi%3D10.1186%2Fs12859-016-1433-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W9E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W9E','PDB','5W9E'); return false;">PDB: 5W9E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W8R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W8R','PDB','5W8R'); return false;">PDB: 5W8R</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=41H8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=41H8','PDB','41H8'); return false;">PDB: 41H8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W80" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W80','PDB','5W80'); return false;">PDB: 5W80</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W91" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W91','PDB','5W91'); return false;">PDB: 5W91</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IHP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IHP','PDB','4IHP'); return false;">PDB: 4IHP</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i36"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01192">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_13317"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01192">10.1021/acs.jmedchem.7b01192</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Compound synthesis, characterization, metabolism analysis, X-ray crystallography information, kinome profiling (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Compound <b>24</b> homology model (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_001.pdf">jm7b01192_si_001.pdf (9.83 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_002.pdb">jm7b01192_si_002.pdb (657.58 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01192/suppl_file/jm7b01192_si_003.csv">jm7b01192_si_003.csv (2.29 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The structure factors and pdb coordinates have been deposited at the protein databank (PDB) with the coordinates <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IHP">4IHP</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W8R">5W8R</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W80">5W80</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W9E">5W9E</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W91">5W91</a>. Compound 24 was modeled using the co-crystal structure of compound 13 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W9E">5W9E</a>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01192&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-24%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01192%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01192" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679985fb2bbb3cfa","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
